{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "31977de5",
   "metadata": {},
   "source": [
    "**Notes:**\n",
    "* This code takes the data Phase2_Phase4 filtered data created in previous step and adds more features from AACT database\n",
    "* Additional features are added from these AACT tables - calculated values, eligibilities, officials and countries\n",
    "* Also relevant years of clinical trials starting from 1987 and ending 2024 are only considered\n",
    "* Features are also added from SLM/LLM models - 1. Pregnant Women inclusion, 2. Criteria Robustness, and 3. Human Important Rating"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 104,
   "id": "58dc56b5",
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np\n",
    "from scipy import stats\n",
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "pd.set_option('display.max_columns', None)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 105,
   "id": "f7dcfbf9",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>conditions</th>\n",
       "      <th>disease_type</th>\n",
       "      <th>new_therapy_area</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>rhinitis</td>\n",
       "      <td>Allergic Rhinitis</td>\n",
       "      <td>Respiratory</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>allergic rhinitis</td>\n",
       "      <td>Allergic Rhinitis</td>\n",
       "      <td>Respiratory</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>seasonal allergic rhinitis</td>\n",
       "      <td>Allergic Rhinitis</td>\n",
       "      <td>Respiratory</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>acute rhinosinusitis</td>\n",
       "      <td>Allergic Rhinitis</td>\n",
       "      <td>Respiratory</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>allergic rhino-conjunctivitis</td>\n",
       "      <td>Allergic Rhinitis</td>\n",
       "      <td>Respiratory</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                      conditions       disease_type new_therapy_area\n",
       "0                       rhinitis  Allergic Rhinitis      Respiratory\n",
       "1              allergic rhinitis  Allergic Rhinitis      Respiratory\n",
       "2     seasonal allergic rhinitis  Allergic Rhinitis      Respiratory\n",
       "3           acute rhinosinusitis  Allergic Rhinitis      Respiratory\n",
       "4  allergic rhino-conjunctivitis  Allergic Rhinitis      Respiratory"
      ]
     },
     "execution_count": 105,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# load the conditions to disease type to therapy area mapping\n",
    "df_conditions_ta = pd.read_csv('nov_24/nov_23/df_conditions_ta.txt', sep='|')\n",
    "df_conditions_ta = df_conditions_ta.drop(columns=['Unnamed: 0'])\n",
    "df_conditions_ta.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 106,
   "id": "0f8aca61",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/tmp/ipykernel_139334/3688438151.py:2: DtypeWarning: Columns (24) have mixed types. Specify dtype option on import or set low_memory=False.\n",
      "  df_merged_1021_p2_p4 = pd.read_csv('nov_24/merged_df_1021_p2_p4filter.csv', sep='|')\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0.1</th>\n",
       "      <th>nct_id</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>description</th>\n",
       "      <th>trial_drug_cleaned</th>\n",
       "      <th>conditions</th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>Drug Name</th>\n",
       "      <th>Highest Status</th>\n",
       "      <th>Other Drug Names</th>\n",
       "      <th>Originator Company</th>\n",
       "      <th>Originator Company HQ</th>\n",
       "      <th>Active Companies</th>\n",
       "      <th>Active Companies HQ</th>\n",
       "      <th>Therapy Area</th>\n",
       "      <th>Active Indications</th>\n",
       "      <th>Action</th>\n",
       "      <th>Technologies</th>\n",
       "      <th>Regulatory Designations</th>\n",
       "      <th>Inactive Indications</th>\n",
       "      <th>Inactive Companies</th>\n",
       "      <th>Has Deals</th>\n",
       "      <th>Last Change Date</th>\n",
       "      <th>Added Date</th>\n",
       "      <th>First Launched Date</th>\n",
       "      <th>Extract</th>\n",
       "      <th>Drug Id</th>\n",
       "      <th>cortellis_cleaned_drug</th>\n",
       "      <th>nlm_download_date_description</th>\n",
       "      <th>study_first_submitted_date</th>\n",
       "      <th>results_first_submitted_date</th>\n",
       "      <th>disposition_first_submitted_date</th>\n",
       "      <th>last_update_submitted_date</th>\n",
       "      <th>study_first_submitted_qc_date</th>\n",
       "      <th>study_first_posted_date</th>\n",
       "      <th>study_first_posted_date_type</th>\n",
       "      <th>results_first_submitted_qc_date</th>\n",
       "      <th>results_first_posted_date</th>\n",
       "      <th>results_first_posted_date_type</th>\n",
       "      <th>disposition_first_submitted_qc_date</th>\n",
       "      <th>disposition_first_posted_date</th>\n",
       "      <th>disposition_first_posted_date_type</th>\n",
       "      <th>last_update_submitted_qc_date</th>\n",
       "      <th>last_update_posted_date</th>\n",
       "      <th>last_update_posted_date_type</th>\n",
       "      <th>start_month_year</th>\n",
       "      <th>start_date_type</th>\n",
       "      <th>start_date</th>\n",
       "      <th>verification_month_year</th>\n",
       "      <th>verification_date</th>\n",
       "      <th>completion_month_year</th>\n",
       "      <th>completion_date_type</th>\n",
       "      <th>completion_date</th>\n",
       "      <th>primary_completion_month_year</th>\n",
       "      <th>primary_completion_date_type</th>\n",
       "      <th>primary_completion_date</th>\n",
       "      <th>target_duration</th>\n",
       "      <th>study_type</th>\n",
       "      <th>acronym</th>\n",
       "      <th>baseline_population</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>official_title</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>last_known_status</th>\n",
       "      <th>phase</th>\n",
       "      <th>enrollment</th>\n",
       "      <th>enrollment_type</th>\n",
       "      <th>source</th>\n",
       "      <th>limitations_and_caveats</th>\n",
       "      <th>number_of_arms</th>\n",
       "      <th>number_of_groups</th>\n",
       "      <th>why_stopped</th>\n",
       "      <th>has_expanded_access</th>\n",
       "      <th>expanded_access_type_individual</th>\n",
       "      <th>expanded_access_type_intermediate</th>\n",
       "      <th>expanded_access_type_treatment</th>\n",
       "      <th>has_dmc</th>\n",
       "      <th>is_fda_regulated_drug</th>\n",
       "      <th>is_fda_regulated_device</th>\n",
       "      <th>is_unapproved_device</th>\n",
       "      <th>is_ppsd</th>\n",
       "      <th>is_us_export</th>\n",
       "      <th>biospec_retention</th>\n",
       "      <th>biospec_description</th>\n",
       "      <th>ipd_time_frame</th>\n",
       "      <th>ipd_access_criteria</th>\n",
       "      <th>ipd_url</th>\n",
       "      <th>plan_to_share_ipd</th>\n",
       "      <th>plan_to_share_ipd_description</th>\n",
       "      <th>created_at</th>\n",
       "      <th>updated_at</th>\n",
       "      <th>source_class</th>\n",
       "      <th>delayed_posting</th>\n",
       "      <th>expanded_access_nctid</th>\n",
       "      <th>expanded_access_status_for_nctid</th>\n",
       "      <th>fdaaa801_violation</th>\n",
       "      <th>baseline_type_units_analyzed</th>\n",
       "      <th>patient_registry</th>\n",
       "      <th>drug_outcome</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>4966</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>NCT04165031</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>Administered orally</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>4966</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2019-11-15</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>2021-10</td>\n",
       "      <td>2021-10-31</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>All participants who received at least one dos...</td>\n",
       "      <td>A Study of LY3499446 in Participants With Adva...</td>\n",
       "      <td>A Phase 1/2 Study of LY3499446 Administered to...</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE1/PHASE2</td>\n",
       "      <td>5.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Data are available 6 months after the primary ...</td>\n",
       "      <td>A research proposal must be approved by an ind...</td>\n",
       "      <td>https://vivli.org/</td>\n",
       "      <td>YES</td>\n",
       "      <td>Anonymized individual patient level data will ...</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>NCT02574078</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>NaN</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>4966</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2015-10-09</td>\n",
       "      <td>2021-03-15</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-04-12</td>\n",
       "      <td>2015-10-09</td>\n",
       "      <td>2015-10-12</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2021-04-12</td>\n",
       "      <td>2021-05-06</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-04-12</td>\n",
       "      <td>2021-05-06</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2015-11-23</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2015-11-23</td>\n",
       "      <td>2021-04</td>\n",
       "      <td>2021-04-30</td>\n",
       "      <td>2020-04-15</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-04-15</td>\n",
       "      <td>2020-04-15</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-04-15</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>CheckMate370</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A Study of Nivolumab in Advanced Non-Small Cel...</td>\n",
       "      <td>A Master Protocol of Phase 1/2 Studies of Nivo...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE1/PHASE2</td>\n",
       "      <td>341.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Bristol-Myers Squibb</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 07:48:14.913206</td>\n",
       "      <td>2024-08-04 07:48:14.913206</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>NCT00840125</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150mg tablet daily</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>4966</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2009-02-09</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2012-10-29</td>\n",
       "      <td>2009-02-09</td>\n",
       "      <td>2009-02-10</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2012-10-29</td>\n",
       "      <td>2012-10-30</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2009-02</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2009-02-28</td>\n",
       "      <td>2012-10</td>\n",
       "      <td>2012-10-31</td>\n",
       "      <td>2011-08</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2011-08-31</td>\n",
       "      <td>2010-12</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-12-31</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Erlotinib With Docetaxel in Selected ...</td>\n",
       "      <td>A Phase II Open-Label Study Designed to Evalua...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>4.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Meir Medical Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-09 19:59:10.21038</td>\n",
       "      <td>2024-08-09 19:59:10.21038</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>NCT00563784</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg by mouth daily for 7 Weeks</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>4966</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2007-11-21</td>\n",
       "      <td>2019-09-03</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-11-18</td>\n",
       "      <td>2007-11-23</td>\n",
       "      <td>2007-11-26</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2019-11-18</td>\n",
       "      <td>2019-11-20</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-11-18</td>\n",
       "      <td>2019-11-20</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2007-11</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2007-11-30</td>\n",
       "      <td>2019-11</td>\n",
       "      <td>2019-11-30</td>\n",
       "      <td>2018-05-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2018-05-30</td>\n",
       "      <td>2018-05-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2018-05-30</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>48 patients registered and treated under the p...</td>\n",
       "      <td>TARCEVA (Erlotinib) in Combination With Chemor...</td>\n",
       "      <td>A Phase II Study of TARCEVA (Erlotinib) in Com...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>68.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>M.D. Anderson Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 12:54:21.848967</td>\n",
       "      <td>2024-08-04 12:54:21.848967</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Unnamed: 0.1       nct_id intervention_type  \\\n",
       "0             0  NCT00606502              DRUG   \n",
       "1             1  NCT04165031              DRUG   \n",
       "2             2  NCT02574078              DRUG   \n",
       "3             3  NCT00840125              DRUG   \n",
       "4             4  NCT00563784              DRUG   \n",
       "\n",
       "                                         description trial_drug_cleaned  \\\n",
       "0  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "1                                Administered orally          erlotinib   \n",
       "2                                                NaN          erlotinib   \n",
       "3                                 150mg tablet daily          erlotinib   \n",
       "4                  150 mg by mouth daily for 7 Weeks          erlotinib   \n",
       "\n",
       "                   conditions  Unnamed: 0  Drug Name Highest Status  \\\n",
       "0  non-small cell lung cancer        4966  erlotinib       Launched   \n",
       "1  non-small cell lung cancer        4966  erlotinib       Launched   \n",
       "2  non-small cell lung cancer        4966  erlotinib       Launched   \n",
       "3  non-small cell lung cancer        4966  erlotinib       Launched   \n",
       "4  non-small cell lung cancer        4966  erlotinib       Launched   \n",
       "\n",
       "                                    Other Drug Names       Originator Company  \\\n",
       "0  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "1  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "2  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "3  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "4  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "\n",
       "          Originator Company HQ  \\\n",
       "0  OSI Pharmaceuticals Inc (US)   \n",
       "1  OSI Pharmaceuticals Inc (US)   \n",
       "2  OSI Pharmaceuticals Inc (US)   \n",
       "3  OSI Pharmaceuticals Inc (US)   \n",
       "4  OSI Pharmaceuticals Inc (US)   \n",
       "\n",
       "                                    Active Companies  \\\n",
       "0  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "1  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "2  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "3  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "4  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "\n",
       "                                 Active Companies HQ          Therapy Area  \\\n",
       "0  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "1  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "2  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "3  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "4  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "\n",
       "                                  Active Indications  \\\n",
       "0  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "1  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "2  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "3  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "4  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "\n",
       "                                              Action  \\\n",
       "0  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "1  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "2  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "3  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "4  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "\n",
       "                                        Technologies  Regulatory Designations  \\\n",
       "0  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "1  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "2  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "3  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "4  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "\n",
       "                                Inactive Indications  \\\n",
       "0  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "1  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "2  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "3  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "4  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "\n",
       "            Inactive Companies Has Deals Last Change Date  Added Date  \\\n",
       "0  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "1  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "2  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "3  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "4  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "\n",
       "  First Launched Date                                            Extract  \\\n",
       "0          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "1          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "2          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "3          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "4          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "\n",
       "   Drug Id cortellis_cleaned_drug  nlm_download_date_description  \\\n",
       "0    11961              erlotinib                            NaN   \n",
       "1    11961              erlotinib                            NaN   \n",
       "2    11961              erlotinib                            NaN   \n",
       "3    11961              erlotinib                            NaN   \n",
       "4    11961              erlotinib                            NaN   \n",
       "\n",
       "  study_first_submitted_date results_first_submitted_date  \\\n",
       "0                 2008-01-22                   2010-12-22   \n",
       "1                 2019-11-14                   2021-10-27   \n",
       "2                 2015-10-09                   2021-03-15   \n",
       "3                 2009-02-09                          NaN   \n",
       "4                 2007-11-21                   2019-09-03   \n",
       "\n",
       "  disposition_first_submitted_date last_update_submitted_date  \\\n",
       "0                              NaN                 2021-02-08   \n",
       "1                              NaN                 2021-10-27   \n",
       "2                              NaN                 2021-04-12   \n",
       "3                              NaN                 2012-10-29   \n",
       "4                              NaN                 2019-11-18   \n",
       "\n",
       "  study_first_submitted_qc_date study_first_posted_date  \\\n",
       "0                    2008-02-01              2008-02-04   \n",
       "1                    2019-11-14              2019-11-15   \n",
       "2                    2015-10-09              2015-10-12   \n",
       "3                    2009-02-09              2009-02-10   \n",
       "4                    2007-11-23              2007-11-26   \n",
       "\n",
       "  study_first_posted_date_type results_first_submitted_qc_date  \\\n",
       "0                    ESTIMATED                      2010-12-22   \n",
       "1                       ACTUAL                      2021-10-27   \n",
       "2                    ESTIMATED                      2021-04-12   \n",
       "3                    ESTIMATED                             NaN   \n",
       "4                    ESTIMATED                      2019-11-18   \n",
       "\n",
       "  results_first_posted_date results_first_posted_date_type  \\\n",
       "0                2011-01-20                      ESTIMATED   \n",
       "1                2021-11-24                         ACTUAL   \n",
       "2                2021-05-06                         ACTUAL   \n",
       "3                       NaN                            NaN   \n",
       "4                2019-11-20                         ACTUAL   \n",
       "\n",
       "  disposition_first_submitted_qc_date disposition_first_posted_date  \\\n",
       "0                                 NaN                           NaN   \n",
       "1                                 NaN                           NaN   \n",
       "2                                 NaN                           NaN   \n",
       "3                                 NaN                           NaN   \n",
       "4                                 NaN                           NaN   \n",
       "\n",
       "  disposition_first_posted_date_type last_update_submitted_qc_date  \\\n",
       "0                                NaN                    2021-02-08   \n",
       "1                                NaN                    2021-10-27   \n",
       "2                                NaN                    2021-04-12   \n",
       "3                                NaN                    2012-10-29   \n",
       "4                                NaN                    2019-11-18   \n",
       "\n",
       "  last_update_posted_date last_update_posted_date_type start_month_year  \\\n",
       "0              2021-03-05                       ACTUAL          2008-01   \n",
       "1              2021-11-24                       ACTUAL       2019-11-28   \n",
       "2              2021-05-06                       ACTUAL       2015-11-23   \n",
       "3              2012-10-30                    ESTIMATED          2009-02   \n",
       "4              2019-11-20                       ACTUAL          2007-11   \n",
       "\n",
       "  start_date_type  start_date verification_month_year verification_date  \\\n",
       "0             NaN  2008-01-31                 2021-02        2021-02-28   \n",
       "1          ACTUAL  2019-11-28                 2021-10        2021-10-31   \n",
       "2          ACTUAL  2015-11-23                 2021-04        2021-04-30   \n",
       "3             NaN  2009-02-28                 2012-10        2012-10-31   \n",
       "4          ACTUAL  2007-11-30                 2019-11        2019-11-30   \n",
       "\n",
       "  completion_month_year completion_date_type completion_date  \\\n",
       "0            2010-06-24               ACTUAL      2010-06-24   \n",
       "1            2020-10-30               ACTUAL      2020-10-30   \n",
       "2            2020-04-15               ACTUAL      2020-04-15   \n",
       "3               2011-08               ACTUAL      2011-08-31   \n",
       "4            2018-05-30               ACTUAL      2018-05-30   \n",
       "\n",
       "  primary_completion_month_year primary_completion_date_type  \\\n",
       "0                    2010-06-24                       ACTUAL   \n",
       "1                    2020-10-30                       ACTUAL   \n",
       "2                    2020-04-15                       ACTUAL   \n",
       "3                       2010-12                       ACTUAL   \n",
       "4                    2018-05-30                       ACTUAL   \n",
       "\n",
       "  primary_completion_date  target_duration      study_type       acronym  \\\n",
       "0              2010-06-24              NaN  INTERVENTIONAL           NaN   \n",
       "1              2020-10-30              NaN  INTERVENTIONAL           NaN   \n",
       "2              2020-04-15              NaN  INTERVENTIONAL  CheckMate370   \n",
       "3              2010-12-31              NaN  INTERVENTIONAL           NaN   \n",
       "4              2018-05-30              NaN  INTERVENTIONAL           NaN   \n",
       "\n",
       "                                 baseline_population  \\\n",
       "0                                                NaN   \n",
       "1  All participants who received at least one dos...   \n",
       "2                                                NaN   \n",
       "3                                                NaN   \n",
       "4  48 patients registered and treated under the p...   \n",
       "\n",
       "                                         brief_title  \\\n",
       "0  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "1  A Study of LY3499446 in Participants With Adva...   \n",
       "2  A Study of Nivolumab in Advanced Non-Small Cel...   \n",
       "3  Study of Erlotinib With Docetaxel in Selected ...   \n",
       "4  TARCEVA (Erlotinib) in Combination With Chemor...   \n",
       "\n",
       "                                      official_title overall_status  \\\n",
       "0  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "1  A Phase 1/2 Study of LY3499446 Administered to...     TERMINATED   \n",
       "2  A Master Protocol of Phase 1/2 Studies of Nivo...      COMPLETED   \n",
       "3  A Phase II Open-Label Study Designed to Evalua...      COMPLETED   \n",
       "4  A Phase II Study of TARCEVA (Erlotinib) in Com...      COMPLETED   \n",
       "\n",
       "   last_known_status          phase  enrollment enrollment_type  \\\n",
       "0                NaN         PHASE2       201.0          ACTUAL   \n",
       "1                NaN  PHASE1/PHASE2         5.0          ACTUAL   \n",
       "2                NaN  PHASE1/PHASE2       341.0          ACTUAL   \n",
       "3                NaN         PHASE2         4.0          ACTUAL   \n",
       "4                NaN         PHASE2        68.0          ACTUAL   \n",
       "\n",
       "                          source  \\\n",
       "0  Spectrum Pharmaceuticals, Inc   \n",
       "1          Eli Lilly and Company   \n",
       "2           Bristol-Myers Squibb   \n",
       "3            Meir Medical Center   \n",
       "4    M.D. Anderson Cancer Center   \n",
       "\n",
       "                             limitations_and_caveats  number_of_arms  \\\n",
       "0  The date of the CRF database cut-off for patie...             2.0   \n",
       "1  The study was terminated due to an unexpected ...             6.0   \n",
       "2                                                NaN            10.0   \n",
       "3                                                NaN             1.0   \n",
       "4                                                NaN             1.0   \n",
       "\n",
       "   number_of_groups                                        why_stopped  \\\n",
       "0               NaN                                                NaN   \n",
       "1               NaN  The study was terminated due to an unexpected ...   \n",
       "2               NaN                                                NaN   \n",
       "3               NaN                                                NaN   \n",
       "4               NaN                                                NaN   \n",
       "\n",
       "  has_expanded_access  expanded_access_type_individual  \\\n",
       "0                   f                              NaN   \n",
       "1                   f                              NaN   \n",
       "2                   f                              NaN   \n",
       "3                   f                              NaN   \n",
       "4                   f                              NaN   \n",
       "\n",
       "   expanded_access_type_intermediate  expanded_access_type_treatment has_dmc  \\\n",
       "0                                NaN                             NaN     NaN   \n",
       "1                                NaN                             NaN       f   \n",
       "2                                NaN                             NaN       t   \n",
       "3                                NaN                             NaN       t   \n",
       "4                                NaN                             NaN       f   \n",
       "\n",
       "  is_fda_regulated_drug is_fda_regulated_device is_unapproved_device  is_ppsd  \\\n",
       "0                   NaN                     NaN                  NaN      NaN   \n",
       "1                     t                       f                  NaN      NaN   \n",
       "2                   NaN                     NaN                  NaN      NaN   \n",
       "3                   NaN                     NaN                  NaN      NaN   \n",
       "4                     t                       f                  NaN      NaN   \n",
       "\n",
       "  is_us_export  biospec_retention  biospec_description  \\\n",
       "0          NaN                NaN                  NaN   \n",
       "1          NaN                NaN                  NaN   \n",
       "2          NaN                NaN                  NaN   \n",
       "3          NaN                NaN                  NaN   \n",
       "4          NaN                NaN                  NaN   \n",
       "\n",
       "                                      ipd_time_frame  \\\n",
       "0                                                NaN   \n",
       "1  Data are available 6 months after the primary ...   \n",
       "2                                                NaN   \n",
       "3                                                NaN   \n",
       "4                                                NaN   \n",
       "\n",
       "                                 ipd_access_criteria             ipd_url  \\\n",
       "0                                                NaN                 NaN   \n",
       "1  A research proposal must be approved by an ind...  https://vivli.org/   \n",
       "2                                                NaN                 NaN   \n",
       "3                                                NaN                 NaN   \n",
       "4                                                NaN                 NaN   \n",
       "\n",
       "  plan_to_share_ipd                      plan_to_share_ipd_description  \\\n",
       "0               NaN                                                NaN   \n",
       "1               YES  Anonymized individual patient level data will ...   \n",
       "2               NaN                                                NaN   \n",
       "3               NaN                                                NaN   \n",
       "4               NaN                                                NaN   \n",
       "\n",
       "                   created_at                  updated_at source_class  \\\n",
       "0  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "1  2024-08-10 03:04:24.451964  2024-08-10 03:04:24.451964     INDUSTRY   \n",
       "2  2024-08-04 07:48:14.913206  2024-08-04 07:48:14.913206     INDUSTRY   \n",
       "3   2024-08-09 19:59:10.21038   2024-08-09 19:59:10.21038        OTHER   \n",
       "4  2024-08-04 12:54:21.848967  2024-08-04 12:54:21.848967        OTHER   \n",
       "\n",
       "   delayed_posting expanded_access_nctid expanded_access_status_for_nctid  \\\n",
       "0              NaN                   NaN                              NaN   \n",
       "1              NaN                   NaN                              NaN   \n",
       "2              NaN                   NaN                              NaN   \n",
       "3              NaN                   NaN                              NaN   \n",
       "4              NaN                   NaN                              NaN   \n",
       "\n",
       "   fdaaa801_violation  baseline_type_units_analyzed  patient_registry  \\\n",
       "0                 NaN                           NaN               NaN   \n",
       "1                 NaN                           NaN               NaN   \n",
       "2                 NaN                           NaN               NaN   \n",
       "3                 NaN                           NaN               NaN   \n",
       "4                 NaN                           NaN               NaN   \n",
       "\n",
       "  drug_outcome  \n",
       "0      success  \n",
       "1      success  \n",
       "2      success  \n",
       "3      success  \n",
       "4      success  "
      ]
     },
     "execution_count": 106,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# load the dataset with phase 2 and phase 4 trials filtered\n",
    "df_merged_1021_p2_p4 = pd.read_csv('nov_24/merged_df_1021_p2_p4filter.csv', sep='|')\n",
    "df_merged_1021_p2_p4.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 118,
   "id": "1a4d9997",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nct_id</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>description</th>\n",
       "      <th>trial_drug_cleaned</th>\n",
       "      <th>conditions</th>\n",
       "      <th>Drug Name</th>\n",
       "      <th>Highest Status</th>\n",
       "      <th>Other Drug Names</th>\n",
       "      <th>Originator Company</th>\n",
       "      <th>Originator Company HQ</th>\n",
       "      <th>Active Companies</th>\n",
       "      <th>Active Companies HQ</th>\n",
       "      <th>Therapy Area</th>\n",
       "      <th>Active Indications</th>\n",
       "      <th>Action</th>\n",
       "      <th>Technologies</th>\n",
       "      <th>Regulatory Designations</th>\n",
       "      <th>Inactive Indications</th>\n",
       "      <th>Inactive Companies</th>\n",
       "      <th>Has Deals</th>\n",
       "      <th>Last Change Date</th>\n",
       "      <th>Added Date</th>\n",
       "      <th>First Launched Date</th>\n",
       "      <th>Extract</th>\n",
       "      <th>Drug Id</th>\n",
       "      <th>cortellis_cleaned_drug</th>\n",
       "      <th>nlm_download_date_description</th>\n",
       "      <th>study_first_submitted_date</th>\n",
       "      <th>results_first_submitted_date</th>\n",
       "      <th>disposition_first_submitted_date</th>\n",
       "      <th>last_update_submitted_date</th>\n",
       "      <th>study_first_submitted_qc_date</th>\n",
       "      <th>study_first_posted_date</th>\n",
       "      <th>study_first_posted_date_type</th>\n",
       "      <th>results_first_submitted_qc_date</th>\n",
       "      <th>results_first_posted_date</th>\n",
       "      <th>results_first_posted_date_type</th>\n",
       "      <th>disposition_first_submitted_qc_date</th>\n",
       "      <th>disposition_first_posted_date</th>\n",
       "      <th>disposition_first_posted_date_type</th>\n",
       "      <th>last_update_submitted_qc_date</th>\n",
       "      <th>last_update_posted_date</th>\n",
       "      <th>last_update_posted_date_type</th>\n",
       "      <th>start_month_year</th>\n",
       "      <th>start_date_type</th>\n",
       "      <th>start_date</th>\n",
       "      <th>verification_month_year</th>\n",
       "      <th>verification_date</th>\n",
       "      <th>completion_month_year</th>\n",
       "      <th>completion_date_type</th>\n",
       "      <th>completion_date</th>\n",
       "      <th>primary_completion_month_year</th>\n",
       "      <th>primary_completion_date_type</th>\n",
       "      <th>primary_completion_date</th>\n",
       "      <th>target_duration</th>\n",
       "      <th>study_type</th>\n",
       "      <th>acronym</th>\n",
       "      <th>baseline_population</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>official_title</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>last_known_status</th>\n",
       "      <th>phase</th>\n",
       "      <th>enrollment</th>\n",
       "      <th>enrollment_type</th>\n",
       "      <th>source</th>\n",
       "      <th>limitations_and_caveats</th>\n",
       "      <th>number_of_arms</th>\n",
       "      <th>number_of_groups</th>\n",
       "      <th>why_stopped</th>\n",
       "      <th>has_expanded_access</th>\n",
       "      <th>expanded_access_type_individual</th>\n",
       "      <th>expanded_access_type_intermediate</th>\n",
       "      <th>expanded_access_type_treatment</th>\n",
       "      <th>has_dmc</th>\n",
       "      <th>is_fda_regulated_drug</th>\n",
       "      <th>is_fda_regulated_device</th>\n",
       "      <th>is_unapproved_device</th>\n",
       "      <th>is_ppsd</th>\n",
       "      <th>is_us_export</th>\n",
       "      <th>biospec_retention</th>\n",
       "      <th>biospec_description</th>\n",
       "      <th>ipd_time_frame</th>\n",
       "      <th>ipd_access_criteria</th>\n",
       "      <th>ipd_url</th>\n",
       "      <th>plan_to_share_ipd</th>\n",
       "      <th>plan_to_share_ipd_description</th>\n",
       "      <th>created_at</th>\n",
       "      <th>updated_at</th>\n",
       "      <th>source_class</th>\n",
       "      <th>delayed_posting</th>\n",
       "      <th>expanded_access_nctid</th>\n",
       "      <th>expanded_access_status_for_nctid</th>\n",
       "      <th>fdaaa801_violation</th>\n",
       "      <th>baseline_type_units_analyzed</th>\n",
       "      <th>patient_registry</th>\n",
       "      <th>drug_outcome</th>\n",
       "      <th>disease_type</th>\n",
       "      <th>new_therapy_area</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT04165031</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>Administered orally</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2019-11-15</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>2021-10</td>\n",
       "      <td>2021-10-31</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>All participants who received at least one dos...</td>\n",
       "      <td>A Study of LY3499446 in Participants With Adva...</td>\n",
       "      <td>A Phase 1/2 Study of LY3499446 Administered to...</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE1/PHASE2</td>\n",
       "      <td>5.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Data are available 6 months after the primary ...</td>\n",
       "      <td>A research proposal must be approved by an ind...</td>\n",
       "      <td>https://vivli.org/</td>\n",
       "      <td>YES</td>\n",
       "      <td>Anonymized individual patient level data will ...</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT02574078</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>NaN</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2015-10-09</td>\n",
       "      <td>2021-03-15</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-04-12</td>\n",
       "      <td>2015-10-09</td>\n",
       "      <td>2015-10-12</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2021-04-12</td>\n",
       "      <td>2021-05-06</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-04-12</td>\n",
       "      <td>2021-05-06</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2015-11-23</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2015-11-23</td>\n",
       "      <td>2021-04</td>\n",
       "      <td>2021-04-30</td>\n",
       "      <td>2020-04-15</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-04-15</td>\n",
       "      <td>2020-04-15</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-04-15</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>CheckMate370</td>\n",
       "      <td>NaN</td>\n",
       "      <td>A Study of Nivolumab in Advanced Non-Small Cel...</td>\n",
       "      <td>A Master Protocol of Phase 1/2 Studies of Nivo...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE1/PHASE2</td>\n",
       "      <td>341.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Bristol-Myers Squibb</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 07:48:14.913206</td>\n",
       "      <td>2024-08-04 07:48:14.913206</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00840125</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150mg tablet daily</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2009-02-09</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2012-10-29</td>\n",
       "      <td>2009-02-09</td>\n",
       "      <td>2009-02-10</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2012-10-29</td>\n",
       "      <td>2012-10-30</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2009-02</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2009-02-28</td>\n",
       "      <td>2012-10</td>\n",
       "      <td>2012-10-31</td>\n",
       "      <td>2011-08</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2011-08-31</td>\n",
       "      <td>2010-12</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-12-31</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Erlotinib With Docetaxel in Selected ...</td>\n",
       "      <td>A Phase II Open-Label Study Designed to Evalua...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>4.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Meir Medical Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-09 19:59:10.21038</td>\n",
       "      <td>2024-08-09 19:59:10.21038</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT00563784</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg by mouth daily for 7 Weeks</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2007-11-21</td>\n",
       "      <td>2019-09-03</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-11-18</td>\n",
       "      <td>2007-11-23</td>\n",
       "      <td>2007-11-26</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2019-11-18</td>\n",
       "      <td>2019-11-20</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-11-18</td>\n",
       "      <td>2019-11-20</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2007-11</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2007-11-30</td>\n",
       "      <td>2019-11</td>\n",
       "      <td>2019-11-30</td>\n",
       "      <td>2018-05-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2018-05-30</td>\n",
       "      <td>2018-05-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2018-05-30</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>48 patients registered and treated under the p...</td>\n",
       "      <td>TARCEVA (Erlotinib) in Combination With Chemor...</td>\n",
       "      <td>A Phase II Study of TARCEVA (Erlotinib) in Com...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>68.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>M.D. Anderson Cancer Center</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 12:54:21.848967</td>\n",
       "      <td>2024-08-04 12:54:21.848967</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        nct_id intervention_type  \\\n",
       "0  NCT00606502              DRUG   \n",
       "1  NCT04165031              DRUG   \n",
       "2  NCT02574078              DRUG   \n",
       "3  NCT00840125              DRUG   \n",
       "4  NCT00563784              DRUG   \n",
       "\n",
       "                                         description trial_drug_cleaned  \\\n",
       "0  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "1                                Administered orally          erlotinib   \n",
       "2                                                NaN          erlotinib   \n",
       "3                                 150mg tablet daily          erlotinib   \n",
       "4                  150 mg by mouth daily for 7 Weeks          erlotinib   \n",
       "\n",
       "                   conditions  Drug Name Highest Status  \\\n",
       "0  non-small cell lung cancer  erlotinib       Launched   \n",
       "1  non-small cell lung cancer  erlotinib       Launched   \n",
       "2  non-small cell lung cancer  erlotinib       Launched   \n",
       "3  non-small cell lung cancer  erlotinib       Launched   \n",
       "4  non-small cell lung cancer  erlotinib       Launched   \n",
       "\n",
       "                                    Other Drug Names       Originator Company  \\\n",
       "0  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "1  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "2  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "3  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "4  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "\n",
       "          Originator Company HQ  \\\n",
       "0  OSI Pharmaceuticals Inc (US)   \n",
       "1  OSI Pharmaceuticals Inc (US)   \n",
       "2  OSI Pharmaceuticals Inc (US)   \n",
       "3  OSI Pharmaceuticals Inc (US)   \n",
       "4  OSI Pharmaceuticals Inc (US)   \n",
       "\n",
       "                                    Active Companies  \\\n",
       "0  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "1  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "2  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "3  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "4  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "\n",
       "                                 Active Companies HQ          Therapy Area  \\\n",
       "0  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "1  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "2  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "3  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "4  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "\n",
       "                                  Active Indications  \\\n",
       "0  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "1  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "2  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "3  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "4  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "\n",
       "                                              Action  \\\n",
       "0  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "1  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "2  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "3  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "4  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "\n",
       "                                        Technologies  Regulatory Designations  \\\n",
       "0  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "1  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "2  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "3  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "4  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "\n",
       "                                Inactive Indications  \\\n",
       "0  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "1  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "2  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "3  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "4  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "\n",
       "            Inactive Companies Has Deals Last Change Date  Added Date  \\\n",
       "0  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "1  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "2  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "3  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "4  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "\n",
       "  First Launched Date                                            Extract  \\\n",
       "0          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "1          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "2          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "3          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "4          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "\n",
       "   Drug Id cortellis_cleaned_drug  nlm_download_date_description  \\\n",
       "0    11961              erlotinib                            NaN   \n",
       "1    11961              erlotinib                            NaN   \n",
       "2    11961              erlotinib                            NaN   \n",
       "3    11961              erlotinib                            NaN   \n",
       "4    11961              erlotinib                            NaN   \n",
       "\n",
       "  study_first_submitted_date results_first_submitted_date  \\\n",
       "0                 2008-01-22                   2010-12-22   \n",
       "1                 2019-11-14                   2021-10-27   \n",
       "2                 2015-10-09                   2021-03-15   \n",
       "3                 2009-02-09                          NaN   \n",
       "4                 2007-11-21                   2019-09-03   \n",
       "\n",
       "  disposition_first_submitted_date last_update_submitted_date  \\\n",
       "0                              NaN                 2021-02-08   \n",
       "1                              NaN                 2021-10-27   \n",
       "2                              NaN                 2021-04-12   \n",
       "3                              NaN                 2012-10-29   \n",
       "4                              NaN                 2019-11-18   \n",
       "\n",
       "  study_first_submitted_qc_date study_first_posted_date  \\\n",
       "0                    2008-02-01              2008-02-04   \n",
       "1                    2019-11-14              2019-11-15   \n",
       "2                    2015-10-09              2015-10-12   \n",
       "3                    2009-02-09              2009-02-10   \n",
       "4                    2007-11-23              2007-11-26   \n",
       "\n",
       "  study_first_posted_date_type results_first_submitted_qc_date  \\\n",
       "0                    ESTIMATED                      2010-12-22   \n",
       "1                       ACTUAL                      2021-10-27   \n",
       "2                    ESTIMATED                      2021-04-12   \n",
       "3                    ESTIMATED                             NaN   \n",
       "4                    ESTIMATED                      2019-11-18   \n",
       "\n",
       "  results_first_posted_date results_first_posted_date_type  \\\n",
       "0                2011-01-20                      ESTIMATED   \n",
       "1                2021-11-24                         ACTUAL   \n",
       "2                2021-05-06                         ACTUAL   \n",
       "3                       NaN                            NaN   \n",
       "4                2019-11-20                         ACTUAL   \n",
       "\n",
       "  disposition_first_submitted_qc_date disposition_first_posted_date  \\\n",
       "0                                 NaN                           NaN   \n",
       "1                                 NaN                           NaN   \n",
       "2                                 NaN                           NaN   \n",
       "3                                 NaN                           NaN   \n",
       "4                                 NaN                           NaN   \n",
       "\n",
       "  disposition_first_posted_date_type last_update_submitted_qc_date  \\\n",
       "0                                NaN                    2021-02-08   \n",
       "1                                NaN                    2021-10-27   \n",
       "2                                NaN                    2021-04-12   \n",
       "3                                NaN                    2012-10-29   \n",
       "4                                NaN                    2019-11-18   \n",
       "\n",
       "  last_update_posted_date last_update_posted_date_type start_month_year  \\\n",
       "0              2021-03-05                       ACTUAL          2008-01   \n",
       "1              2021-11-24                       ACTUAL       2019-11-28   \n",
       "2              2021-05-06                       ACTUAL       2015-11-23   \n",
       "3              2012-10-30                    ESTIMATED          2009-02   \n",
       "4              2019-11-20                       ACTUAL          2007-11   \n",
       "\n",
       "  start_date_type  start_date verification_month_year verification_date  \\\n",
       "0             NaN  2008-01-31                 2021-02        2021-02-28   \n",
       "1          ACTUAL  2019-11-28                 2021-10        2021-10-31   \n",
       "2          ACTUAL  2015-11-23                 2021-04        2021-04-30   \n",
       "3             NaN  2009-02-28                 2012-10        2012-10-31   \n",
       "4          ACTUAL  2007-11-30                 2019-11        2019-11-30   \n",
       "\n",
       "  completion_month_year completion_date_type completion_date  \\\n",
       "0            2010-06-24               ACTUAL      2010-06-24   \n",
       "1            2020-10-30               ACTUAL      2020-10-30   \n",
       "2            2020-04-15               ACTUAL      2020-04-15   \n",
       "3               2011-08               ACTUAL      2011-08-31   \n",
       "4            2018-05-30               ACTUAL      2018-05-30   \n",
       "\n",
       "  primary_completion_month_year primary_completion_date_type  \\\n",
       "0                    2010-06-24                       ACTUAL   \n",
       "1                    2020-10-30                       ACTUAL   \n",
       "2                    2020-04-15                       ACTUAL   \n",
       "3                       2010-12                       ACTUAL   \n",
       "4                    2018-05-30                       ACTUAL   \n",
       "\n",
       "  primary_completion_date  target_duration      study_type       acronym  \\\n",
       "0              2010-06-24              NaN  INTERVENTIONAL           NaN   \n",
       "1              2020-10-30              NaN  INTERVENTIONAL           NaN   \n",
       "2              2020-04-15              NaN  INTERVENTIONAL  CheckMate370   \n",
       "3              2010-12-31              NaN  INTERVENTIONAL           NaN   \n",
       "4              2018-05-30              NaN  INTERVENTIONAL           NaN   \n",
       "\n",
       "                                 baseline_population  \\\n",
       "0                                                NaN   \n",
       "1  All participants who received at least one dos...   \n",
       "2                                                NaN   \n",
       "3                                                NaN   \n",
       "4  48 patients registered and treated under the p...   \n",
       "\n",
       "                                         brief_title  \\\n",
       "0  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "1  A Study of LY3499446 in Participants With Adva...   \n",
       "2  A Study of Nivolumab in Advanced Non-Small Cel...   \n",
       "3  Study of Erlotinib With Docetaxel in Selected ...   \n",
       "4  TARCEVA (Erlotinib) in Combination With Chemor...   \n",
       "\n",
       "                                      official_title overall_status  \\\n",
       "0  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "1  A Phase 1/2 Study of LY3499446 Administered to...     TERMINATED   \n",
       "2  A Master Protocol of Phase 1/2 Studies of Nivo...      COMPLETED   \n",
       "3  A Phase II Open-Label Study Designed to Evalua...      COMPLETED   \n",
       "4  A Phase II Study of TARCEVA (Erlotinib) in Com...      COMPLETED   \n",
       "\n",
       "   last_known_status          phase  enrollment enrollment_type  \\\n",
       "0                NaN         PHASE2       201.0          ACTUAL   \n",
       "1                NaN  PHASE1/PHASE2         5.0          ACTUAL   \n",
       "2                NaN  PHASE1/PHASE2       341.0          ACTUAL   \n",
       "3                NaN         PHASE2         4.0          ACTUAL   \n",
       "4                NaN         PHASE2        68.0          ACTUAL   \n",
       "\n",
       "                          source  \\\n",
       "0  Spectrum Pharmaceuticals, Inc   \n",
       "1          Eli Lilly and Company   \n",
       "2           Bristol-Myers Squibb   \n",
       "3            Meir Medical Center   \n",
       "4    M.D. Anderson Cancer Center   \n",
       "\n",
       "                             limitations_and_caveats  number_of_arms  \\\n",
       "0  The date of the CRF database cut-off for patie...             2.0   \n",
       "1  The study was terminated due to an unexpected ...             6.0   \n",
       "2                                                NaN            10.0   \n",
       "3                                                NaN             1.0   \n",
       "4                                                NaN             1.0   \n",
       "\n",
       "   number_of_groups                                        why_stopped  \\\n",
       "0               NaN                                                NaN   \n",
       "1               NaN  The study was terminated due to an unexpected ...   \n",
       "2               NaN                                                NaN   \n",
       "3               NaN                                                NaN   \n",
       "4               NaN                                                NaN   \n",
       "\n",
       "  has_expanded_access  expanded_access_type_individual  \\\n",
       "0                   f                              NaN   \n",
       "1                   f                              NaN   \n",
       "2                   f                              NaN   \n",
       "3                   f                              NaN   \n",
       "4                   f                              NaN   \n",
       "\n",
       "   expanded_access_type_intermediate  expanded_access_type_treatment has_dmc  \\\n",
       "0                                NaN                             NaN     NaN   \n",
       "1                                NaN                             NaN       f   \n",
       "2                                NaN                             NaN       t   \n",
       "3                                NaN                             NaN       t   \n",
       "4                                NaN                             NaN       f   \n",
       "\n",
       "  is_fda_regulated_drug is_fda_regulated_device is_unapproved_device  is_ppsd  \\\n",
       "0                   NaN                     NaN                  NaN      NaN   \n",
       "1                     t                       f                  NaN      NaN   \n",
       "2                   NaN                     NaN                  NaN      NaN   \n",
       "3                   NaN                     NaN                  NaN      NaN   \n",
       "4                     t                       f                  NaN      NaN   \n",
       "\n",
       "  is_us_export  biospec_retention  biospec_description  \\\n",
       "0          NaN                NaN                  NaN   \n",
       "1          NaN                NaN                  NaN   \n",
       "2          NaN                NaN                  NaN   \n",
       "3          NaN                NaN                  NaN   \n",
       "4          NaN                NaN                  NaN   \n",
       "\n",
       "                                      ipd_time_frame  \\\n",
       "0                                                NaN   \n",
       "1  Data are available 6 months after the primary ...   \n",
       "2                                                NaN   \n",
       "3                                                NaN   \n",
       "4                                                NaN   \n",
       "\n",
       "                                 ipd_access_criteria             ipd_url  \\\n",
       "0                                                NaN                 NaN   \n",
       "1  A research proposal must be approved by an ind...  https://vivli.org/   \n",
       "2                                                NaN                 NaN   \n",
       "3                                                NaN                 NaN   \n",
       "4                                                NaN                 NaN   \n",
       "\n",
       "  plan_to_share_ipd                      plan_to_share_ipd_description  \\\n",
       "0               NaN                                                NaN   \n",
       "1               YES  Anonymized individual patient level data will ...   \n",
       "2               NaN                                                NaN   \n",
       "3               NaN                                                NaN   \n",
       "4               NaN                                                NaN   \n",
       "\n",
       "                   created_at                  updated_at source_class  \\\n",
       "0  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "1  2024-08-10 03:04:24.451964  2024-08-10 03:04:24.451964     INDUSTRY   \n",
       "2  2024-08-04 07:48:14.913206  2024-08-04 07:48:14.913206     INDUSTRY   \n",
       "3   2024-08-09 19:59:10.21038   2024-08-09 19:59:10.21038        OTHER   \n",
       "4  2024-08-04 12:54:21.848967  2024-08-04 12:54:21.848967        OTHER   \n",
       "\n",
       "   delayed_posting expanded_access_nctid expanded_access_status_for_nctid  \\\n",
       "0              NaN                   NaN                              NaN   \n",
       "1              NaN                   NaN                              NaN   \n",
       "2              NaN                   NaN                              NaN   \n",
       "3              NaN                   NaN                              NaN   \n",
       "4              NaN                   NaN                              NaN   \n",
       "\n",
       "   fdaaa801_violation  baseline_type_units_analyzed  patient_registry  \\\n",
       "0                 NaN                           NaN               NaN   \n",
       "1                 NaN                           NaN               NaN   \n",
       "2                 NaN                           NaN               NaN   \n",
       "3                 NaN                           NaN               NaN   \n",
       "4                 NaN                           NaN               NaN   \n",
       "\n",
       "  drug_outcome          disease_type new_therapy_area  \n",
       "0      success  Lung, Non-Small Cell         Oncology  \n",
       "1      success  Lung, Non-Small Cell         Oncology  \n",
       "2      success  Lung, Non-Small Cell         Oncology  \n",
       "3      success  Lung, Non-Small Cell         Oncology  \n",
       "4      success  Lung, Non-Small Cell         Oncology  "
      ]
     },
     "execution_count": 118,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# merge p2_p4 filtered data with conditions-to-disease_type-to-therapyarea mapping\n",
    "merged_df_1123 = pd.merge(df_merged_1021_p2_p4, df_conditions_ta, left_on=\"conditions\", right_on=\"conditions\", how=\"inner\")\n",
    "merged_df_1123 = merged_df_1123.drop(columns=['Unnamed: 0', 'Unnamed: 0.1'])\n",
    "merged_df_1123.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 119,
   "id": "1fc767e9",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['nct_id',\n",
       " 'intervention_type',\n",
       " 'description',\n",
       " 'trial_drug_cleaned',\n",
       " 'conditions',\n",
       " 'Drug Name',\n",
       " 'Highest Status',\n",
       " 'Other Drug Names',\n",
       " 'Originator Company',\n",
       " 'Originator Company HQ',\n",
       " 'Active Companies',\n",
       " 'Active Companies HQ',\n",
       " 'Therapy Area',\n",
       " 'Active Indications',\n",
       " 'Action',\n",
       " 'Technologies',\n",
       " 'Regulatory Designations',\n",
       " 'Inactive Indications',\n",
       " 'Inactive Companies',\n",
       " 'Has Deals',\n",
       " 'Last Change Date',\n",
       " 'Added Date',\n",
       " 'First Launched Date',\n",
       " 'Extract',\n",
       " 'Drug Id',\n",
       " 'cortellis_cleaned_drug',\n",
       " 'nlm_download_date_description',\n",
       " 'study_first_submitted_date',\n",
       " 'results_first_submitted_date',\n",
       " 'disposition_first_submitted_date',\n",
       " 'last_update_submitted_date',\n",
       " 'study_first_submitted_qc_date',\n",
       " 'study_first_posted_date',\n",
       " 'study_first_posted_date_type',\n",
       " 'results_first_submitted_qc_date',\n",
       " 'results_first_posted_date',\n",
       " 'results_first_posted_date_type',\n",
       " 'disposition_first_submitted_qc_date',\n",
       " 'disposition_first_posted_date',\n",
       " 'disposition_first_posted_date_type',\n",
       " 'last_update_submitted_qc_date',\n",
       " 'last_update_posted_date',\n",
       " 'last_update_posted_date_type',\n",
       " 'start_month_year',\n",
       " 'start_date_type',\n",
       " 'start_date',\n",
       " 'verification_month_year',\n",
       " 'verification_date',\n",
       " 'completion_month_year',\n",
       " 'completion_date_type',\n",
       " 'completion_date',\n",
       " 'primary_completion_month_year',\n",
       " 'primary_completion_date_type',\n",
       " 'primary_completion_date',\n",
       " 'target_duration',\n",
       " 'study_type',\n",
       " 'acronym',\n",
       " 'baseline_population',\n",
       " 'brief_title',\n",
       " 'official_title',\n",
       " 'overall_status',\n",
       " 'last_known_status',\n",
       " 'phase',\n",
       " 'enrollment',\n",
       " 'enrollment_type',\n",
       " 'source',\n",
       " 'limitations_and_caveats',\n",
       " 'number_of_arms',\n",
       " 'number_of_groups',\n",
       " 'why_stopped',\n",
       " 'has_expanded_access',\n",
       " 'expanded_access_type_individual',\n",
       " 'expanded_access_type_intermediate',\n",
       " 'expanded_access_type_treatment',\n",
       " 'has_dmc',\n",
       " 'is_fda_regulated_drug',\n",
       " 'is_fda_regulated_device',\n",
       " 'is_unapproved_device',\n",
       " 'is_ppsd',\n",
       " 'is_us_export',\n",
       " 'biospec_retention',\n",
       " 'biospec_description',\n",
       " 'ipd_time_frame',\n",
       " 'ipd_access_criteria',\n",
       " 'ipd_url',\n",
       " 'plan_to_share_ipd',\n",
       " 'plan_to_share_ipd_description',\n",
       " 'created_at',\n",
       " 'updated_at',\n",
       " 'source_class',\n",
       " 'delayed_posting',\n",
       " 'expanded_access_nctid',\n",
       " 'expanded_access_status_for_nctid',\n",
       " 'fdaaa801_violation',\n",
       " 'baseline_type_units_analyzed',\n",
       " 'patient_registry',\n",
       " 'drug_outcome',\n",
       " 'disease_type',\n",
       " 'new_therapy_area']"
      ]
     },
     "execution_count": 119,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "merged_df_1123.columns.to_list()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 120,
   "id": "5fcd6724",
   "metadata": {},
   "outputs": [],
   "source": [
    "# change the data type of start_date and primary_completion_date to datetime from string\n",
    "merged_df_1123['start_date'] = pd.to_datetime(merged_df_1123['start_date'], errors='coerce')\n",
    "merged_df_1123['primary_completion_date'] = pd.to_datetime(merged_df_1123['primary_completion_date'], errors='coerce')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 121,
   "id": "b3ad17ef",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Drop rows with NaT (invalid dates)\n",
    "merged_df_1123 = merged_df_1123.dropna(subset=['primary_completion_date'])\n",
    "merged_df_1123 = merged_df_1123.dropna(subset=['start_date'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 122,
   "id": "8ece7a6d",
   "metadata": {},
   "outputs": [],
   "source": [
    "# filter on primary completion date type as \"Actual\"\n",
    "merged_df_1123 = merged_df_1123[merged_df_1123['primary_completion_date_type'] == 'ACTUAL']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 123,
   "id": "f1bca8e0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(10616, 99)"
      ]
     },
     "execution_count": 123,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "merged_df_1123.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 124,
   "id": "d09b3e76",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>0</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>1987</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>1988</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>1989</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>1990</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>1991</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>1992</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>1993</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>1994</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>1995</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>1996</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>1997</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>1998</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>1999</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>2000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>2001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>2002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>2003</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>2004</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>2005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>2006</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>2007</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2008</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>2009</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>2010</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>2011</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>2012</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>2013</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>2014</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2015</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>2016</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>2017</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>2018</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>2020</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>2021</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>2023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>2024</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       0\n",
       "32  1987\n",
       "36  1988\n",
       "37  1989\n",
       "34  1990\n",
       "29  1991\n",
       "33  1992\n",
       "35  1993\n",
       "27  1994\n",
       "26  1995\n",
       "28  1996\n",
       "24  1997\n",
       "23  1998\n",
       "19  1999\n",
       "25  2000\n",
       "21  2001\n",
       "22  2002\n",
       "18  2003\n",
       "8   2004\n",
       "10  2005\n",
       "7   2006\n",
       "4   2007\n",
       "0   2008\n",
       "3   2009\n",
       "5   2010\n",
       "12  2011\n",
       "13  2012\n",
       "15  2013\n",
       "9   2014\n",
       "2   2015\n",
       "6   2016\n",
       "11  2017\n",
       "14  2018\n",
       "1   2019\n",
       "20  2020\n",
       "16  2021\n",
       "17  2022\n",
       "30  2023\n",
       "31  2024"
      ]
     },
     "execution_count": 124,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# check unique start dates\n",
    "pd.DataFrame(merged_df_1123['start_date'].dt.year.unique()).sort_values(by=0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 125,
   "id": "8b98d221",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>0</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>1994</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>1996</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>1997</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>1998</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>1999</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>2000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>2001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>2002</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>2003</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>2004</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>2005</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>2006</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>2007</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>2008</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>2009</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2010</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>2011</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>2012</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>2013</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>2014</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>2015</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>2016</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>2017</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2018</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>2019</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2020</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>2021</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>2022</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>2023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>2024</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       0\n",
       "29  1994\n",
       "27  1996\n",
       "26  1997\n",
       "28  1998\n",
       "25  1999\n",
       "24  2000\n",
       "22  2001\n",
       "20  2002\n",
       "21  2003\n",
       "19  2004\n",
       "18  2005\n",
       "17  2006\n",
       "15  2007\n",
       "8   2008\n",
       "10  2009\n",
       "0   2010\n",
       "7   2011\n",
       "6   2012\n",
       "14  2013\n",
       "3   2014\n",
       "4   2015\n",
       "12  2016\n",
       "11  2017\n",
       "2   2018\n",
       "5   2019\n",
       "1   2020\n",
       "9   2021\n",
       "13  2022\n",
       "16  2023\n",
       "23  2024"
      ]
     },
     "execution_count": 125,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# check unique primary completion dates\n",
    "pd.DataFrame(merged_df_1123['primary_completion_date'].dt.year.unique()).sort_values(by=0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 126,
   "id": "6216e08f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>nct_id</th>\n",
       "      <th>number_of_facilities</th>\n",
       "      <th>number_of_nsae_subjects</th>\n",
       "      <th>number_of_sae_subjects</th>\n",
       "      <th>registered_in_calendar_year</th>\n",
       "      <th>nlm_download_date</th>\n",
       "      <th>actual_duration</th>\n",
       "      <th>were_results_reported</th>\n",
       "      <th>months_to_report_results</th>\n",
       "      <th>has_us_facility</th>\n",
       "      <th>has_single_facility</th>\n",
       "      <th>minimum_age_num</th>\n",
       "      <th>maximum_age_num</th>\n",
       "      <th>minimum_age_unit</th>\n",
       "      <th>maximum_age_unit</th>\n",
       "      <th>number_of_primary_outcomes_to_measure</th>\n",
       "      <th>number_of_secondary_outcomes_to_measure</th>\n",
       "      <th>number_of_other_outcomes_to_measure</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>29892566</td>\n",
       "      <td>NCT02198898</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2013</td>\n",
       "      <td>NaN</td>\n",
       "      <td>30.0</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>20.0</td>\n",
       "      <td>80.0</td>\n",
       "      <td>Years</td>\n",
       "      <td>Years</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>29990558</td>\n",
       "      <td>NCT01492660</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2011</td>\n",
       "      <td>NaN</td>\n",
       "      <td>12.0</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>18.0</td>\n",
       "      <td>80.0</td>\n",
       "      <td>Years</td>\n",
       "      <td>Years</td>\n",
       "      <td>1.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>30039632</td>\n",
       "      <td>NCT00800774</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>129.0</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>8.0</td>\n",
       "      <td>15.0</td>\n",
       "      <td>Years</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>29739658</td>\n",
       "      <td>NCT02415101</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2015</td>\n",
       "      <td>NaN</td>\n",
       "      <td>50.0</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>18.0</td>\n",
       "      <td>80.0</td>\n",
       "      <td>Years</td>\n",
       "      <td>Years</td>\n",
       "      <td>1.0</td>\n",
       "      <td>12.0</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>29867616</td>\n",
       "      <td>NCT01097122</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2010</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3.0</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>20.0</td>\n",
       "      <td>50.0</td>\n",
       "      <td>Years</td>\n",
       "      <td>Years</td>\n",
       "      <td>1.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         id       nct_id  number_of_facilities  number_of_nsae_subjects  \\\n",
       "0  29892566  NCT02198898                   1.0                      NaN   \n",
       "1  29990558  NCT01492660                   1.0                      NaN   \n",
       "2  30039632  NCT00800774                   1.0                      NaN   \n",
       "3  29739658  NCT02415101                   1.0                      NaN   \n",
       "4  29867616  NCT01097122                   1.0                      NaN   \n",
       "\n",
       "   number_of_sae_subjects  registered_in_calendar_year  nlm_download_date  \\\n",
       "0                     NaN                         2013                NaN   \n",
       "1                     NaN                         2011                NaN   \n",
       "2                     NaN                         2008                NaN   \n",
       "3                     NaN                         2015                NaN   \n",
       "4                     NaN                         2010                NaN   \n",
       "\n",
       "   actual_duration were_results_reported  months_to_report_results  \\\n",
       "0             30.0                     f                       NaN   \n",
       "1             12.0                     f                       NaN   \n",
       "2            129.0                     f                       NaN   \n",
       "3             50.0                     f                       NaN   \n",
       "4              3.0                     f                       NaN   \n",
       "\n",
       "  has_us_facility has_single_facility  minimum_age_num  maximum_age_num  \\\n",
       "0               f                   t             20.0             80.0   \n",
       "1               f                   t             18.0             80.0   \n",
       "2               f                   t              8.0             15.0   \n",
       "3               f                   t             18.0             80.0   \n",
       "4               f                   t             20.0             50.0   \n",
       "\n",
       "  minimum_age_unit maximum_age_unit  number_of_primary_outcomes_to_measure  \\\n",
       "0            Years            Years                                    1.0   \n",
       "1            Years            Years                                    1.0   \n",
       "2            Years            Years                                    NaN   \n",
       "3            Years            Years                                    1.0   \n",
       "4            Years            Years                                    1.0   \n",
       "\n",
       "   number_of_secondary_outcomes_to_measure  \\\n",
       "0                                      NaN   \n",
       "1                                      5.0   \n",
       "2                                      NaN   \n",
       "3                                     12.0   \n",
       "4                                      NaN   \n",
       "\n",
       "   number_of_other_outcomes_to_measure  \n",
       "0                                  NaN  \n",
       "1                                  NaN  \n",
       "2                                  NaN  \n",
       "3                                  NaN  \n",
       "4                                  NaN  "
      ]
     },
     "execution_count": 126,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# load calculated values table from AACT\n",
    "df_calculated_values = pd.read_csv('b3t0zvq5n6oyhvv9h6v8qsqg4j57/calculated_values.txt', sep='|')\n",
    "df_calculated_values.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 127,
   "id": "83f989ac",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nct_id</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>description</th>\n",
       "      <th>trial_drug_cleaned</th>\n",
       "      <th>conditions</th>\n",
       "      <th>Drug Name</th>\n",
       "      <th>Highest Status</th>\n",
       "      <th>Other Drug Names</th>\n",
       "      <th>Originator Company</th>\n",
       "      <th>Originator Company HQ</th>\n",
       "      <th>Active Companies</th>\n",
       "      <th>Active Companies HQ</th>\n",
       "      <th>Therapy Area</th>\n",
       "      <th>Active Indications</th>\n",
       "      <th>Action</th>\n",
       "      <th>Technologies</th>\n",
       "      <th>Regulatory Designations</th>\n",
       "      <th>Inactive Indications</th>\n",
       "      <th>Inactive Companies</th>\n",
       "      <th>Has Deals</th>\n",
       "      <th>Last Change Date</th>\n",
       "      <th>Added Date</th>\n",
       "      <th>First Launched Date</th>\n",
       "      <th>Extract</th>\n",
       "      <th>Drug Id</th>\n",
       "      <th>cortellis_cleaned_drug</th>\n",
       "      <th>nlm_download_date_description</th>\n",
       "      <th>study_first_submitted_date</th>\n",
       "      <th>results_first_submitted_date</th>\n",
       "      <th>disposition_first_submitted_date</th>\n",
       "      <th>last_update_submitted_date</th>\n",
       "      <th>study_first_submitted_qc_date</th>\n",
       "      <th>study_first_posted_date</th>\n",
       "      <th>study_first_posted_date_type</th>\n",
       "      <th>results_first_submitted_qc_date</th>\n",
       "      <th>results_first_posted_date</th>\n",
       "      <th>results_first_posted_date_type</th>\n",
       "      <th>disposition_first_submitted_qc_date</th>\n",
       "      <th>disposition_first_posted_date</th>\n",
       "      <th>disposition_first_posted_date_type</th>\n",
       "      <th>last_update_submitted_qc_date</th>\n",
       "      <th>last_update_posted_date</th>\n",
       "      <th>last_update_posted_date_type</th>\n",
       "      <th>start_month_year</th>\n",
       "      <th>start_date_type</th>\n",
       "      <th>start_date</th>\n",
       "      <th>verification_month_year</th>\n",
       "      <th>verification_date</th>\n",
       "      <th>completion_month_year</th>\n",
       "      <th>completion_date_type</th>\n",
       "      <th>completion_date</th>\n",
       "      <th>primary_completion_month_year</th>\n",
       "      <th>primary_completion_date_type</th>\n",
       "      <th>primary_completion_date</th>\n",
       "      <th>target_duration</th>\n",
       "      <th>study_type</th>\n",
       "      <th>acronym</th>\n",
       "      <th>baseline_population</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>official_title</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>last_known_status</th>\n",
       "      <th>phase</th>\n",
       "      <th>enrollment</th>\n",
       "      <th>enrollment_type</th>\n",
       "      <th>source</th>\n",
       "      <th>limitations_and_caveats</th>\n",
       "      <th>number_of_arms</th>\n",
       "      <th>number_of_groups</th>\n",
       "      <th>why_stopped</th>\n",
       "      <th>has_expanded_access</th>\n",
       "      <th>expanded_access_type_individual</th>\n",
       "      <th>expanded_access_type_intermediate</th>\n",
       "      <th>expanded_access_type_treatment</th>\n",
       "      <th>has_dmc</th>\n",
       "      <th>is_fda_regulated_drug</th>\n",
       "      <th>is_fda_regulated_device</th>\n",
       "      <th>is_unapproved_device</th>\n",
       "      <th>is_ppsd</th>\n",
       "      <th>is_us_export</th>\n",
       "      <th>biospec_retention</th>\n",
       "      <th>biospec_description</th>\n",
       "      <th>ipd_time_frame</th>\n",
       "      <th>ipd_access_criteria</th>\n",
       "      <th>ipd_url</th>\n",
       "      <th>plan_to_share_ipd</th>\n",
       "      <th>plan_to_share_ipd_description</th>\n",
       "      <th>created_at</th>\n",
       "      <th>updated_at</th>\n",
       "      <th>source_class</th>\n",
       "      <th>delayed_posting</th>\n",
       "      <th>expanded_access_nctid</th>\n",
       "      <th>expanded_access_status_for_nctid</th>\n",
       "      <th>fdaaa801_violation</th>\n",
       "      <th>baseline_type_units_analyzed</th>\n",
       "      <th>patient_registry</th>\n",
       "      <th>drug_outcome</th>\n",
       "      <th>disease_type</th>\n",
       "      <th>new_therapy_area</th>\n",
       "      <th>id</th>\n",
       "      <th>number_of_facilities</th>\n",
       "      <th>number_of_nsae_subjects</th>\n",
       "      <th>number_of_sae_subjects</th>\n",
       "      <th>registered_in_calendar_year</th>\n",
       "      <th>nlm_download_date</th>\n",
       "      <th>actual_duration</th>\n",
       "      <th>were_results_reported</th>\n",
       "      <th>months_to_report_results</th>\n",
       "      <th>has_us_facility</th>\n",
       "      <th>has_single_facility</th>\n",
       "      <th>minimum_age_num</th>\n",
       "      <th>maximum_age_num</th>\n",
       "      <th>minimum_age_unit</th>\n",
       "      <th>maximum_age_unit</th>\n",
       "      <th>number_of_primary_outcomes_to_measure</th>\n",
       "      <th>number_of_secondary_outcomes_to_measure</th>\n",
       "      <th>number_of_other_outcomes_to_measure</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT04165031</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>Administered orally</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2019-11-15</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>2021-10</td>\n",
       "      <td>2021-10-31</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>All participants who received at least one dos...</td>\n",
       "      <td>A Study of LY3499446 in Participants With Adva...</td>\n",
       "      <td>A Phase 1/2 Study of LY3499446 Administered to...</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE1/PHASE2</td>\n",
       "      <td>5.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Data are available 6 months after the primary ...</td>\n",
       "      <td>A research proposal must be approved by an ind...</td>\n",
       "      <td>https://vivli.org/</td>\n",
       "      <td>YES</td>\n",
       "      <td>Anonymized individual patient level data will ...</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29905748</td>\n",
       "      <td>6.0</td>\n",
       "      <td>33.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>2019</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>12.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3.0</td>\n",
       "      <td>8.0</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT04165031</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>Administered orally</td>\n",
       "      <td>ly3499446</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>LY-3499446</td>\n",
       "      <td>Discontinued</td>\n",
       "      <td>KRAS G12C inhibitor (cancer), Eli Lilly; LY-34...</td>\n",
       "      <td>Eli Lilly &amp; Co</td>\n",
       "      <td>Eli Lilly &amp; Co (US)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Anticancer; K-Ras GTPase inhibitor</td>\n",
       "      <td>Oral formulation; Small molecule therapeutic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Colorectal tumor; Non-small-cell lung cancer; ...</td>\n",
       "      <td>Eli Lilly &amp; Co</td>\n",
       "      <td>No</td>\n",
       "      <td>2023-10-04</td>\n",
       "      <td>2019-11-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Eli Lilly was developing LY-3499446, a selecti...</td>\n",
       "      <td>120133</td>\n",
       "      <td>ly3499446</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2019-11-15</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>2021-10</td>\n",
       "      <td>2021-10-31</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>All participants who received at least one dos...</td>\n",
       "      <td>A Study of LY3499446 in Participants With Adva...</td>\n",
       "      <td>A Phase 1/2 Study of LY3499446 Administered to...</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE1/PHASE2</td>\n",
       "      <td>5.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Data are available 6 months after the primary ...</td>\n",
       "      <td>A research proposal must be approved by an ind...</td>\n",
       "      <td>https://vivli.org/</td>\n",
       "      <td>YES</td>\n",
       "      <td>Anonymized individual patient level data will ...</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>failure</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29905748</td>\n",
       "      <td>6.0</td>\n",
       "      <td>33.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>2019</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>12.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3.0</td>\n",
       "      <td>8.0</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT04165031</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>Administered IV</td>\n",
       "      <td>cetuximab</td>\n",
       "      <td>colorectal cancer</td>\n",
       "      <td>cetuximab</td>\n",
       "      <td>Launched</td>\n",
       "      <td>BMS-564717; C225; EMD-271786; EMR-62202; Erbit...</td>\n",
       "      <td>Imclone Systems Inc</td>\n",
       "      <td>Imclone Systems Inc (US)</td>\n",
       "      <td>Imclone Systems Inc; Merck KGaA; Merck Serono SA</td>\n",
       "      <td>Imclone Systems Inc (US); Merck KGaA (Germany)...</td>\n",
       "      <td>Cancer; Neurology/Psychiatric</td>\n",
       "      <td>Anal tumor; Cutaneous squamous cell carcinoma;...</td>\n",
       "      <td>Analgesic; Anticancer; Anticancer monoclonal a...</td>\n",
       "      <td>Biological therapeutic; Chimeric monoclonal an...</td>\n",
       "      <td>Accelerated Approval; Fast Track; Orphan Drug;...</td>\n",
       "      <td>Biliary cancer; Bladder cancer; Breast tumor; ...</td>\n",
       "      <td>Bristol-Myers Squibb Co; Inven2</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-03</td>\n",
       "      <td>1996-02-16</td>\n",
       "      <td>2003-12-01</td>\n",
       "      <td>Cetuximab (Erbitux) is a human-murine chimeric...</td>\n",
       "      <td>10388</td>\n",
       "      <td>cetuximab</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2019-11-15</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>2021-10</td>\n",
       "      <td>2021-10-31</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>All participants who received at least one dos...</td>\n",
       "      <td>A Study of LY3499446 in Participants With Adva...</td>\n",
       "      <td>A Phase 1/2 Study of LY3499446 Administered to...</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE1/PHASE2</td>\n",
       "      <td>5.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Data are available 6 months after the primary ...</td>\n",
       "      <td>A research proposal must be approved by an ind...</td>\n",
       "      <td>https://vivli.org/</td>\n",
       "      <td>YES</td>\n",
       "      <td>Anonymized individual patient level data will ...</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Colorectal (Oncology)</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29905748</td>\n",
       "      <td>6.0</td>\n",
       "      <td>33.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>2019</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>12.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3.0</td>\n",
       "      <td>8.0</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT04165031</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>Administered orally</td>\n",
       "      <td>ly3499446</td>\n",
       "      <td>colorectal cancer</td>\n",
       "      <td>LY-3499446</td>\n",
       "      <td>Discontinued</td>\n",
       "      <td>KRAS G12C inhibitor (cancer), Eli Lilly; LY-34...</td>\n",
       "      <td>Eli Lilly &amp; Co</td>\n",
       "      <td>Eli Lilly &amp; Co (US)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Anticancer; K-Ras GTPase inhibitor</td>\n",
       "      <td>Oral formulation; Small molecule therapeutic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Colorectal tumor; Non-small-cell lung cancer; ...</td>\n",
       "      <td>Eli Lilly &amp; Co</td>\n",
       "      <td>No</td>\n",
       "      <td>2023-10-04</td>\n",
       "      <td>2019-11-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Eli Lilly was developing LY-3499446, a selecti...</td>\n",
       "      <td>120133</td>\n",
       "      <td>ly3499446</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2019-11-15</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>2021-10</td>\n",
       "      <td>2021-10-31</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>All participants who received at least one dos...</td>\n",
       "      <td>A Study of LY3499446 in Participants With Adva...</td>\n",
       "      <td>A Phase 1/2 Study of LY3499446 Administered to...</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE1/PHASE2</td>\n",
       "      <td>5.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Data are available 6 months after the primary ...</td>\n",
       "      <td>A research proposal must be approved by an ind...</td>\n",
       "      <td>https://vivli.org/</td>\n",
       "      <td>YES</td>\n",
       "      <td>Anonymized individual patient level data will ...</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>failure</td>\n",
       "      <td>Colorectal (Oncology)</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29905748</td>\n",
       "      <td>6.0</td>\n",
       "      <td>33.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>2019</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>12.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3.0</td>\n",
       "      <td>8.0</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        nct_id intervention_type  \\\n",
       "0  NCT00606502              DRUG   \n",
       "1  NCT04165031              DRUG   \n",
       "2  NCT04165031              DRUG   \n",
       "3  NCT04165031              DRUG   \n",
       "4  NCT04165031              DRUG   \n",
       "\n",
       "                                         description trial_drug_cleaned  \\\n",
       "0  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "1                                Administered orally          erlotinib   \n",
       "2                                Administered orally          ly3499446   \n",
       "3                                    Administered IV          cetuximab   \n",
       "4                                Administered orally          ly3499446   \n",
       "\n",
       "                   conditions   Drug Name Highest Status  \\\n",
       "0  non-small cell lung cancer   erlotinib       Launched   \n",
       "1  non-small cell lung cancer   erlotinib       Launched   \n",
       "2  non-small cell lung cancer  LY-3499446   Discontinued   \n",
       "3           colorectal cancer   cetuximab       Launched   \n",
       "4           colorectal cancer  LY-3499446   Discontinued   \n",
       "\n",
       "                                    Other Drug Names       Originator Company  \\\n",
       "0  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "1  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "2  KRAS G12C inhibitor (cancer), Eli Lilly; LY-34...           Eli Lilly & Co   \n",
       "3  BMS-564717; C225; EMD-271786; EMR-62202; Erbit...      Imclone Systems Inc   \n",
       "4  KRAS G12C inhibitor (cancer), Eli Lilly; LY-34...           Eli Lilly & Co   \n",
       "\n",
       "          Originator Company HQ  \\\n",
       "0  OSI Pharmaceuticals Inc (US)   \n",
       "1  OSI Pharmaceuticals Inc (US)   \n",
       "2           Eli Lilly & Co (US)   \n",
       "3      Imclone Systems Inc (US)   \n",
       "4           Eli Lilly & Co (US)   \n",
       "\n",
       "                                    Active Companies  \\\n",
       "0  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "1  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "2                                                NaN   \n",
       "3   Imclone Systems Inc; Merck KGaA; Merck Serono SA   \n",
       "4                                                NaN   \n",
       "\n",
       "                                 Active Companies HQ  \\\n",
       "0  Astellas Pharma Inc (Japan); Baheal Pharmaceut...   \n",
       "1  Astellas Pharma Inc (Japan); Baheal Pharmaceut...   \n",
       "2                                                NaN   \n",
       "3  Imclone Systems Inc (US); Merck KGaA (Germany)...   \n",
       "4                                                NaN   \n",
       "\n",
       "                    Therapy Area  \\\n",
       "0           Cancer; Dermatologic   \n",
       "1           Cancer; Dermatologic   \n",
       "2                         Cancer   \n",
       "3  Cancer; Neurology/Psychiatric   \n",
       "4                         Cancer   \n",
       "\n",
       "                                  Active Indications  \\\n",
       "0  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "1  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "2                                                NaN   \n",
       "3  Anal tumor; Cutaneous squamous cell carcinoma;...   \n",
       "4                                                NaN   \n",
       "\n",
       "                                              Action  \\\n",
       "0  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "1  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "2                 Anticancer; K-Ras GTPase inhibitor   \n",
       "3  Analgesic; Anticancer; Anticancer monoclonal a...   \n",
       "4                 Anticancer; K-Ras GTPase inhibitor   \n",
       "\n",
       "                                        Technologies  \\\n",
       "0  Film coating; Oral formulation; Small molecule...   \n",
       "1  Film coating; Oral formulation; Small molecule...   \n",
       "2       Oral formulation; Small molecule therapeutic   \n",
       "3  Biological therapeutic; Chimeric monoclonal an...   \n",
       "4       Oral formulation; Small molecule therapeutic   \n",
       "\n",
       "                             Regulatory Designations  \\\n",
       "0                            Fast Track; Orphan Drug   \n",
       "1                            Fast Track; Orphan Drug   \n",
       "2                                                NaN   \n",
       "3  Accelerated Approval; Fast Track; Orphan Drug;...   \n",
       "4                                                NaN   \n",
       "\n",
       "                                Inactive Indications  \\\n",
       "0  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "1  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "2  Colorectal tumor; Non-small-cell lung cancer; ...   \n",
       "3  Biliary cancer; Bladder cancer; Breast tumor; ...   \n",
       "4  Colorectal tumor; Non-small-cell lung cancer; ...   \n",
       "\n",
       "                Inactive Companies Has Deals Last Change Date  Added Date  \\\n",
       "0      Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "1      Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "2                   Eli Lilly & Co        No       2023-10-04  2019-11-22   \n",
       "3  Bristol-Myers Squibb Co; Inven2       Yes       2024-07-03  1996-02-16   \n",
       "4                   Eli Lilly & Co        No       2023-10-04  2019-11-22   \n",
       "\n",
       "  First Launched Date                                            Extract  \\\n",
       "0          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "1          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "2                 NaN  Eli Lilly was developing LY-3499446, a selecti...   \n",
       "3          2003-12-01  Cetuximab (Erbitux) is a human-murine chimeric...   \n",
       "4                 NaN  Eli Lilly was developing LY-3499446, a selecti...   \n",
       "\n",
       "   Drug Id cortellis_cleaned_drug  nlm_download_date_description  \\\n",
       "0    11961              erlotinib                            NaN   \n",
       "1    11961              erlotinib                            NaN   \n",
       "2   120133              ly3499446                            NaN   \n",
       "3    10388              cetuximab                            NaN   \n",
       "4   120133              ly3499446                            NaN   \n",
       "\n",
       "  study_first_submitted_date results_first_submitted_date  \\\n",
       "0                 2008-01-22                   2010-12-22   \n",
       "1                 2019-11-14                   2021-10-27   \n",
       "2                 2019-11-14                   2021-10-27   \n",
       "3                 2019-11-14                   2021-10-27   \n",
       "4                 2019-11-14                   2021-10-27   \n",
       "\n",
       "  disposition_first_submitted_date last_update_submitted_date  \\\n",
       "0                              NaN                 2021-02-08   \n",
       "1                              NaN                 2021-10-27   \n",
       "2                              NaN                 2021-10-27   \n",
       "3                              NaN                 2021-10-27   \n",
       "4                              NaN                 2021-10-27   \n",
       "\n",
       "  study_first_submitted_qc_date study_first_posted_date  \\\n",
       "0                    2008-02-01              2008-02-04   \n",
       "1                    2019-11-14              2019-11-15   \n",
       "2                    2019-11-14              2019-11-15   \n",
       "3                    2019-11-14              2019-11-15   \n",
       "4                    2019-11-14              2019-11-15   \n",
       "\n",
       "  study_first_posted_date_type results_first_submitted_qc_date  \\\n",
       "0                    ESTIMATED                      2010-12-22   \n",
       "1                       ACTUAL                      2021-10-27   \n",
       "2                       ACTUAL                      2021-10-27   \n",
       "3                       ACTUAL                      2021-10-27   \n",
       "4                       ACTUAL                      2021-10-27   \n",
       "\n",
       "  results_first_posted_date results_first_posted_date_type  \\\n",
       "0                2011-01-20                      ESTIMATED   \n",
       "1                2021-11-24                         ACTUAL   \n",
       "2                2021-11-24                         ACTUAL   \n",
       "3                2021-11-24                         ACTUAL   \n",
       "4                2021-11-24                         ACTUAL   \n",
       "\n",
       "  disposition_first_submitted_qc_date disposition_first_posted_date  \\\n",
       "0                                 NaN                           NaN   \n",
       "1                                 NaN                           NaN   \n",
       "2                                 NaN                           NaN   \n",
       "3                                 NaN                           NaN   \n",
       "4                                 NaN                           NaN   \n",
       "\n",
       "  disposition_first_posted_date_type last_update_submitted_qc_date  \\\n",
       "0                                NaN                    2021-02-08   \n",
       "1                                NaN                    2021-10-27   \n",
       "2                                NaN                    2021-10-27   \n",
       "3                                NaN                    2021-10-27   \n",
       "4                                NaN                    2021-10-27   \n",
       "\n",
       "  last_update_posted_date last_update_posted_date_type start_month_year  \\\n",
       "0              2021-03-05                       ACTUAL          2008-01   \n",
       "1              2021-11-24                       ACTUAL       2019-11-28   \n",
       "2              2021-11-24                       ACTUAL       2019-11-28   \n",
       "3              2021-11-24                       ACTUAL       2019-11-28   \n",
       "4              2021-11-24                       ACTUAL       2019-11-28   \n",
       "\n",
       "  start_date_type start_date verification_month_year verification_date  \\\n",
       "0             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "1          ACTUAL 2019-11-28                 2021-10        2021-10-31   \n",
       "2          ACTUAL 2019-11-28                 2021-10        2021-10-31   \n",
       "3          ACTUAL 2019-11-28                 2021-10        2021-10-31   \n",
       "4          ACTUAL 2019-11-28                 2021-10        2021-10-31   \n",
       "\n",
       "  completion_month_year completion_date_type completion_date  \\\n",
       "0            2010-06-24               ACTUAL      2010-06-24   \n",
       "1            2020-10-30               ACTUAL      2020-10-30   \n",
       "2            2020-10-30               ACTUAL      2020-10-30   \n",
       "3            2020-10-30               ACTUAL      2020-10-30   \n",
       "4            2020-10-30               ACTUAL      2020-10-30   \n",
       "\n",
       "  primary_completion_month_year primary_completion_date_type  \\\n",
       "0                    2010-06-24                       ACTUAL   \n",
       "1                    2020-10-30                       ACTUAL   \n",
       "2                    2020-10-30                       ACTUAL   \n",
       "3                    2020-10-30                       ACTUAL   \n",
       "4                    2020-10-30                       ACTUAL   \n",
       "\n",
       "  primary_completion_date  target_duration      study_type acronym  \\\n",
       "0              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "1              2020-10-30              NaN  INTERVENTIONAL     NaN   \n",
       "2              2020-10-30              NaN  INTERVENTIONAL     NaN   \n",
       "3              2020-10-30              NaN  INTERVENTIONAL     NaN   \n",
       "4              2020-10-30              NaN  INTERVENTIONAL     NaN   \n",
       "\n",
       "                                 baseline_population  \\\n",
       "0                                                NaN   \n",
       "1  All participants who received at least one dos...   \n",
       "2  All participants who received at least one dos...   \n",
       "3  All participants who received at least one dos...   \n",
       "4  All participants who received at least one dos...   \n",
       "\n",
       "                                         brief_title  \\\n",
       "0  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "1  A Study of LY3499446 in Participants With Adva...   \n",
       "2  A Study of LY3499446 in Participants With Adva...   \n",
       "3  A Study of LY3499446 in Participants With Adva...   \n",
       "4  A Study of LY3499446 in Participants With Adva...   \n",
       "\n",
       "                                      official_title overall_status  \\\n",
       "0  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "1  A Phase 1/2 Study of LY3499446 Administered to...     TERMINATED   \n",
       "2  A Phase 1/2 Study of LY3499446 Administered to...     TERMINATED   \n",
       "3  A Phase 1/2 Study of LY3499446 Administered to...     TERMINATED   \n",
       "4  A Phase 1/2 Study of LY3499446 Administered to...     TERMINATED   \n",
       "\n",
       "   last_known_status          phase  enrollment enrollment_type  \\\n",
       "0                NaN         PHASE2       201.0          ACTUAL   \n",
       "1                NaN  PHASE1/PHASE2         5.0          ACTUAL   \n",
       "2                NaN  PHASE1/PHASE2         5.0          ACTUAL   \n",
       "3                NaN  PHASE1/PHASE2         5.0          ACTUAL   \n",
       "4                NaN  PHASE1/PHASE2         5.0          ACTUAL   \n",
       "\n",
       "                          source  \\\n",
       "0  Spectrum Pharmaceuticals, Inc   \n",
       "1          Eli Lilly and Company   \n",
       "2          Eli Lilly and Company   \n",
       "3          Eli Lilly and Company   \n",
       "4          Eli Lilly and Company   \n",
       "\n",
       "                             limitations_and_caveats  number_of_arms  \\\n",
       "0  The date of the CRF database cut-off for patie...             2.0   \n",
       "1  The study was terminated due to an unexpected ...             6.0   \n",
       "2  The study was terminated due to an unexpected ...             6.0   \n",
       "3  The study was terminated due to an unexpected ...             6.0   \n",
       "4  The study was terminated due to an unexpected ...             6.0   \n",
       "\n",
       "   number_of_groups                                        why_stopped  \\\n",
       "0               NaN                                                NaN   \n",
       "1               NaN  The study was terminated due to an unexpected ...   \n",
       "2               NaN  The study was terminated due to an unexpected ...   \n",
       "3               NaN  The study was terminated due to an unexpected ...   \n",
       "4               NaN  The study was terminated due to an unexpected ...   \n",
       "\n",
       "  has_expanded_access  expanded_access_type_individual  \\\n",
       "0                   f                              NaN   \n",
       "1                   f                              NaN   \n",
       "2                   f                              NaN   \n",
       "3                   f                              NaN   \n",
       "4                   f                              NaN   \n",
       "\n",
       "   expanded_access_type_intermediate  expanded_access_type_treatment has_dmc  \\\n",
       "0                                NaN                             NaN     NaN   \n",
       "1                                NaN                             NaN       f   \n",
       "2                                NaN                             NaN       f   \n",
       "3                                NaN                             NaN       f   \n",
       "4                                NaN                             NaN       f   \n",
       "\n",
       "  is_fda_regulated_drug is_fda_regulated_device is_unapproved_device  is_ppsd  \\\n",
       "0                   NaN                     NaN                  NaN      NaN   \n",
       "1                     t                       f                  NaN      NaN   \n",
       "2                     t                       f                  NaN      NaN   \n",
       "3                     t                       f                  NaN      NaN   \n",
       "4                     t                       f                  NaN      NaN   \n",
       "\n",
       "  is_us_export  biospec_retention  biospec_description  \\\n",
       "0          NaN                NaN                  NaN   \n",
       "1          NaN                NaN                  NaN   \n",
       "2          NaN                NaN                  NaN   \n",
       "3          NaN                NaN                  NaN   \n",
       "4          NaN                NaN                  NaN   \n",
       "\n",
       "                                      ipd_time_frame  \\\n",
       "0                                                NaN   \n",
       "1  Data are available 6 months after the primary ...   \n",
       "2  Data are available 6 months after the primary ...   \n",
       "3  Data are available 6 months after the primary ...   \n",
       "4  Data are available 6 months after the primary ...   \n",
       "\n",
       "                                 ipd_access_criteria             ipd_url  \\\n",
       "0                                                NaN                 NaN   \n",
       "1  A research proposal must be approved by an ind...  https://vivli.org/   \n",
       "2  A research proposal must be approved by an ind...  https://vivli.org/   \n",
       "3  A research proposal must be approved by an ind...  https://vivli.org/   \n",
       "4  A research proposal must be approved by an ind...  https://vivli.org/   \n",
       "\n",
       "  plan_to_share_ipd                      plan_to_share_ipd_description  \\\n",
       "0               NaN                                                NaN   \n",
       "1               YES  Anonymized individual patient level data will ...   \n",
       "2               YES  Anonymized individual patient level data will ...   \n",
       "3               YES  Anonymized individual patient level data will ...   \n",
       "4               YES  Anonymized individual patient level data will ...   \n",
       "\n",
       "                   created_at                  updated_at source_class  \\\n",
       "0  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "1  2024-08-10 03:04:24.451964  2024-08-10 03:04:24.451964     INDUSTRY   \n",
       "2  2024-08-10 03:04:24.451964  2024-08-10 03:04:24.451964     INDUSTRY   \n",
       "3  2024-08-10 03:04:24.451964  2024-08-10 03:04:24.451964     INDUSTRY   \n",
       "4  2024-08-10 03:04:24.451964  2024-08-10 03:04:24.451964     INDUSTRY   \n",
       "\n",
       "   delayed_posting expanded_access_nctid expanded_access_status_for_nctid  \\\n",
       "0              NaN                   NaN                              NaN   \n",
       "1              NaN                   NaN                              NaN   \n",
       "2              NaN                   NaN                              NaN   \n",
       "3              NaN                   NaN                              NaN   \n",
       "4              NaN                   NaN                              NaN   \n",
       "\n",
       "   fdaaa801_violation  baseline_type_units_analyzed  patient_registry  \\\n",
       "0                 NaN                           NaN               NaN   \n",
       "1                 NaN                           NaN               NaN   \n",
       "2                 NaN                           NaN               NaN   \n",
       "3                 NaN                           NaN               NaN   \n",
       "4                 NaN                           NaN               NaN   \n",
       "\n",
       "  drug_outcome           disease_type new_therapy_area        id  \\\n",
       "0      success   Lung, Non-Small Cell         Oncology  29671336   \n",
       "1      success   Lung, Non-Small Cell         Oncology  29905748   \n",
       "2      failure   Lung, Non-Small Cell         Oncology  29905748   \n",
       "3      success  Colorectal (Oncology)         Oncology  29905748   \n",
       "4      failure  Colorectal (Oncology)         Oncology  29905748   \n",
       "\n",
       "   number_of_facilities  number_of_nsae_subjects  number_of_sae_subjects  \\\n",
       "0                  47.0                    540.0                   124.0   \n",
       "1                   6.0                     33.0                     5.0   \n",
       "2                   6.0                     33.0                     5.0   \n",
       "3                   6.0                     33.0                     5.0   \n",
       "4                   6.0                     33.0                     5.0   \n",
       "\n",
       "   registered_in_calendar_year  nlm_download_date  actual_duration  \\\n",
       "0                         2008                NaN             29.0   \n",
       "1                         2019                NaN              NaN   \n",
       "2                         2019                NaN              NaN   \n",
       "3                         2019                NaN              NaN   \n",
       "4                         2019                NaN              NaN   \n",
       "\n",
       "  were_results_reported  months_to_report_results has_us_facility  \\\n",
       "0                     t                       6.0               t   \n",
       "1                     t                      12.0               t   \n",
       "2                     t                      12.0               t   \n",
       "3                     t                      12.0               t   \n",
       "4                     t                      12.0               t   \n",
       "\n",
       "  has_single_facility  minimum_age_num  maximum_age_num minimum_age_unit  \\\n",
       "0                   f             18.0              NaN            Years   \n",
       "1                   f             18.0              NaN            Years   \n",
       "2                   f             18.0              NaN            Years   \n",
       "3                   f             18.0              NaN            Years   \n",
       "4                   f             18.0              NaN            Years   \n",
       "\n",
       "  maximum_age_unit  number_of_primary_outcomes_to_measure  \\\n",
       "0              NaN                                    1.0   \n",
       "1              NaN                                    3.0   \n",
       "2              NaN                                    3.0   \n",
       "3              NaN                                    3.0   \n",
       "4              NaN                                    3.0   \n",
       "\n",
       "   number_of_secondary_outcomes_to_measure  \\\n",
       "0                                      3.0   \n",
       "1                                      8.0   \n",
       "2                                      8.0   \n",
       "3                                      8.0   \n",
       "4                                      8.0   \n",
       "\n",
       "   number_of_other_outcomes_to_measure  \n",
       "0                                  NaN  \n",
       "1                                  NaN  \n",
       "2                                  NaN  \n",
       "3                                  NaN  \n",
       "4                                  NaN  "
      ]
     },
     "execution_count": 127,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# merge calculated values table with p2_p4 table\n",
    "merged_df_1123 = pd.merge(merged_df_1123, df_calculated_values, left_on=\"nct_id\", right_on=\"nct_id\", how=\"inner\")\n",
    "merged_df_1123.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 128,
   "id": "744f053b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(10616, 117)"
      ]
     },
     "execution_count": 128,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "merged_df_1123.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 129,
   "id": "3c678ad5",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>nct_id</th>\n",
       "      <th>sampling_method</th>\n",
       "      <th>gender</th>\n",
       "      <th>minimum_age</th>\n",
       "      <th>maximum_age</th>\n",
       "      <th>healthy_volunteers</th>\n",
       "      <th>population</th>\n",
       "      <th>criteria</th>\n",
       "      <th>gender_description</th>\n",
       "      <th>gender_based</th>\n",
       "      <th>adult</th>\n",
       "      <th>child</th>\n",
       "      <th>older_adult</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>7469903</td>\n",
       "      <td>NCT04882709</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>99 Years</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Adults (18-99 years) wit...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>7469904</td>\n",
       "      <td>NCT02714556</td>\n",
       "      <td>NON_PROBABILITY_SAMPLE</td>\n",
       "      <td>FEMALE</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>Pregnant women scheduled for elective caesarea...</td>\n",
       "      <td>Inclusion Criteria:~* Written informed consent...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>7469905</td>\n",
       "      <td>NCT04478656</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>65 Years</td>\n",
       "      <td>t</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~1. Normal healthy male and...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>7469906</td>\n",
       "      <td>NCT02448056</td>\n",
       "      <td>NON_PROBABILITY_SAMPLE</td>\n",
       "      <td>ALL</td>\n",
       "      <td>20 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>HCC receive surgery, RFA, TACE or Sorafenib tx.</td>\n",
       "      <td>Inclusion Criteria:~* HCC, diagnosed by AASLD ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>7469907</td>\n",
       "      <td>NCT03516409</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>6 Months</td>\n",
       "      <td>35 Months</td>\n",
       "      <td>t</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* 1. Parents / legal guard...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        id       nct_id         sampling_method  gender minimum_age  \\\n",
       "0  7469903  NCT04882709                     NaN     ALL    18 Years   \n",
       "1  7469904  NCT02714556  NON_PROBABILITY_SAMPLE  FEMALE    18 Years   \n",
       "2  7469905  NCT04478656                     NaN     ALL    18 Years   \n",
       "3  7469906  NCT02448056  NON_PROBABILITY_SAMPLE     ALL    20 Years   \n",
       "4  7469907  NCT03516409                     NaN     ALL    6 Months   \n",
       "\n",
       "  maximum_age healthy_volunteers  \\\n",
       "0    99 Years                  f   \n",
       "1         NaN                  f   \n",
       "2    65 Years                  t   \n",
       "3         NaN                  f   \n",
       "4   35 Months                  t   \n",
       "\n",
       "                                          population  \\\n",
       "0                                                NaN   \n",
       "1  Pregnant women scheduled for elective caesarea...   \n",
       "2                                                NaN   \n",
       "3    HCC receive surgery, RFA, TACE or Sorafenib tx.   \n",
       "4                                                NaN   \n",
       "\n",
       "                                            criteria gender_description  \\\n",
       "0  Inclusion Criteria:~* Adults (18-99 years) wit...                NaN   \n",
       "1  Inclusion Criteria:~* Written informed consent...                NaN   \n",
       "2  Inclusion Criteria:~1. Normal healthy male and...                NaN   \n",
       "3  Inclusion Criteria:~* HCC, diagnosed by AASLD ...                NaN   \n",
       "4  Inclusion Criteria:~* 1. Parents / legal guard...                NaN   \n",
       "\n",
       "  gender_based adult child older_adult  \n",
       "0          NaN     t     f           t  \n",
       "1          NaN     t     f           t  \n",
       "2          NaN     t     f           t  \n",
       "3          NaN     t     f           t  \n",
       "4          NaN     f     t           f  "
      ]
     },
     "execution_count": 129,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# load eligibilities table from AACT\n",
    "df_eligibilities = pd.read_csv('b3t0zvq5n6oyhvv9h6v8qsqg4j57/eligibilities.txt', sep='|')\n",
    "df_eligibilities.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 130,
   "id": "3737b614",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nct_id</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>description</th>\n",
       "      <th>trial_drug_cleaned</th>\n",
       "      <th>conditions</th>\n",
       "      <th>Drug Name</th>\n",
       "      <th>Highest Status</th>\n",
       "      <th>Other Drug Names</th>\n",
       "      <th>Originator Company</th>\n",
       "      <th>Originator Company HQ</th>\n",
       "      <th>Active Companies</th>\n",
       "      <th>Active Companies HQ</th>\n",
       "      <th>Therapy Area</th>\n",
       "      <th>Active Indications</th>\n",
       "      <th>Action</th>\n",
       "      <th>Technologies</th>\n",
       "      <th>Regulatory Designations</th>\n",
       "      <th>Inactive Indications</th>\n",
       "      <th>Inactive Companies</th>\n",
       "      <th>Has Deals</th>\n",
       "      <th>Last Change Date</th>\n",
       "      <th>Added Date</th>\n",
       "      <th>First Launched Date</th>\n",
       "      <th>Extract</th>\n",
       "      <th>Drug Id</th>\n",
       "      <th>cortellis_cleaned_drug</th>\n",
       "      <th>nlm_download_date_description</th>\n",
       "      <th>study_first_submitted_date</th>\n",
       "      <th>results_first_submitted_date</th>\n",
       "      <th>disposition_first_submitted_date</th>\n",
       "      <th>last_update_submitted_date</th>\n",
       "      <th>study_first_submitted_qc_date</th>\n",
       "      <th>study_first_posted_date</th>\n",
       "      <th>study_first_posted_date_type</th>\n",
       "      <th>results_first_submitted_qc_date</th>\n",
       "      <th>results_first_posted_date</th>\n",
       "      <th>results_first_posted_date_type</th>\n",
       "      <th>disposition_first_submitted_qc_date</th>\n",
       "      <th>disposition_first_posted_date</th>\n",
       "      <th>disposition_first_posted_date_type</th>\n",
       "      <th>last_update_submitted_qc_date</th>\n",
       "      <th>last_update_posted_date</th>\n",
       "      <th>last_update_posted_date_type</th>\n",
       "      <th>start_month_year</th>\n",
       "      <th>start_date_type</th>\n",
       "      <th>start_date</th>\n",
       "      <th>verification_month_year</th>\n",
       "      <th>verification_date</th>\n",
       "      <th>completion_month_year</th>\n",
       "      <th>completion_date_type</th>\n",
       "      <th>completion_date</th>\n",
       "      <th>primary_completion_month_year</th>\n",
       "      <th>primary_completion_date_type</th>\n",
       "      <th>primary_completion_date</th>\n",
       "      <th>target_duration</th>\n",
       "      <th>study_type</th>\n",
       "      <th>acronym</th>\n",
       "      <th>baseline_population</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>official_title</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>last_known_status</th>\n",
       "      <th>phase</th>\n",
       "      <th>enrollment</th>\n",
       "      <th>enrollment_type</th>\n",
       "      <th>source</th>\n",
       "      <th>limitations_and_caveats</th>\n",
       "      <th>number_of_arms</th>\n",
       "      <th>number_of_groups</th>\n",
       "      <th>why_stopped</th>\n",
       "      <th>has_expanded_access</th>\n",
       "      <th>expanded_access_type_individual</th>\n",
       "      <th>expanded_access_type_intermediate</th>\n",
       "      <th>expanded_access_type_treatment</th>\n",
       "      <th>has_dmc</th>\n",
       "      <th>is_fda_regulated_drug</th>\n",
       "      <th>is_fda_regulated_device</th>\n",
       "      <th>is_unapproved_device</th>\n",
       "      <th>is_ppsd</th>\n",
       "      <th>is_us_export</th>\n",
       "      <th>biospec_retention</th>\n",
       "      <th>biospec_description</th>\n",
       "      <th>ipd_time_frame</th>\n",
       "      <th>ipd_access_criteria</th>\n",
       "      <th>ipd_url</th>\n",
       "      <th>plan_to_share_ipd</th>\n",
       "      <th>plan_to_share_ipd_description</th>\n",
       "      <th>created_at</th>\n",
       "      <th>updated_at</th>\n",
       "      <th>source_class</th>\n",
       "      <th>delayed_posting</th>\n",
       "      <th>expanded_access_nctid</th>\n",
       "      <th>expanded_access_status_for_nctid</th>\n",
       "      <th>fdaaa801_violation</th>\n",
       "      <th>baseline_type_units_analyzed</th>\n",
       "      <th>patient_registry</th>\n",
       "      <th>drug_outcome</th>\n",
       "      <th>disease_type</th>\n",
       "      <th>new_therapy_area</th>\n",
       "      <th>id_x</th>\n",
       "      <th>number_of_facilities</th>\n",
       "      <th>number_of_nsae_subjects</th>\n",
       "      <th>number_of_sae_subjects</th>\n",
       "      <th>registered_in_calendar_year</th>\n",
       "      <th>nlm_download_date</th>\n",
       "      <th>actual_duration</th>\n",
       "      <th>were_results_reported</th>\n",
       "      <th>months_to_report_results</th>\n",
       "      <th>has_us_facility</th>\n",
       "      <th>has_single_facility</th>\n",
       "      <th>minimum_age_num</th>\n",
       "      <th>maximum_age_num</th>\n",
       "      <th>minimum_age_unit</th>\n",
       "      <th>maximum_age_unit</th>\n",
       "      <th>number_of_primary_outcomes_to_measure</th>\n",
       "      <th>number_of_secondary_outcomes_to_measure</th>\n",
       "      <th>number_of_other_outcomes_to_measure</th>\n",
       "      <th>id_y</th>\n",
       "      <th>sampling_method</th>\n",
       "      <th>gender</th>\n",
       "      <th>minimum_age</th>\n",
       "      <th>maximum_age</th>\n",
       "      <th>healthy_volunteers</th>\n",
       "      <th>population</th>\n",
       "      <th>criteria</th>\n",
       "      <th>gender_description</th>\n",
       "      <th>gender_based</th>\n",
       "      <th>adult</th>\n",
       "      <th>child</th>\n",
       "      <th>older_adult</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT04165031</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>Administered orally</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2019-11-15</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>2021-10</td>\n",
       "      <td>2021-10-31</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>All participants who received at least one dos...</td>\n",
       "      <td>A Study of LY3499446 in Participants With Adva...</td>\n",
       "      <td>A Phase 1/2 Study of LY3499446 Administered to...</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE1/PHASE2</td>\n",
       "      <td>5.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Data are available 6 months after the primary ...</td>\n",
       "      <td>A research proposal must be approved by an ind...</td>\n",
       "      <td>https://vivli.org/</td>\n",
       "      <td>YES</td>\n",
       "      <td>Anonymized individual patient level data will ...</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29905748</td>\n",
       "      <td>6.0</td>\n",
       "      <td>33.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>2019</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>12.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3.0</td>\n",
       "      <td>8.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7625501</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Participants must have d...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT04165031</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>Administered orally</td>\n",
       "      <td>ly3499446</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>LY-3499446</td>\n",
       "      <td>Discontinued</td>\n",
       "      <td>KRAS G12C inhibitor (cancer), Eli Lilly; LY-34...</td>\n",
       "      <td>Eli Lilly &amp; Co</td>\n",
       "      <td>Eli Lilly &amp; Co (US)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Anticancer; K-Ras GTPase inhibitor</td>\n",
       "      <td>Oral formulation; Small molecule therapeutic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Colorectal tumor; Non-small-cell lung cancer; ...</td>\n",
       "      <td>Eli Lilly &amp; Co</td>\n",
       "      <td>No</td>\n",
       "      <td>2023-10-04</td>\n",
       "      <td>2019-11-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Eli Lilly was developing LY-3499446, a selecti...</td>\n",
       "      <td>120133</td>\n",
       "      <td>ly3499446</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2019-11-15</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>2021-10</td>\n",
       "      <td>2021-10-31</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>All participants who received at least one dos...</td>\n",
       "      <td>A Study of LY3499446 in Participants With Adva...</td>\n",
       "      <td>A Phase 1/2 Study of LY3499446 Administered to...</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE1/PHASE2</td>\n",
       "      <td>5.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Data are available 6 months after the primary ...</td>\n",
       "      <td>A research proposal must be approved by an ind...</td>\n",
       "      <td>https://vivli.org/</td>\n",
       "      <td>YES</td>\n",
       "      <td>Anonymized individual patient level data will ...</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>failure</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29905748</td>\n",
       "      <td>6.0</td>\n",
       "      <td>33.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>2019</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>12.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3.0</td>\n",
       "      <td>8.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7625501</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Participants must have d...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT04165031</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>Administered IV</td>\n",
       "      <td>cetuximab</td>\n",
       "      <td>colorectal cancer</td>\n",
       "      <td>cetuximab</td>\n",
       "      <td>Launched</td>\n",
       "      <td>BMS-564717; C225; EMD-271786; EMR-62202; Erbit...</td>\n",
       "      <td>Imclone Systems Inc</td>\n",
       "      <td>Imclone Systems Inc (US)</td>\n",
       "      <td>Imclone Systems Inc; Merck KGaA; Merck Serono SA</td>\n",
       "      <td>Imclone Systems Inc (US); Merck KGaA (Germany)...</td>\n",
       "      <td>Cancer; Neurology/Psychiatric</td>\n",
       "      <td>Anal tumor; Cutaneous squamous cell carcinoma;...</td>\n",
       "      <td>Analgesic; Anticancer; Anticancer monoclonal a...</td>\n",
       "      <td>Biological therapeutic; Chimeric monoclonal an...</td>\n",
       "      <td>Accelerated Approval; Fast Track; Orphan Drug;...</td>\n",
       "      <td>Biliary cancer; Bladder cancer; Breast tumor; ...</td>\n",
       "      <td>Bristol-Myers Squibb Co; Inven2</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-03</td>\n",
       "      <td>1996-02-16</td>\n",
       "      <td>2003-12-01</td>\n",
       "      <td>Cetuximab (Erbitux) is a human-murine chimeric...</td>\n",
       "      <td>10388</td>\n",
       "      <td>cetuximab</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2019-11-15</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>2021-10</td>\n",
       "      <td>2021-10-31</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>All participants who received at least one dos...</td>\n",
       "      <td>A Study of LY3499446 in Participants With Adva...</td>\n",
       "      <td>A Phase 1/2 Study of LY3499446 Administered to...</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE1/PHASE2</td>\n",
       "      <td>5.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Data are available 6 months after the primary ...</td>\n",
       "      <td>A research proposal must be approved by an ind...</td>\n",
       "      <td>https://vivli.org/</td>\n",
       "      <td>YES</td>\n",
       "      <td>Anonymized individual patient level data will ...</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Colorectal (Oncology)</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29905748</td>\n",
       "      <td>6.0</td>\n",
       "      <td>33.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>2019</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>12.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3.0</td>\n",
       "      <td>8.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7625501</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Participants must have d...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT04165031</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>Administered orally</td>\n",
       "      <td>ly3499446</td>\n",
       "      <td>colorectal cancer</td>\n",
       "      <td>LY-3499446</td>\n",
       "      <td>Discontinued</td>\n",
       "      <td>KRAS G12C inhibitor (cancer), Eli Lilly; LY-34...</td>\n",
       "      <td>Eli Lilly &amp; Co</td>\n",
       "      <td>Eli Lilly &amp; Co (US)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Anticancer; K-Ras GTPase inhibitor</td>\n",
       "      <td>Oral formulation; Small molecule therapeutic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Colorectal tumor; Non-small-cell lung cancer; ...</td>\n",
       "      <td>Eli Lilly &amp; Co</td>\n",
       "      <td>No</td>\n",
       "      <td>2023-10-04</td>\n",
       "      <td>2019-11-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Eli Lilly was developing LY-3499446, a selecti...</td>\n",
       "      <td>120133</td>\n",
       "      <td>ly3499446</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2019-11-15</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>2021-10</td>\n",
       "      <td>2021-10-31</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>All participants who received at least one dos...</td>\n",
       "      <td>A Study of LY3499446 in Participants With Adva...</td>\n",
       "      <td>A Phase 1/2 Study of LY3499446 Administered to...</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE1/PHASE2</td>\n",
       "      <td>5.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Data are available 6 months after the primary ...</td>\n",
       "      <td>A research proposal must be approved by an ind...</td>\n",
       "      <td>https://vivli.org/</td>\n",
       "      <td>YES</td>\n",
       "      <td>Anonymized individual patient level data will ...</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>failure</td>\n",
       "      <td>Colorectal (Oncology)</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29905748</td>\n",
       "      <td>6.0</td>\n",
       "      <td>33.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>2019</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>12.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3.0</td>\n",
       "      <td>8.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7625501</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Participants must have d...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        nct_id intervention_type  \\\n",
       "0  NCT00606502              DRUG   \n",
       "1  NCT04165031              DRUG   \n",
       "2  NCT04165031              DRUG   \n",
       "3  NCT04165031              DRUG   \n",
       "4  NCT04165031              DRUG   \n",
       "\n",
       "                                         description trial_drug_cleaned  \\\n",
       "0  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "1                                Administered orally          erlotinib   \n",
       "2                                Administered orally          ly3499446   \n",
       "3                                    Administered IV          cetuximab   \n",
       "4                                Administered orally          ly3499446   \n",
       "\n",
       "                   conditions   Drug Name Highest Status  \\\n",
       "0  non-small cell lung cancer   erlotinib       Launched   \n",
       "1  non-small cell lung cancer   erlotinib       Launched   \n",
       "2  non-small cell lung cancer  LY-3499446   Discontinued   \n",
       "3           colorectal cancer   cetuximab       Launched   \n",
       "4           colorectal cancer  LY-3499446   Discontinued   \n",
       "\n",
       "                                    Other Drug Names       Originator Company  \\\n",
       "0  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "1  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "2  KRAS G12C inhibitor (cancer), Eli Lilly; LY-34...           Eli Lilly & Co   \n",
       "3  BMS-564717; C225; EMD-271786; EMR-62202; Erbit...      Imclone Systems Inc   \n",
       "4  KRAS G12C inhibitor (cancer), Eli Lilly; LY-34...           Eli Lilly & Co   \n",
       "\n",
       "          Originator Company HQ  \\\n",
       "0  OSI Pharmaceuticals Inc (US)   \n",
       "1  OSI Pharmaceuticals Inc (US)   \n",
       "2           Eli Lilly & Co (US)   \n",
       "3      Imclone Systems Inc (US)   \n",
       "4           Eli Lilly & Co (US)   \n",
       "\n",
       "                                    Active Companies  \\\n",
       "0  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "1  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "2                                                NaN   \n",
       "3   Imclone Systems Inc; Merck KGaA; Merck Serono SA   \n",
       "4                                                NaN   \n",
       "\n",
       "                                 Active Companies HQ  \\\n",
       "0  Astellas Pharma Inc (Japan); Baheal Pharmaceut...   \n",
       "1  Astellas Pharma Inc (Japan); Baheal Pharmaceut...   \n",
       "2                                                NaN   \n",
       "3  Imclone Systems Inc (US); Merck KGaA (Germany)...   \n",
       "4                                                NaN   \n",
       "\n",
       "                    Therapy Area  \\\n",
       "0           Cancer; Dermatologic   \n",
       "1           Cancer; Dermatologic   \n",
       "2                         Cancer   \n",
       "3  Cancer; Neurology/Psychiatric   \n",
       "4                         Cancer   \n",
       "\n",
       "                                  Active Indications  \\\n",
       "0  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "1  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "2                                                NaN   \n",
       "3  Anal tumor; Cutaneous squamous cell carcinoma;...   \n",
       "4                                                NaN   \n",
       "\n",
       "                                              Action  \\\n",
       "0  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "1  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "2                 Anticancer; K-Ras GTPase inhibitor   \n",
       "3  Analgesic; Anticancer; Anticancer monoclonal a...   \n",
       "4                 Anticancer; K-Ras GTPase inhibitor   \n",
       "\n",
       "                                        Technologies  \\\n",
       "0  Film coating; Oral formulation; Small molecule...   \n",
       "1  Film coating; Oral formulation; Small molecule...   \n",
       "2       Oral formulation; Small molecule therapeutic   \n",
       "3  Biological therapeutic; Chimeric monoclonal an...   \n",
       "4       Oral formulation; Small molecule therapeutic   \n",
       "\n",
       "                             Regulatory Designations  \\\n",
       "0                            Fast Track; Orphan Drug   \n",
       "1                            Fast Track; Orphan Drug   \n",
       "2                                                NaN   \n",
       "3  Accelerated Approval; Fast Track; Orphan Drug;...   \n",
       "4                                                NaN   \n",
       "\n",
       "                                Inactive Indications  \\\n",
       "0  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "1  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "2  Colorectal tumor; Non-small-cell lung cancer; ...   \n",
       "3  Biliary cancer; Bladder cancer; Breast tumor; ...   \n",
       "4  Colorectal tumor; Non-small-cell lung cancer; ...   \n",
       "\n",
       "                Inactive Companies Has Deals Last Change Date  Added Date  \\\n",
       "0      Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "1      Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "2                   Eli Lilly & Co        No       2023-10-04  2019-11-22   \n",
       "3  Bristol-Myers Squibb Co; Inven2       Yes       2024-07-03  1996-02-16   \n",
       "4                   Eli Lilly & Co        No       2023-10-04  2019-11-22   \n",
       "\n",
       "  First Launched Date                                            Extract  \\\n",
       "0          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "1          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "2                 NaN  Eli Lilly was developing LY-3499446, a selecti...   \n",
       "3          2003-12-01  Cetuximab (Erbitux) is a human-murine chimeric...   \n",
       "4                 NaN  Eli Lilly was developing LY-3499446, a selecti...   \n",
       "\n",
       "   Drug Id cortellis_cleaned_drug  nlm_download_date_description  \\\n",
       "0    11961              erlotinib                            NaN   \n",
       "1    11961              erlotinib                            NaN   \n",
       "2   120133              ly3499446                            NaN   \n",
       "3    10388              cetuximab                            NaN   \n",
       "4   120133              ly3499446                            NaN   \n",
       "\n",
       "  study_first_submitted_date results_first_submitted_date  \\\n",
       "0                 2008-01-22                   2010-12-22   \n",
       "1                 2019-11-14                   2021-10-27   \n",
       "2                 2019-11-14                   2021-10-27   \n",
       "3                 2019-11-14                   2021-10-27   \n",
       "4                 2019-11-14                   2021-10-27   \n",
       "\n",
       "  disposition_first_submitted_date last_update_submitted_date  \\\n",
       "0                              NaN                 2021-02-08   \n",
       "1                              NaN                 2021-10-27   \n",
       "2                              NaN                 2021-10-27   \n",
       "3                              NaN                 2021-10-27   \n",
       "4                              NaN                 2021-10-27   \n",
       "\n",
       "  study_first_submitted_qc_date study_first_posted_date  \\\n",
       "0                    2008-02-01              2008-02-04   \n",
       "1                    2019-11-14              2019-11-15   \n",
       "2                    2019-11-14              2019-11-15   \n",
       "3                    2019-11-14              2019-11-15   \n",
       "4                    2019-11-14              2019-11-15   \n",
       "\n",
       "  study_first_posted_date_type results_first_submitted_qc_date  \\\n",
       "0                    ESTIMATED                      2010-12-22   \n",
       "1                       ACTUAL                      2021-10-27   \n",
       "2                       ACTUAL                      2021-10-27   \n",
       "3                       ACTUAL                      2021-10-27   \n",
       "4                       ACTUAL                      2021-10-27   \n",
       "\n",
       "  results_first_posted_date results_first_posted_date_type  \\\n",
       "0                2011-01-20                      ESTIMATED   \n",
       "1                2021-11-24                         ACTUAL   \n",
       "2                2021-11-24                         ACTUAL   \n",
       "3                2021-11-24                         ACTUAL   \n",
       "4                2021-11-24                         ACTUAL   \n",
       "\n",
       "  disposition_first_submitted_qc_date disposition_first_posted_date  \\\n",
       "0                                 NaN                           NaN   \n",
       "1                                 NaN                           NaN   \n",
       "2                                 NaN                           NaN   \n",
       "3                                 NaN                           NaN   \n",
       "4                                 NaN                           NaN   \n",
       "\n",
       "  disposition_first_posted_date_type last_update_submitted_qc_date  \\\n",
       "0                                NaN                    2021-02-08   \n",
       "1                                NaN                    2021-10-27   \n",
       "2                                NaN                    2021-10-27   \n",
       "3                                NaN                    2021-10-27   \n",
       "4                                NaN                    2021-10-27   \n",
       "\n",
       "  last_update_posted_date last_update_posted_date_type start_month_year  \\\n",
       "0              2021-03-05                       ACTUAL          2008-01   \n",
       "1              2021-11-24                       ACTUAL       2019-11-28   \n",
       "2              2021-11-24                       ACTUAL       2019-11-28   \n",
       "3              2021-11-24                       ACTUAL       2019-11-28   \n",
       "4              2021-11-24                       ACTUAL       2019-11-28   \n",
       "\n",
       "  start_date_type start_date verification_month_year verification_date  \\\n",
       "0             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "1          ACTUAL 2019-11-28                 2021-10        2021-10-31   \n",
       "2          ACTUAL 2019-11-28                 2021-10        2021-10-31   \n",
       "3          ACTUAL 2019-11-28                 2021-10        2021-10-31   \n",
       "4          ACTUAL 2019-11-28                 2021-10        2021-10-31   \n",
       "\n",
       "  completion_month_year completion_date_type completion_date  \\\n",
       "0            2010-06-24               ACTUAL      2010-06-24   \n",
       "1            2020-10-30               ACTUAL      2020-10-30   \n",
       "2            2020-10-30               ACTUAL      2020-10-30   \n",
       "3            2020-10-30               ACTUAL      2020-10-30   \n",
       "4            2020-10-30               ACTUAL      2020-10-30   \n",
       "\n",
       "  primary_completion_month_year primary_completion_date_type  \\\n",
       "0                    2010-06-24                       ACTUAL   \n",
       "1                    2020-10-30                       ACTUAL   \n",
       "2                    2020-10-30                       ACTUAL   \n",
       "3                    2020-10-30                       ACTUAL   \n",
       "4                    2020-10-30                       ACTUAL   \n",
       "\n",
       "  primary_completion_date  target_duration      study_type acronym  \\\n",
       "0              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "1              2020-10-30              NaN  INTERVENTIONAL     NaN   \n",
       "2              2020-10-30              NaN  INTERVENTIONAL     NaN   \n",
       "3              2020-10-30              NaN  INTERVENTIONAL     NaN   \n",
       "4              2020-10-30              NaN  INTERVENTIONAL     NaN   \n",
       "\n",
       "                                 baseline_population  \\\n",
       "0                                                NaN   \n",
       "1  All participants who received at least one dos...   \n",
       "2  All participants who received at least one dos...   \n",
       "3  All participants who received at least one dos...   \n",
       "4  All participants who received at least one dos...   \n",
       "\n",
       "                                         brief_title  \\\n",
       "0  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "1  A Study of LY3499446 in Participants With Adva...   \n",
       "2  A Study of LY3499446 in Participants With Adva...   \n",
       "3  A Study of LY3499446 in Participants With Adva...   \n",
       "4  A Study of LY3499446 in Participants With Adva...   \n",
       "\n",
       "                                      official_title overall_status  \\\n",
       "0  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "1  A Phase 1/2 Study of LY3499446 Administered to...     TERMINATED   \n",
       "2  A Phase 1/2 Study of LY3499446 Administered to...     TERMINATED   \n",
       "3  A Phase 1/2 Study of LY3499446 Administered to...     TERMINATED   \n",
       "4  A Phase 1/2 Study of LY3499446 Administered to...     TERMINATED   \n",
       "\n",
       "   last_known_status          phase  enrollment enrollment_type  \\\n",
       "0                NaN         PHASE2       201.0          ACTUAL   \n",
       "1                NaN  PHASE1/PHASE2         5.0          ACTUAL   \n",
       "2                NaN  PHASE1/PHASE2         5.0          ACTUAL   \n",
       "3                NaN  PHASE1/PHASE2         5.0          ACTUAL   \n",
       "4                NaN  PHASE1/PHASE2         5.0          ACTUAL   \n",
       "\n",
       "                          source  \\\n",
       "0  Spectrum Pharmaceuticals, Inc   \n",
       "1          Eli Lilly and Company   \n",
       "2          Eli Lilly and Company   \n",
       "3          Eli Lilly and Company   \n",
       "4          Eli Lilly and Company   \n",
       "\n",
       "                             limitations_and_caveats  number_of_arms  \\\n",
       "0  The date of the CRF database cut-off for patie...             2.0   \n",
       "1  The study was terminated due to an unexpected ...             6.0   \n",
       "2  The study was terminated due to an unexpected ...             6.0   \n",
       "3  The study was terminated due to an unexpected ...             6.0   \n",
       "4  The study was terminated due to an unexpected ...             6.0   \n",
       "\n",
       "   number_of_groups                                        why_stopped  \\\n",
       "0               NaN                                                NaN   \n",
       "1               NaN  The study was terminated due to an unexpected ...   \n",
       "2               NaN  The study was terminated due to an unexpected ...   \n",
       "3               NaN  The study was terminated due to an unexpected ...   \n",
       "4               NaN  The study was terminated due to an unexpected ...   \n",
       "\n",
       "  has_expanded_access  expanded_access_type_individual  \\\n",
       "0                   f                              NaN   \n",
       "1                   f                              NaN   \n",
       "2                   f                              NaN   \n",
       "3                   f                              NaN   \n",
       "4                   f                              NaN   \n",
       "\n",
       "   expanded_access_type_intermediate  expanded_access_type_treatment has_dmc  \\\n",
       "0                                NaN                             NaN     NaN   \n",
       "1                                NaN                             NaN       f   \n",
       "2                                NaN                             NaN       f   \n",
       "3                                NaN                             NaN       f   \n",
       "4                                NaN                             NaN       f   \n",
       "\n",
       "  is_fda_regulated_drug is_fda_regulated_device is_unapproved_device  is_ppsd  \\\n",
       "0                   NaN                     NaN                  NaN      NaN   \n",
       "1                     t                       f                  NaN      NaN   \n",
       "2                     t                       f                  NaN      NaN   \n",
       "3                     t                       f                  NaN      NaN   \n",
       "4                     t                       f                  NaN      NaN   \n",
       "\n",
       "  is_us_export  biospec_retention  biospec_description  \\\n",
       "0          NaN                NaN                  NaN   \n",
       "1          NaN                NaN                  NaN   \n",
       "2          NaN                NaN                  NaN   \n",
       "3          NaN                NaN                  NaN   \n",
       "4          NaN                NaN                  NaN   \n",
       "\n",
       "                                      ipd_time_frame  \\\n",
       "0                                                NaN   \n",
       "1  Data are available 6 months after the primary ...   \n",
       "2  Data are available 6 months after the primary ...   \n",
       "3  Data are available 6 months after the primary ...   \n",
       "4  Data are available 6 months after the primary ...   \n",
       "\n",
       "                                 ipd_access_criteria             ipd_url  \\\n",
       "0                                                NaN                 NaN   \n",
       "1  A research proposal must be approved by an ind...  https://vivli.org/   \n",
       "2  A research proposal must be approved by an ind...  https://vivli.org/   \n",
       "3  A research proposal must be approved by an ind...  https://vivli.org/   \n",
       "4  A research proposal must be approved by an ind...  https://vivli.org/   \n",
       "\n",
       "  plan_to_share_ipd                      plan_to_share_ipd_description  \\\n",
       "0               NaN                                                NaN   \n",
       "1               YES  Anonymized individual patient level data will ...   \n",
       "2               YES  Anonymized individual patient level data will ...   \n",
       "3               YES  Anonymized individual patient level data will ...   \n",
       "4               YES  Anonymized individual patient level data will ...   \n",
       "\n",
       "                   created_at                  updated_at source_class  \\\n",
       "0  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "1  2024-08-10 03:04:24.451964  2024-08-10 03:04:24.451964     INDUSTRY   \n",
       "2  2024-08-10 03:04:24.451964  2024-08-10 03:04:24.451964     INDUSTRY   \n",
       "3  2024-08-10 03:04:24.451964  2024-08-10 03:04:24.451964     INDUSTRY   \n",
       "4  2024-08-10 03:04:24.451964  2024-08-10 03:04:24.451964     INDUSTRY   \n",
       "\n",
       "   delayed_posting expanded_access_nctid expanded_access_status_for_nctid  \\\n",
       "0              NaN                   NaN                              NaN   \n",
       "1              NaN                   NaN                              NaN   \n",
       "2              NaN                   NaN                              NaN   \n",
       "3              NaN                   NaN                              NaN   \n",
       "4              NaN                   NaN                              NaN   \n",
       "\n",
       "   fdaaa801_violation  baseline_type_units_analyzed  patient_registry  \\\n",
       "0                 NaN                           NaN               NaN   \n",
       "1                 NaN                           NaN               NaN   \n",
       "2                 NaN                           NaN               NaN   \n",
       "3                 NaN                           NaN               NaN   \n",
       "4                 NaN                           NaN               NaN   \n",
       "\n",
       "  drug_outcome           disease_type new_therapy_area      id_x  \\\n",
       "0      success   Lung, Non-Small Cell         Oncology  29671336   \n",
       "1      success   Lung, Non-Small Cell         Oncology  29905748   \n",
       "2      failure   Lung, Non-Small Cell         Oncology  29905748   \n",
       "3      success  Colorectal (Oncology)         Oncology  29905748   \n",
       "4      failure  Colorectal (Oncology)         Oncology  29905748   \n",
       "\n",
       "   number_of_facilities  number_of_nsae_subjects  number_of_sae_subjects  \\\n",
       "0                  47.0                    540.0                   124.0   \n",
       "1                   6.0                     33.0                     5.0   \n",
       "2                   6.0                     33.0                     5.0   \n",
       "3                   6.0                     33.0                     5.0   \n",
       "4                   6.0                     33.0                     5.0   \n",
       "\n",
       "   registered_in_calendar_year  nlm_download_date  actual_duration  \\\n",
       "0                         2008                NaN             29.0   \n",
       "1                         2019                NaN              NaN   \n",
       "2                         2019                NaN              NaN   \n",
       "3                         2019                NaN              NaN   \n",
       "4                         2019                NaN              NaN   \n",
       "\n",
       "  were_results_reported  months_to_report_results has_us_facility  \\\n",
       "0                     t                       6.0               t   \n",
       "1                     t                      12.0               t   \n",
       "2                     t                      12.0               t   \n",
       "3                     t                      12.0               t   \n",
       "4                     t                      12.0               t   \n",
       "\n",
       "  has_single_facility  minimum_age_num  maximum_age_num minimum_age_unit  \\\n",
       "0                   f             18.0              NaN            Years   \n",
       "1                   f             18.0              NaN            Years   \n",
       "2                   f             18.0              NaN            Years   \n",
       "3                   f             18.0              NaN            Years   \n",
       "4                   f             18.0              NaN            Years   \n",
       "\n",
       "  maximum_age_unit  number_of_primary_outcomes_to_measure  \\\n",
       "0              NaN                                    1.0   \n",
       "1              NaN                                    3.0   \n",
       "2              NaN                                    3.0   \n",
       "3              NaN                                    3.0   \n",
       "4              NaN                                    3.0   \n",
       "\n",
       "   number_of_secondary_outcomes_to_measure  \\\n",
       "0                                      3.0   \n",
       "1                                      8.0   \n",
       "2                                      8.0   \n",
       "3                                      8.0   \n",
       "4                                      8.0   \n",
       "\n",
       "   number_of_other_outcomes_to_measure     id_y sampling_method gender  \\\n",
       "0                                  NaN  7316876             NaN    ALL   \n",
       "1                                  NaN  7625501             NaN    ALL   \n",
       "2                                  NaN  7625501             NaN    ALL   \n",
       "3                                  NaN  7625501             NaN    ALL   \n",
       "4                                  NaN  7625501             NaN    ALL   \n",
       "\n",
       "  minimum_age maximum_age healthy_volunteers population  \\\n",
       "0    18 Years         NaN                  f        NaN   \n",
       "1    18 Years         NaN                  f        NaN   \n",
       "2    18 Years         NaN                  f        NaN   \n",
       "3    18 Years         NaN                  f        NaN   \n",
       "4    18 Years         NaN                  f        NaN   \n",
       "\n",
       "                                            criteria gender_description  \\\n",
       "0  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "1  Inclusion Criteria:~* Participants must have d...                NaN   \n",
       "2  Inclusion Criteria:~* Participants must have d...                NaN   \n",
       "3  Inclusion Criteria:~* Participants must have d...                NaN   \n",
       "4  Inclusion Criteria:~* Participants must have d...                NaN   \n",
       "\n",
       "  gender_based adult child older_adult  \n",
       "0          NaN     t     f           t  \n",
       "1          NaN     t     f           t  \n",
       "2          NaN     t     f           t  \n",
       "3          NaN     t     f           t  \n",
       "4          NaN     t     f           t  "
      ]
     },
     "execution_count": 130,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# merge eligibilities table with p2_p4 table\n",
    "merged_df_1123 = pd.merge(merged_df_1123, df_eligibilities, left_on=\"nct_id\", right_on=\"nct_id\", how=\"inner\")\n",
    "merged_df_1123.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 131,
   "id": "e291aa28",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(10616, 130)"
      ]
     },
     "execution_count": 131,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "merged_df_1123.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 132,
   "id": "16b55410",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>nct_id</th>\n",
       "      <th>role</th>\n",
       "      <th>name</th>\n",
       "      <th>affiliation</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>6906313</td>\n",
       "      <td>NCT01905826</td>\n",
       "      <td>PRINCIPAL_INVESTIGATOR</td>\n",
       "      <td>Steven M Holland, M.D.</td>\n",
       "      <td>National Institute of Allergy and Infectious D...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>6906314</td>\n",
       "      <td>NCT06456398</td>\n",
       "      <td>PRINCIPAL_INVESTIGATOR</td>\n",
       "      <td>Xu-Heng Chiang, MD</td>\n",
       "      <td>National Taiwan University Hospital</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>6906315</td>\n",
       "      <td>NCT06324253</td>\n",
       "      <td>PRINCIPAL_INVESTIGATOR</td>\n",
       "      <td>AMAL G SAFAN, MD</td>\n",
       "      <td>Menoufia University</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>6906316</td>\n",
       "      <td>NCT06059846</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Kamal Hamed, MD</td>\n",
       "      <td>Spero Therapeutics</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>6906317</td>\n",
       "      <td>NCT04571242</td>\n",
       "      <td>STUDY_CHAIR</td>\n",
       "      <td>Ricardo Vallejo, MD</td>\n",
       "      <td>SGX Medical</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>477338</th>\n",
       "      <td>6811038</td>\n",
       "      <td>NCT01608191</td>\n",
       "      <td>PRINCIPAL_INVESTIGATOR</td>\n",
       "      <td>Jan Karlsson</td>\n",
       "      <td>Universitetssjukvrdens forskningscentrum, UFC...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>477339</th>\n",
       "      <td>6811039</td>\n",
       "      <td>NCT00039299</td>\n",
       "      <td>STUDY_CHAIR</td>\n",
       "      <td>Allan Pantuck, MD</td>\n",
       "      <td>Jonsson Comprehensive Cancer Center</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>477340</th>\n",
       "      <td>6811040</td>\n",
       "      <td>NCT03258606</td>\n",
       "      <td>PRINCIPAL_INVESTIGATOR</td>\n",
       "      <td>Marion Danis, M.D.</td>\n",
       "      <td>National Institutes of Health Clinical Center ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>477341</th>\n",
       "      <td>6811041</td>\n",
       "      <td>NCT02938156</td>\n",
       "      <td>PRINCIPAL_INVESTIGATOR</td>\n",
       "      <td>Pratima Chowdary</td>\n",
       "      <td>Royal Free Hospitals NHS Foundation Trust</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>477342</th>\n",
       "      <td>6811042</td>\n",
       "      <td>NCT02011399</td>\n",
       "      <td>PRINCIPAL_INVESTIGATOR</td>\n",
       "      <td>Jane E. Huggins, PhD</td>\n",
       "      <td>University of Michigan</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>477343 rows  5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "             id       nct_id                    role                    name  \\\n",
       "0       6906313  NCT01905826  PRINCIPAL_INVESTIGATOR  Steven M Holland, M.D.   \n",
       "1       6906314  NCT06456398  PRINCIPAL_INVESTIGATOR      Xu-Heng Chiang, MD   \n",
       "2       6906315  NCT06324253  PRINCIPAL_INVESTIGATOR        AMAL G SAFAN, MD   \n",
       "3       6906316  NCT06059846          STUDY_DIRECTOR         Kamal Hamed, MD   \n",
       "4       6906317  NCT04571242             STUDY_CHAIR     Ricardo Vallejo, MD   \n",
       "...         ...          ...                     ...                     ...   \n",
       "477338  6811038  NCT01608191  PRINCIPAL_INVESTIGATOR            Jan Karlsson   \n",
       "477339  6811039  NCT00039299             STUDY_CHAIR       Allan Pantuck, MD   \n",
       "477340  6811040  NCT03258606  PRINCIPAL_INVESTIGATOR      Marion Danis, M.D.   \n",
       "477341  6811041  NCT02938156  PRINCIPAL_INVESTIGATOR        Pratima Chowdary   \n",
       "477342  6811042  NCT02011399  PRINCIPAL_INVESTIGATOR    Jane E. Huggins, PhD   \n",
       "\n",
       "                                              affiliation  \n",
       "0       National Institute of Allergy and Infectious D...  \n",
       "1                     National Taiwan University Hospital  \n",
       "2                                     Menoufia University  \n",
       "3                                      Spero Therapeutics  \n",
       "4                                             SGX Medical  \n",
       "...                                                   ...  \n",
       "477338  Universitetssjukvrdens forskningscentrum, UFC...  \n",
       "477339                Jonsson Comprehensive Cancer Center  \n",
       "477340  National Institutes of Health Clinical Center ...  \n",
       "477341          Royal Free Hospitals NHS Foundation Trust  \n",
       "477342                             University of Michigan  \n",
       "\n",
       "[477343 rows x 5 columns]"
      ]
     },
     "execution_count": 132,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# load officials table from AACT\n",
    "df_overall_officials = pd.read_csv('b3t0zvq5n6oyhvv9h6v8qsqg4j57/overall_officials.txt', sep='|')\n",
    "df_overall_officials"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 133,
   "id": "61d76ee9",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nct_id</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>description</th>\n",
       "      <th>trial_drug_cleaned</th>\n",
       "      <th>conditions</th>\n",
       "      <th>Drug Name</th>\n",
       "      <th>Highest Status</th>\n",
       "      <th>Other Drug Names</th>\n",
       "      <th>Originator Company</th>\n",
       "      <th>Originator Company HQ</th>\n",
       "      <th>Active Companies</th>\n",
       "      <th>Active Companies HQ</th>\n",
       "      <th>Therapy Area</th>\n",
       "      <th>Active Indications</th>\n",
       "      <th>Action</th>\n",
       "      <th>Technologies</th>\n",
       "      <th>Regulatory Designations</th>\n",
       "      <th>Inactive Indications</th>\n",
       "      <th>Inactive Companies</th>\n",
       "      <th>Has Deals</th>\n",
       "      <th>Last Change Date</th>\n",
       "      <th>Added Date</th>\n",
       "      <th>First Launched Date</th>\n",
       "      <th>Extract</th>\n",
       "      <th>Drug Id</th>\n",
       "      <th>cortellis_cleaned_drug</th>\n",
       "      <th>nlm_download_date_description</th>\n",
       "      <th>study_first_submitted_date</th>\n",
       "      <th>results_first_submitted_date</th>\n",
       "      <th>disposition_first_submitted_date</th>\n",
       "      <th>last_update_submitted_date</th>\n",
       "      <th>study_first_submitted_qc_date</th>\n",
       "      <th>study_first_posted_date</th>\n",
       "      <th>study_first_posted_date_type</th>\n",
       "      <th>results_first_submitted_qc_date</th>\n",
       "      <th>results_first_posted_date</th>\n",
       "      <th>results_first_posted_date_type</th>\n",
       "      <th>disposition_first_submitted_qc_date</th>\n",
       "      <th>disposition_first_posted_date</th>\n",
       "      <th>disposition_first_posted_date_type</th>\n",
       "      <th>last_update_submitted_qc_date</th>\n",
       "      <th>last_update_posted_date</th>\n",
       "      <th>last_update_posted_date_type</th>\n",
       "      <th>start_month_year</th>\n",
       "      <th>start_date_type</th>\n",
       "      <th>start_date</th>\n",
       "      <th>verification_month_year</th>\n",
       "      <th>verification_date</th>\n",
       "      <th>completion_month_year</th>\n",
       "      <th>completion_date_type</th>\n",
       "      <th>completion_date</th>\n",
       "      <th>primary_completion_month_year</th>\n",
       "      <th>primary_completion_date_type</th>\n",
       "      <th>primary_completion_date</th>\n",
       "      <th>target_duration</th>\n",
       "      <th>study_type</th>\n",
       "      <th>acronym</th>\n",
       "      <th>baseline_population</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>official_title</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>last_known_status</th>\n",
       "      <th>phase</th>\n",
       "      <th>enrollment</th>\n",
       "      <th>enrollment_type</th>\n",
       "      <th>source</th>\n",
       "      <th>limitations_and_caveats</th>\n",
       "      <th>number_of_arms</th>\n",
       "      <th>number_of_groups</th>\n",
       "      <th>why_stopped</th>\n",
       "      <th>has_expanded_access</th>\n",
       "      <th>expanded_access_type_individual</th>\n",
       "      <th>expanded_access_type_intermediate</th>\n",
       "      <th>expanded_access_type_treatment</th>\n",
       "      <th>has_dmc</th>\n",
       "      <th>is_fda_regulated_drug</th>\n",
       "      <th>is_fda_regulated_device</th>\n",
       "      <th>is_unapproved_device</th>\n",
       "      <th>is_ppsd</th>\n",
       "      <th>is_us_export</th>\n",
       "      <th>biospec_retention</th>\n",
       "      <th>biospec_description</th>\n",
       "      <th>ipd_time_frame</th>\n",
       "      <th>ipd_access_criteria</th>\n",
       "      <th>ipd_url</th>\n",
       "      <th>plan_to_share_ipd</th>\n",
       "      <th>plan_to_share_ipd_description</th>\n",
       "      <th>created_at</th>\n",
       "      <th>updated_at</th>\n",
       "      <th>source_class</th>\n",
       "      <th>delayed_posting</th>\n",
       "      <th>expanded_access_nctid</th>\n",
       "      <th>expanded_access_status_for_nctid</th>\n",
       "      <th>fdaaa801_violation</th>\n",
       "      <th>baseline_type_units_analyzed</th>\n",
       "      <th>patient_registry</th>\n",
       "      <th>drug_outcome</th>\n",
       "      <th>disease_type</th>\n",
       "      <th>new_therapy_area</th>\n",
       "      <th>id_x</th>\n",
       "      <th>number_of_facilities</th>\n",
       "      <th>number_of_nsae_subjects</th>\n",
       "      <th>number_of_sae_subjects</th>\n",
       "      <th>registered_in_calendar_year</th>\n",
       "      <th>nlm_download_date</th>\n",
       "      <th>actual_duration</th>\n",
       "      <th>were_results_reported</th>\n",
       "      <th>months_to_report_results</th>\n",
       "      <th>has_us_facility</th>\n",
       "      <th>has_single_facility</th>\n",
       "      <th>minimum_age_num</th>\n",
       "      <th>maximum_age_num</th>\n",
       "      <th>minimum_age_unit</th>\n",
       "      <th>maximum_age_unit</th>\n",
       "      <th>number_of_primary_outcomes_to_measure</th>\n",
       "      <th>number_of_secondary_outcomes_to_measure</th>\n",
       "      <th>number_of_other_outcomes_to_measure</th>\n",
       "      <th>id_y</th>\n",
       "      <th>sampling_method</th>\n",
       "      <th>gender</th>\n",
       "      <th>minimum_age</th>\n",
       "      <th>maximum_age</th>\n",
       "      <th>healthy_volunteers</th>\n",
       "      <th>population</th>\n",
       "      <th>criteria</th>\n",
       "      <th>gender_description</th>\n",
       "      <th>gender_based</th>\n",
       "      <th>adult</th>\n",
       "      <th>child</th>\n",
       "      <th>older_adult</th>\n",
       "      <th>id</th>\n",
       "      <th>role</th>\n",
       "      <th>name</th>\n",
       "      <th>affiliation</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>6937223</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT04165031</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>Administered orally</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2019-11-15</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>2021-10</td>\n",
       "      <td>2021-10-31</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>All participants who received at least one dos...</td>\n",
       "      <td>A Study of LY3499446 in Participants With Adva...</td>\n",
       "      <td>A Phase 1/2 Study of LY3499446 Administered to...</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE1/PHASE2</td>\n",
       "      <td>5.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Data are available 6 months after the primary ...</td>\n",
       "      <td>A research proposal must be approved by an ind...</td>\n",
       "      <td>https://vivli.org/</td>\n",
       "      <td>YES</td>\n",
       "      <td>Anonymized individual patient level data will ...</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29905748</td>\n",
       "      <td>6.0</td>\n",
       "      <td>33.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>2019</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>12.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3.0</td>\n",
       "      <td>8.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7625501</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Participants must have d...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>7228546</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Call 1-877-CTLILLY (1-877-285-4559) or 1-317-6...</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT04165031</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>Administered orally</td>\n",
       "      <td>ly3499446</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>LY-3499446</td>\n",
       "      <td>Discontinued</td>\n",
       "      <td>KRAS G12C inhibitor (cancer), Eli Lilly; LY-34...</td>\n",
       "      <td>Eli Lilly &amp; Co</td>\n",
       "      <td>Eli Lilly &amp; Co (US)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Anticancer; K-Ras GTPase inhibitor</td>\n",
       "      <td>Oral formulation; Small molecule therapeutic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Colorectal tumor; Non-small-cell lung cancer; ...</td>\n",
       "      <td>Eli Lilly &amp; Co</td>\n",
       "      <td>No</td>\n",
       "      <td>2023-10-04</td>\n",
       "      <td>2019-11-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Eli Lilly was developing LY-3499446, a selecti...</td>\n",
       "      <td>120133</td>\n",
       "      <td>ly3499446</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2019-11-15</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>2021-10</td>\n",
       "      <td>2021-10-31</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>All participants who received at least one dos...</td>\n",
       "      <td>A Study of LY3499446 in Participants With Adva...</td>\n",
       "      <td>A Phase 1/2 Study of LY3499446 Administered to...</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE1/PHASE2</td>\n",
       "      <td>5.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Data are available 6 months after the primary ...</td>\n",
       "      <td>A research proposal must be approved by an ind...</td>\n",
       "      <td>https://vivli.org/</td>\n",
       "      <td>YES</td>\n",
       "      <td>Anonymized individual patient level data will ...</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>failure</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29905748</td>\n",
       "      <td>6.0</td>\n",
       "      <td>33.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>2019</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>12.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3.0</td>\n",
       "      <td>8.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7625501</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Participants must have d...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>7228546</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Call 1-877-CTLILLY (1-877-285-4559) or 1-317-6...</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT04165031</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>Administered IV</td>\n",
       "      <td>cetuximab</td>\n",
       "      <td>colorectal cancer</td>\n",
       "      <td>cetuximab</td>\n",
       "      <td>Launched</td>\n",
       "      <td>BMS-564717; C225; EMD-271786; EMR-62202; Erbit...</td>\n",
       "      <td>Imclone Systems Inc</td>\n",
       "      <td>Imclone Systems Inc (US)</td>\n",
       "      <td>Imclone Systems Inc; Merck KGaA; Merck Serono SA</td>\n",
       "      <td>Imclone Systems Inc (US); Merck KGaA (Germany)...</td>\n",
       "      <td>Cancer; Neurology/Psychiatric</td>\n",
       "      <td>Anal tumor; Cutaneous squamous cell carcinoma;...</td>\n",
       "      <td>Analgesic; Anticancer; Anticancer monoclonal a...</td>\n",
       "      <td>Biological therapeutic; Chimeric monoclonal an...</td>\n",
       "      <td>Accelerated Approval; Fast Track; Orphan Drug;...</td>\n",
       "      <td>Biliary cancer; Bladder cancer; Breast tumor; ...</td>\n",
       "      <td>Bristol-Myers Squibb Co; Inven2</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-03</td>\n",
       "      <td>1996-02-16</td>\n",
       "      <td>2003-12-01</td>\n",
       "      <td>Cetuximab (Erbitux) is a human-murine chimeric...</td>\n",
       "      <td>10388</td>\n",
       "      <td>cetuximab</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2019-11-15</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>2021-10</td>\n",
       "      <td>2021-10-31</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>All participants who received at least one dos...</td>\n",
       "      <td>A Study of LY3499446 in Participants With Adva...</td>\n",
       "      <td>A Phase 1/2 Study of LY3499446 Administered to...</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE1/PHASE2</td>\n",
       "      <td>5.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Data are available 6 months after the primary ...</td>\n",
       "      <td>A research proposal must be approved by an ind...</td>\n",
       "      <td>https://vivli.org/</td>\n",
       "      <td>YES</td>\n",
       "      <td>Anonymized individual patient level data will ...</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Colorectal (Oncology)</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29905748</td>\n",
       "      <td>6.0</td>\n",
       "      <td>33.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>2019</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>12.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3.0</td>\n",
       "      <td>8.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7625501</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Participants must have d...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>7228546</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Call 1-877-CTLILLY (1-877-285-4559) or 1-317-6...</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT04165031</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>Administered orally</td>\n",
       "      <td>ly3499446</td>\n",
       "      <td>colorectal cancer</td>\n",
       "      <td>LY-3499446</td>\n",
       "      <td>Discontinued</td>\n",
       "      <td>KRAS G12C inhibitor (cancer), Eli Lilly; LY-34...</td>\n",
       "      <td>Eli Lilly &amp; Co</td>\n",
       "      <td>Eli Lilly &amp; Co (US)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cancer</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Anticancer; K-Ras GTPase inhibitor</td>\n",
       "      <td>Oral formulation; Small molecule therapeutic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Colorectal tumor; Non-small-cell lung cancer; ...</td>\n",
       "      <td>Eli Lilly &amp; Co</td>\n",
       "      <td>No</td>\n",
       "      <td>2023-10-04</td>\n",
       "      <td>2019-11-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Eli Lilly was developing LY-3499446, a selecti...</td>\n",
       "      <td>120133</td>\n",
       "      <td>ly3499446</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2019-11-14</td>\n",
       "      <td>2019-11-15</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-10-27</td>\n",
       "      <td>2021-11-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2019-11-28</td>\n",
       "      <td>2021-10</td>\n",
       "      <td>2021-10-31</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2020-10-30</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>All participants who received at least one dos...</td>\n",
       "      <td>A Study of LY3499446 in Participants With Adva...</td>\n",
       "      <td>A Phase 1/2 Study of LY3499446 Administered to...</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE1/PHASE2</td>\n",
       "      <td>5.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>6.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The study was terminated due to an unexpected ...</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Data are available 6 months after the primary ...</td>\n",
       "      <td>A research proposal must be approved by an ind...</td>\n",
       "      <td>https://vivli.org/</td>\n",
       "      <td>YES</td>\n",
       "      <td>Anonymized individual patient level data will ...</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>2024-08-10 03:04:24.451964</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>failure</td>\n",
       "      <td>Colorectal (Oncology)</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29905748</td>\n",
       "      <td>6.0</td>\n",
       "      <td>33.0</td>\n",
       "      <td>5.0</td>\n",
       "      <td>2019</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>12.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3.0</td>\n",
       "      <td>8.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7625501</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Participants must have d...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>7228546</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Call 1-877-CTLILLY (1-877-285-4559) or 1-317-6...</td>\n",
       "      <td>Eli Lilly and Company</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        nct_id intervention_type  \\\n",
       "0  NCT00606502              DRUG   \n",
       "1  NCT04165031              DRUG   \n",
       "2  NCT04165031              DRUG   \n",
       "3  NCT04165031              DRUG   \n",
       "4  NCT04165031              DRUG   \n",
       "\n",
       "                                         description trial_drug_cleaned  \\\n",
       "0  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "1                                Administered orally          erlotinib   \n",
       "2                                Administered orally          ly3499446   \n",
       "3                                    Administered IV          cetuximab   \n",
       "4                                Administered orally          ly3499446   \n",
       "\n",
       "                   conditions   Drug Name Highest Status  \\\n",
       "0  non-small cell lung cancer   erlotinib       Launched   \n",
       "1  non-small cell lung cancer   erlotinib       Launched   \n",
       "2  non-small cell lung cancer  LY-3499446   Discontinued   \n",
       "3           colorectal cancer   cetuximab       Launched   \n",
       "4           colorectal cancer  LY-3499446   Discontinued   \n",
       "\n",
       "                                    Other Drug Names       Originator Company  \\\n",
       "0  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "1  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "2  KRAS G12C inhibitor (cancer), Eli Lilly; LY-34...           Eli Lilly & Co   \n",
       "3  BMS-564717; C225; EMD-271786; EMR-62202; Erbit...      Imclone Systems Inc   \n",
       "4  KRAS G12C inhibitor (cancer), Eli Lilly; LY-34...           Eli Lilly & Co   \n",
       "\n",
       "          Originator Company HQ  \\\n",
       "0  OSI Pharmaceuticals Inc (US)   \n",
       "1  OSI Pharmaceuticals Inc (US)   \n",
       "2           Eli Lilly & Co (US)   \n",
       "3      Imclone Systems Inc (US)   \n",
       "4           Eli Lilly & Co (US)   \n",
       "\n",
       "                                    Active Companies  \\\n",
       "0  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "1  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "2                                                NaN   \n",
       "3   Imclone Systems Inc; Merck KGaA; Merck Serono SA   \n",
       "4                                                NaN   \n",
       "\n",
       "                                 Active Companies HQ  \\\n",
       "0  Astellas Pharma Inc (Japan); Baheal Pharmaceut...   \n",
       "1  Astellas Pharma Inc (Japan); Baheal Pharmaceut...   \n",
       "2                                                NaN   \n",
       "3  Imclone Systems Inc (US); Merck KGaA (Germany)...   \n",
       "4                                                NaN   \n",
       "\n",
       "                    Therapy Area  \\\n",
       "0           Cancer; Dermatologic   \n",
       "1           Cancer; Dermatologic   \n",
       "2                         Cancer   \n",
       "3  Cancer; Neurology/Psychiatric   \n",
       "4                         Cancer   \n",
       "\n",
       "                                  Active Indications  \\\n",
       "0  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "1  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "2                                                NaN   \n",
       "3  Anal tumor; Cutaneous squamous cell carcinoma;...   \n",
       "4                                                NaN   \n",
       "\n",
       "                                              Action  \\\n",
       "0  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "1  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "2                 Anticancer; K-Ras GTPase inhibitor   \n",
       "3  Analgesic; Anticancer; Anticancer monoclonal a...   \n",
       "4                 Anticancer; K-Ras GTPase inhibitor   \n",
       "\n",
       "                                        Technologies  \\\n",
       "0  Film coating; Oral formulation; Small molecule...   \n",
       "1  Film coating; Oral formulation; Small molecule...   \n",
       "2       Oral formulation; Small molecule therapeutic   \n",
       "3  Biological therapeutic; Chimeric monoclonal an...   \n",
       "4       Oral formulation; Small molecule therapeutic   \n",
       "\n",
       "                             Regulatory Designations  \\\n",
       "0                            Fast Track; Orphan Drug   \n",
       "1                            Fast Track; Orphan Drug   \n",
       "2                                                NaN   \n",
       "3  Accelerated Approval; Fast Track; Orphan Drug;...   \n",
       "4                                                NaN   \n",
       "\n",
       "                                Inactive Indications  \\\n",
       "0  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "1  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "2  Colorectal tumor; Non-small-cell lung cancer; ...   \n",
       "3  Biliary cancer; Bladder cancer; Breast tumor; ...   \n",
       "4  Colorectal tumor; Non-small-cell lung cancer; ...   \n",
       "\n",
       "                Inactive Companies Has Deals Last Change Date  Added Date  \\\n",
       "0      Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "1      Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "2                   Eli Lilly & Co        No       2023-10-04  2019-11-22   \n",
       "3  Bristol-Myers Squibb Co; Inven2       Yes       2024-07-03  1996-02-16   \n",
       "4                   Eli Lilly & Co        No       2023-10-04  2019-11-22   \n",
       "\n",
       "  First Launched Date                                            Extract  \\\n",
       "0          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "1          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "2                 NaN  Eli Lilly was developing LY-3499446, a selecti...   \n",
       "3          2003-12-01  Cetuximab (Erbitux) is a human-murine chimeric...   \n",
       "4                 NaN  Eli Lilly was developing LY-3499446, a selecti...   \n",
       "\n",
       "   Drug Id cortellis_cleaned_drug  nlm_download_date_description  \\\n",
       "0    11961              erlotinib                            NaN   \n",
       "1    11961              erlotinib                            NaN   \n",
       "2   120133              ly3499446                            NaN   \n",
       "3    10388              cetuximab                            NaN   \n",
       "4   120133              ly3499446                            NaN   \n",
       "\n",
       "  study_first_submitted_date results_first_submitted_date  \\\n",
       "0                 2008-01-22                   2010-12-22   \n",
       "1                 2019-11-14                   2021-10-27   \n",
       "2                 2019-11-14                   2021-10-27   \n",
       "3                 2019-11-14                   2021-10-27   \n",
       "4                 2019-11-14                   2021-10-27   \n",
       "\n",
       "  disposition_first_submitted_date last_update_submitted_date  \\\n",
       "0                              NaN                 2021-02-08   \n",
       "1                              NaN                 2021-10-27   \n",
       "2                              NaN                 2021-10-27   \n",
       "3                              NaN                 2021-10-27   \n",
       "4                              NaN                 2021-10-27   \n",
       "\n",
       "  study_first_submitted_qc_date study_first_posted_date  \\\n",
       "0                    2008-02-01              2008-02-04   \n",
       "1                    2019-11-14              2019-11-15   \n",
       "2                    2019-11-14              2019-11-15   \n",
       "3                    2019-11-14              2019-11-15   \n",
       "4                    2019-11-14              2019-11-15   \n",
       "\n",
       "  study_first_posted_date_type results_first_submitted_qc_date  \\\n",
       "0                    ESTIMATED                      2010-12-22   \n",
       "1                       ACTUAL                      2021-10-27   \n",
       "2                       ACTUAL                      2021-10-27   \n",
       "3                       ACTUAL                      2021-10-27   \n",
       "4                       ACTUAL                      2021-10-27   \n",
       "\n",
       "  results_first_posted_date results_first_posted_date_type  \\\n",
       "0                2011-01-20                      ESTIMATED   \n",
       "1                2021-11-24                         ACTUAL   \n",
       "2                2021-11-24                         ACTUAL   \n",
       "3                2021-11-24                         ACTUAL   \n",
       "4                2021-11-24                         ACTUAL   \n",
       "\n",
       "  disposition_first_submitted_qc_date disposition_first_posted_date  \\\n",
       "0                                 NaN                           NaN   \n",
       "1                                 NaN                           NaN   \n",
       "2                                 NaN                           NaN   \n",
       "3                                 NaN                           NaN   \n",
       "4                                 NaN                           NaN   \n",
       "\n",
       "  disposition_first_posted_date_type last_update_submitted_qc_date  \\\n",
       "0                                NaN                    2021-02-08   \n",
       "1                                NaN                    2021-10-27   \n",
       "2                                NaN                    2021-10-27   \n",
       "3                                NaN                    2021-10-27   \n",
       "4                                NaN                    2021-10-27   \n",
       "\n",
       "  last_update_posted_date last_update_posted_date_type start_month_year  \\\n",
       "0              2021-03-05                       ACTUAL          2008-01   \n",
       "1              2021-11-24                       ACTUAL       2019-11-28   \n",
       "2              2021-11-24                       ACTUAL       2019-11-28   \n",
       "3              2021-11-24                       ACTUAL       2019-11-28   \n",
       "4              2021-11-24                       ACTUAL       2019-11-28   \n",
       "\n",
       "  start_date_type start_date verification_month_year verification_date  \\\n",
       "0             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "1          ACTUAL 2019-11-28                 2021-10        2021-10-31   \n",
       "2          ACTUAL 2019-11-28                 2021-10        2021-10-31   \n",
       "3          ACTUAL 2019-11-28                 2021-10        2021-10-31   \n",
       "4          ACTUAL 2019-11-28                 2021-10        2021-10-31   \n",
       "\n",
       "  completion_month_year completion_date_type completion_date  \\\n",
       "0            2010-06-24               ACTUAL      2010-06-24   \n",
       "1            2020-10-30               ACTUAL      2020-10-30   \n",
       "2            2020-10-30               ACTUAL      2020-10-30   \n",
       "3            2020-10-30               ACTUAL      2020-10-30   \n",
       "4            2020-10-30               ACTUAL      2020-10-30   \n",
       "\n",
       "  primary_completion_month_year primary_completion_date_type  \\\n",
       "0                    2010-06-24                       ACTUAL   \n",
       "1                    2020-10-30                       ACTUAL   \n",
       "2                    2020-10-30                       ACTUAL   \n",
       "3                    2020-10-30                       ACTUAL   \n",
       "4                    2020-10-30                       ACTUAL   \n",
       "\n",
       "  primary_completion_date  target_duration      study_type acronym  \\\n",
       "0              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "1              2020-10-30              NaN  INTERVENTIONAL     NaN   \n",
       "2              2020-10-30              NaN  INTERVENTIONAL     NaN   \n",
       "3              2020-10-30              NaN  INTERVENTIONAL     NaN   \n",
       "4              2020-10-30              NaN  INTERVENTIONAL     NaN   \n",
       "\n",
       "                                 baseline_population  \\\n",
       "0                                                NaN   \n",
       "1  All participants who received at least one dos...   \n",
       "2  All participants who received at least one dos...   \n",
       "3  All participants who received at least one dos...   \n",
       "4  All participants who received at least one dos...   \n",
       "\n",
       "                                         brief_title  \\\n",
       "0  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "1  A Study of LY3499446 in Participants With Adva...   \n",
       "2  A Study of LY3499446 in Participants With Adva...   \n",
       "3  A Study of LY3499446 in Participants With Adva...   \n",
       "4  A Study of LY3499446 in Participants With Adva...   \n",
       "\n",
       "                                      official_title overall_status  \\\n",
       "0  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "1  A Phase 1/2 Study of LY3499446 Administered to...     TERMINATED   \n",
       "2  A Phase 1/2 Study of LY3499446 Administered to...     TERMINATED   \n",
       "3  A Phase 1/2 Study of LY3499446 Administered to...     TERMINATED   \n",
       "4  A Phase 1/2 Study of LY3499446 Administered to...     TERMINATED   \n",
       "\n",
       "   last_known_status          phase  enrollment enrollment_type  \\\n",
       "0                NaN         PHASE2       201.0          ACTUAL   \n",
       "1                NaN  PHASE1/PHASE2         5.0          ACTUAL   \n",
       "2                NaN  PHASE1/PHASE2         5.0          ACTUAL   \n",
       "3                NaN  PHASE1/PHASE2         5.0          ACTUAL   \n",
       "4                NaN  PHASE1/PHASE2         5.0          ACTUAL   \n",
       "\n",
       "                          source  \\\n",
       "0  Spectrum Pharmaceuticals, Inc   \n",
       "1          Eli Lilly and Company   \n",
       "2          Eli Lilly and Company   \n",
       "3          Eli Lilly and Company   \n",
       "4          Eli Lilly and Company   \n",
       "\n",
       "                             limitations_and_caveats  number_of_arms  \\\n",
       "0  The date of the CRF database cut-off for patie...             2.0   \n",
       "1  The study was terminated due to an unexpected ...             6.0   \n",
       "2  The study was terminated due to an unexpected ...             6.0   \n",
       "3  The study was terminated due to an unexpected ...             6.0   \n",
       "4  The study was terminated due to an unexpected ...             6.0   \n",
       "\n",
       "   number_of_groups                                        why_stopped  \\\n",
       "0               NaN                                                NaN   \n",
       "1               NaN  The study was terminated due to an unexpected ...   \n",
       "2               NaN  The study was terminated due to an unexpected ...   \n",
       "3               NaN  The study was terminated due to an unexpected ...   \n",
       "4               NaN  The study was terminated due to an unexpected ...   \n",
       "\n",
       "  has_expanded_access  expanded_access_type_individual  \\\n",
       "0                   f                              NaN   \n",
       "1                   f                              NaN   \n",
       "2                   f                              NaN   \n",
       "3                   f                              NaN   \n",
       "4                   f                              NaN   \n",
       "\n",
       "   expanded_access_type_intermediate  expanded_access_type_treatment has_dmc  \\\n",
       "0                                NaN                             NaN     NaN   \n",
       "1                                NaN                             NaN       f   \n",
       "2                                NaN                             NaN       f   \n",
       "3                                NaN                             NaN       f   \n",
       "4                                NaN                             NaN       f   \n",
       "\n",
       "  is_fda_regulated_drug is_fda_regulated_device is_unapproved_device  is_ppsd  \\\n",
       "0                   NaN                     NaN                  NaN      NaN   \n",
       "1                     t                       f                  NaN      NaN   \n",
       "2                     t                       f                  NaN      NaN   \n",
       "3                     t                       f                  NaN      NaN   \n",
       "4                     t                       f                  NaN      NaN   \n",
       "\n",
       "  is_us_export  biospec_retention  biospec_description  \\\n",
       "0          NaN                NaN                  NaN   \n",
       "1          NaN                NaN                  NaN   \n",
       "2          NaN                NaN                  NaN   \n",
       "3          NaN                NaN                  NaN   \n",
       "4          NaN                NaN                  NaN   \n",
       "\n",
       "                                      ipd_time_frame  \\\n",
       "0                                                NaN   \n",
       "1  Data are available 6 months after the primary ...   \n",
       "2  Data are available 6 months after the primary ...   \n",
       "3  Data are available 6 months after the primary ...   \n",
       "4  Data are available 6 months after the primary ...   \n",
       "\n",
       "                                 ipd_access_criteria             ipd_url  \\\n",
       "0                                                NaN                 NaN   \n",
       "1  A research proposal must be approved by an ind...  https://vivli.org/   \n",
       "2  A research proposal must be approved by an ind...  https://vivli.org/   \n",
       "3  A research proposal must be approved by an ind...  https://vivli.org/   \n",
       "4  A research proposal must be approved by an ind...  https://vivli.org/   \n",
       "\n",
       "  plan_to_share_ipd                      plan_to_share_ipd_description  \\\n",
       "0               NaN                                                NaN   \n",
       "1               YES  Anonymized individual patient level data will ...   \n",
       "2               YES  Anonymized individual patient level data will ...   \n",
       "3               YES  Anonymized individual patient level data will ...   \n",
       "4               YES  Anonymized individual patient level data will ...   \n",
       "\n",
       "                   created_at                  updated_at source_class  \\\n",
       "0  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "1  2024-08-10 03:04:24.451964  2024-08-10 03:04:24.451964     INDUSTRY   \n",
       "2  2024-08-10 03:04:24.451964  2024-08-10 03:04:24.451964     INDUSTRY   \n",
       "3  2024-08-10 03:04:24.451964  2024-08-10 03:04:24.451964     INDUSTRY   \n",
       "4  2024-08-10 03:04:24.451964  2024-08-10 03:04:24.451964     INDUSTRY   \n",
       "\n",
       "   delayed_posting expanded_access_nctid expanded_access_status_for_nctid  \\\n",
       "0              NaN                   NaN                              NaN   \n",
       "1              NaN                   NaN                              NaN   \n",
       "2              NaN                   NaN                              NaN   \n",
       "3              NaN                   NaN                              NaN   \n",
       "4              NaN                   NaN                              NaN   \n",
       "\n",
       "   fdaaa801_violation  baseline_type_units_analyzed  patient_registry  \\\n",
       "0                 NaN                           NaN               NaN   \n",
       "1                 NaN                           NaN               NaN   \n",
       "2                 NaN                           NaN               NaN   \n",
       "3                 NaN                           NaN               NaN   \n",
       "4                 NaN                           NaN               NaN   \n",
       "\n",
       "  drug_outcome           disease_type new_therapy_area      id_x  \\\n",
       "0      success   Lung, Non-Small Cell         Oncology  29671336   \n",
       "1      success   Lung, Non-Small Cell         Oncology  29905748   \n",
       "2      failure   Lung, Non-Small Cell         Oncology  29905748   \n",
       "3      success  Colorectal (Oncology)         Oncology  29905748   \n",
       "4      failure  Colorectal (Oncology)         Oncology  29905748   \n",
       "\n",
       "   number_of_facilities  number_of_nsae_subjects  number_of_sae_subjects  \\\n",
       "0                  47.0                    540.0                   124.0   \n",
       "1                   6.0                     33.0                     5.0   \n",
       "2                   6.0                     33.0                     5.0   \n",
       "3                   6.0                     33.0                     5.0   \n",
       "4                   6.0                     33.0                     5.0   \n",
       "\n",
       "   registered_in_calendar_year  nlm_download_date  actual_duration  \\\n",
       "0                         2008                NaN             29.0   \n",
       "1                         2019                NaN              NaN   \n",
       "2                         2019                NaN              NaN   \n",
       "3                         2019                NaN              NaN   \n",
       "4                         2019                NaN              NaN   \n",
       "\n",
       "  were_results_reported  months_to_report_results has_us_facility  \\\n",
       "0                     t                       6.0               t   \n",
       "1                     t                      12.0               t   \n",
       "2                     t                      12.0               t   \n",
       "3                     t                      12.0               t   \n",
       "4                     t                      12.0               t   \n",
       "\n",
       "  has_single_facility  minimum_age_num  maximum_age_num minimum_age_unit  \\\n",
       "0                   f             18.0              NaN            Years   \n",
       "1                   f             18.0              NaN            Years   \n",
       "2                   f             18.0              NaN            Years   \n",
       "3                   f             18.0              NaN            Years   \n",
       "4                   f             18.0              NaN            Years   \n",
       "\n",
       "  maximum_age_unit  number_of_primary_outcomes_to_measure  \\\n",
       "0              NaN                                    1.0   \n",
       "1              NaN                                    3.0   \n",
       "2              NaN                                    3.0   \n",
       "3              NaN                                    3.0   \n",
       "4              NaN                                    3.0   \n",
       "\n",
       "   number_of_secondary_outcomes_to_measure  \\\n",
       "0                                      3.0   \n",
       "1                                      8.0   \n",
       "2                                      8.0   \n",
       "3                                      8.0   \n",
       "4                                      8.0   \n",
       "\n",
       "   number_of_other_outcomes_to_measure     id_y sampling_method gender  \\\n",
       "0                                  NaN  7316876             NaN    ALL   \n",
       "1                                  NaN  7625501             NaN    ALL   \n",
       "2                                  NaN  7625501             NaN    ALL   \n",
       "3                                  NaN  7625501             NaN    ALL   \n",
       "4                                  NaN  7625501             NaN    ALL   \n",
       "\n",
       "  minimum_age maximum_age healthy_volunteers population  \\\n",
       "0    18 Years         NaN                  f        NaN   \n",
       "1    18 Years         NaN                  f        NaN   \n",
       "2    18 Years         NaN                  f        NaN   \n",
       "3    18 Years         NaN                  f        NaN   \n",
       "4    18 Years         NaN                  f        NaN   \n",
       "\n",
       "                                            criteria gender_description  \\\n",
       "0  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "1  Inclusion Criteria:~* Participants must have d...                NaN   \n",
       "2  Inclusion Criteria:~* Participants must have d...                NaN   \n",
       "3  Inclusion Criteria:~* Participants must have d...                NaN   \n",
       "4  Inclusion Criteria:~* Participants must have d...                NaN   \n",
       "\n",
       "  gender_based adult child older_adult       id            role  \\\n",
       "0          NaN     t     f           t  6937223  STUDY_DIRECTOR   \n",
       "1          NaN     t     f           t  7228546  STUDY_DIRECTOR   \n",
       "2          NaN     t     f           t  7228546  STUDY_DIRECTOR   \n",
       "3          NaN     t     f           t  7228546  STUDY_DIRECTOR   \n",
       "4          NaN     t     f           t  7228546  STUDY_DIRECTOR   \n",
       "\n",
       "                                                name  \\\n",
       "0                                Garry Weems, PharmD   \n",
       "1  Call 1-877-CTLILLY (1-877-285-4559) or 1-317-6...   \n",
       "2  Call 1-877-CTLILLY (1-877-285-4559) or 1-317-6...   \n",
       "3  Call 1-877-CTLILLY (1-877-285-4559) or 1-317-6...   \n",
       "4  Call 1-877-CTLILLY (1-877-285-4559) or 1-317-6...   \n",
       "\n",
       "                     affiliation  \n",
       "0  Spectrum Pharmaceuticals, Inc  \n",
       "1          Eli Lilly and Company  \n",
       "2          Eli Lilly and Company  \n",
       "3          Eli Lilly and Company  \n",
       "4          Eli Lilly and Company  "
      ]
     },
     "execution_count": 133,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# merge officials table with p2_p4 table\n",
    "merged_df_1123 = pd.merge(merged_df_1123, df_overall_officials, left_on=\"nct_id\", right_on=\"nct_id\", how=\"inner\")\n",
    "merged_df_1123.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 134,
   "id": "52b657e6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(11196, 134)"
      ]
     },
     "execution_count": 134,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "merged_df_1123.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 135,
   "id": "4b99d7cd",
   "metadata": {},
   "outputs": [],
   "source": [
    "# rename few columns and drop extra id column\n",
    "merged_df_1123 = merged_df_1123.rename(columns={'name': 'official_name'})\n",
    "merged_df_1123 = merged_df_1123.rename(columns={'affiliation': 'official_affiliation'})\n",
    "merged_df_1123 = merged_df_1123.rename(columns={'role': 'official_role'})\n",
    "merged_df_1123 = merged_df_1123.drop(columns=['id'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 136,
   "id": "918b55ba",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>nct_id</th>\n",
       "      <th>name</th>\n",
       "      <th>removed</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>10471681</td>\n",
       "      <td>NCT00397605</td>\n",
       "      <td>United Kingdom</td>\n",
       "      <td>t</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>10471682</td>\n",
       "      <td>NCT03739710</td>\n",
       "      <td>Australia</td>\n",
       "      <td>t</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>10471683</td>\n",
       "      <td>NCT03739710</td>\n",
       "      <td>Denmark</td>\n",
       "      <td>t</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>10471684</td>\n",
       "      <td>NCT02936102</td>\n",
       "      <td>Germany</td>\n",
       "      <td>t</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>10471685</td>\n",
       "      <td>NCT03712202</td>\n",
       "      <td>Canada</td>\n",
       "      <td>t</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>696288</th>\n",
       "      <td>10054057</td>\n",
       "      <td>NCT00229307</td>\n",
       "      <td>Israel</td>\n",
       "      <td>f</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>696289</th>\n",
       "      <td>10054058</td>\n",
       "      <td>NCT02575209</td>\n",
       "      <td>Spain</td>\n",
       "      <td>f</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>696290</th>\n",
       "      <td>10054059</td>\n",
       "      <td>NCT04520009</td>\n",
       "      <td>United States</td>\n",
       "      <td>f</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>696291</th>\n",
       "      <td>10054060</td>\n",
       "      <td>NCT01974609</td>\n",
       "      <td>United States</td>\n",
       "      <td>f</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>696292</th>\n",
       "      <td>10054061</td>\n",
       "      <td>NCT01974609</td>\n",
       "      <td>Canada</td>\n",
       "      <td>f</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>696293 rows  4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "              id       nct_id            name removed\n",
       "0       10471681  NCT00397605  United Kingdom       t\n",
       "1       10471682  NCT03739710       Australia       t\n",
       "2       10471683  NCT03739710         Denmark       t\n",
       "3       10471684  NCT02936102         Germany       t\n",
       "4       10471685  NCT03712202          Canada       t\n",
       "...          ...          ...             ...     ...\n",
       "696288  10054057  NCT00229307          Israel       f\n",
       "696289  10054058  NCT02575209           Spain       f\n",
       "696290  10054059  NCT04520009   United States       f\n",
       "696291  10054060  NCT01974609   United States       f\n",
       "696292  10054061  NCT01974609          Canada       f\n",
       "\n",
       "[696293 rows x 4 columns]"
      ]
     },
     "execution_count": 136,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# load countries table from AACT\n",
    "df_countries = pd.read_csv('b3t0zvq5n6oyhvv9h6v8qsqg4j57/countries.txt', sep='|')\n",
    "df_countries"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 137,
   "id": "8d84d211",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nct_id</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>description</th>\n",
       "      <th>trial_drug_cleaned</th>\n",
       "      <th>conditions</th>\n",
       "      <th>Drug Name</th>\n",
       "      <th>Highest Status</th>\n",
       "      <th>Other Drug Names</th>\n",
       "      <th>Originator Company</th>\n",
       "      <th>Originator Company HQ</th>\n",
       "      <th>Active Companies</th>\n",
       "      <th>Active Companies HQ</th>\n",
       "      <th>Therapy Area</th>\n",
       "      <th>Active Indications</th>\n",
       "      <th>Action</th>\n",
       "      <th>Technologies</th>\n",
       "      <th>Regulatory Designations</th>\n",
       "      <th>Inactive Indications</th>\n",
       "      <th>Inactive Companies</th>\n",
       "      <th>Has Deals</th>\n",
       "      <th>Last Change Date</th>\n",
       "      <th>Added Date</th>\n",
       "      <th>First Launched Date</th>\n",
       "      <th>Extract</th>\n",
       "      <th>Drug Id</th>\n",
       "      <th>cortellis_cleaned_drug</th>\n",
       "      <th>nlm_download_date_description</th>\n",
       "      <th>study_first_submitted_date</th>\n",
       "      <th>results_first_submitted_date</th>\n",
       "      <th>disposition_first_submitted_date</th>\n",
       "      <th>last_update_submitted_date</th>\n",
       "      <th>study_first_submitted_qc_date</th>\n",
       "      <th>study_first_posted_date</th>\n",
       "      <th>study_first_posted_date_type</th>\n",
       "      <th>results_first_submitted_qc_date</th>\n",
       "      <th>results_first_posted_date</th>\n",
       "      <th>results_first_posted_date_type</th>\n",
       "      <th>disposition_first_submitted_qc_date</th>\n",
       "      <th>disposition_first_posted_date</th>\n",
       "      <th>disposition_first_posted_date_type</th>\n",
       "      <th>last_update_submitted_qc_date</th>\n",
       "      <th>last_update_posted_date</th>\n",
       "      <th>last_update_posted_date_type</th>\n",
       "      <th>start_month_year</th>\n",
       "      <th>start_date_type</th>\n",
       "      <th>start_date</th>\n",
       "      <th>verification_month_year</th>\n",
       "      <th>verification_date</th>\n",
       "      <th>completion_month_year</th>\n",
       "      <th>completion_date_type</th>\n",
       "      <th>completion_date</th>\n",
       "      <th>primary_completion_month_year</th>\n",
       "      <th>primary_completion_date_type</th>\n",
       "      <th>primary_completion_date</th>\n",
       "      <th>target_duration</th>\n",
       "      <th>study_type</th>\n",
       "      <th>acronym</th>\n",
       "      <th>baseline_population</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>official_title</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>last_known_status</th>\n",
       "      <th>phase</th>\n",
       "      <th>enrollment</th>\n",
       "      <th>enrollment_type</th>\n",
       "      <th>source</th>\n",
       "      <th>limitations_and_caveats</th>\n",
       "      <th>number_of_arms</th>\n",
       "      <th>number_of_groups</th>\n",
       "      <th>why_stopped</th>\n",
       "      <th>has_expanded_access</th>\n",
       "      <th>expanded_access_type_individual</th>\n",
       "      <th>expanded_access_type_intermediate</th>\n",
       "      <th>expanded_access_type_treatment</th>\n",
       "      <th>has_dmc</th>\n",
       "      <th>is_fda_regulated_drug</th>\n",
       "      <th>is_fda_regulated_device</th>\n",
       "      <th>is_unapproved_device</th>\n",
       "      <th>is_ppsd</th>\n",
       "      <th>is_us_export</th>\n",
       "      <th>biospec_retention</th>\n",
       "      <th>biospec_description</th>\n",
       "      <th>ipd_time_frame</th>\n",
       "      <th>ipd_access_criteria</th>\n",
       "      <th>ipd_url</th>\n",
       "      <th>plan_to_share_ipd</th>\n",
       "      <th>plan_to_share_ipd_description</th>\n",
       "      <th>created_at</th>\n",
       "      <th>updated_at</th>\n",
       "      <th>source_class</th>\n",
       "      <th>delayed_posting</th>\n",
       "      <th>expanded_access_nctid</th>\n",
       "      <th>expanded_access_status_for_nctid</th>\n",
       "      <th>fdaaa801_violation</th>\n",
       "      <th>baseline_type_units_analyzed</th>\n",
       "      <th>patient_registry</th>\n",
       "      <th>drug_outcome</th>\n",
       "      <th>disease_type</th>\n",
       "      <th>new_therapy_area</th>\n",
       "      <th>id_x</th>\n",
       "      <th>number_of_facilities</th>\n",
       "      <th>number_of_nsae_subjects</th>\n",
       "      <th>number_of_sae_subjects</th>\n",
       "      <th>registered_in_calendar_year</th>\n",
       "      <th>nlm_download_date</th>\n",
       "      <th>actual_duration</th>\n",
       "      <th>were_results_reported</th>\n",
       "      <th>months_to_report_results</th>\n",
       "      <th>has_us_facility</th>\n",
       "      <th>has_single_facility</th>\n",
       "      <th>minimum_age_num</th>\n",
       "      <th>maximum_age_num</th>\n",
       "      <th>minimum_age_unit</th>\n",
       "      <th>maximum_age_unit</th>\n",
       "      <th>number_of_primary_outcomes_to_measure</th>\n",
       "      <th>number_of_secondary_outcomes_to_measure</th>\n",
       "      <th>number_of_other_outcomes_to_measure</th>\n",
       "      <th>id_y</th>\n",
       "      <th>sampling_method</th>\n",
       "      <th>gender</th>\n",
       "      <th>minimum_age</th>\n",
       "      <th>maximum_age</th>\n",
       "      <th>healthy_volunteers</th>\n",
       "      <th>population</th>\n",
       "      <th>criteria</th>\n",
       "      <th>gender_description</th>\n",
       "      <th>gender_based</th>\n",
       "      <th>adult</th>\n",
       "      <th>child</th>\n",
       "      <th>older_adult</th>\n",
       "      <th>official_role</th>\n",
       "      <th>official_name</th>\n",
       "      <th>official_affiliation</th>\n",
       "      <th>id</th>\n",
       "      <th>name</th>\n",
       "      <th>removed</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138299</td>\n",
       "      <td>Czech Republic</td>\n",
       "      <td>t</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138896</td>\n",
       "      <td>United States</td>\n",
       "      <td>f</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138897</td>\n",
       "      <td>Argentina</td>\n",
       "      <td>f</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138898</td>\n",
       "      <td>Brazil</td>\n",
       "      <td>f</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138899</td>\n",
       "      <td>Czechia</td>\n",
       "      <td>f</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        nct_id intervention_type  \\\n",
       "0  NCT00606502              DRUG   \n",
       "1  NCT00606502              DRUG   \n",
       "2  NCT00606502              DRUG   \n",
       "3  NCT00606502              DRUG   \n",
       "4  NCT00606502              DRUG   \n",
       "\n",
       "                                         description trial_drug_cleaned  \\\n",
       "0  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "1  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "2  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "3  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "4  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "\n",
       "                   conditions  Drug Name Highest Status  \\\n",
       "0  non-small cell lung cancer  erlotinib       Launched   \n",
       "1  non-small cell lung cancer  erlotinib       Launched   \n",
       "2  non-small cell lung cancer  erlotinib       Launched   \n",
       "3  non-small cell lung cancer  erlotinib       Launched   \n",
       "4  non-small cell lung cancer  erlotinib       Launched   \n",
       "\n",
       "                                    Other Drug Names       Originator Company  \\\n",
       "0  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "1  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "2  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "3  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "4  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "\n",
       "          Originator Company HQ  \\\n",
       "0  OSI Pharmaceuticals Inc (US)   \n",
       "1  OSI Pharmaceuticals Inc (US)   \n",
       "2  OSI Pharmaceuticals Inc (US)   \n",
       "3  OSI Pharmaceuticals Inc (US)   \n",
       "4  OSI Pharmaceuticals Inc (US)   \n",
       "\n",
       "                                    Active Companies  \\\n",
       "0  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "1  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "2  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "3  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "4  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "\n",
       "                                 Active Companies HQ          Therapy Area  \\\n",
       "0  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "1  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "2  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "3  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "4  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "\n",
       "                                  Active Indications  \\\n",
       "0  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "1  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "2  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "3  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "4  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "\n",
       "                                              Action  \\\n",
       "0  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "1  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "2  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "3  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "4  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "\n",
       "                                        Technologies  Regulatory Designations  \\\n",
       "0  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "1  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "2  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "3  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "4  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "\n",
       "                                Inactive Indications  \\\n",
       "0  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "1  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "2  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "3  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "4  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "\n",
       "            Inactive Companies Has Deals Last Change Date  Added Date  \\\n",
       "0  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "1  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "2  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "3  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "4  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "\n",
       "  First Launched Date                                            Extract  \\\n",
       "0          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "1          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "2          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "3          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "4          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "\n",
       "   Drug Id cortellis_cleaned_drug  nlm_download_date_description  \\\n",
       "0    11961              erlotinib                            NaN   \n",
       "1    11961              erlotinib                            NaN   \n",
       "2    11961              erlotinib                            NaN   \n",
       "3    11961              erlotinib                            NaN   \n",
       "4    11961              erlotinib                            NaN   \n",
       "\n",
       "  study_first_submitted_date results_first_submitted_date  \\\n",
       "0                 2008-01-22                   2010-12-22   \n",
       "1                 2008-01-22                   2010-12-22   \n",
       "2                 2008-01-22                   2010-12-22   \n",
       "3                 2008-01-22                   2010-12-22   \n",
       "4                 2008-01-22                   2010-12-22   \n",
       "\n",
       "  disposition_first_submitted_date last_update_submitted_date  \\\n",
       "0                              NaN                 2021-02-08   \n",
       "1                              NaN                 2021-02-08   \n",
       "2                              NaN                 2021-02-08   \n",
       "3                              NaN                 2021-02-08   \n",
       "4                              NaN                 2021-02-08   \n",
       "\n",
       "  study_first_submitted_qc_date study_first_posted_date  \\\n",
       "0                    2008-02-01              2008-02-04   \n",
       "1                    2008-02-01              2008-02-04   \n",
       "2                    2008-02-01              2008-02-04   \n",
       "3                    2008-02-01              2008-02-04   \n",
       "4                    2008-02-01              2008-02-04   \n",
       "\n",
       "  study_first_posted_date_type results_first_submitted_qc_date  \\\n",
       "0                    ESTIMATED                      2010-12-22   \n",
       "1                    ESTIMATED                      2010-12-22   \n",
       "2                    ESTIMATED                      2010-12-22   \n",
       "3                    ESTIMATED                      2010-12-22   \n",
       "4                    ESTIMATED                      2010-12-22   \n",
       "\n",
       "  results_first_posted_date results_first_posted_date_type  \\\n",
       "0                2011-01-20                      ESTIMATED   \n",
       "1                2011-01-20                      ESTIMATED   \n",
       "2                2011-01-20                      ESTIMATED   \n",
       "3                2011-01-20                      ESTIMATED   \n",
       "4                2011-01-20                      ESTIMATED   \n",
       "\n",
       "  disposition_first_submitted_qc_date disposition_first_posted_date  \\\n",
       "0                                 NaN                           NaN   \n",
       "1                                 NaN                           NaN   \n",
       "2                                 NaN                           NaN   \n",
       "3                                 NaN                           NaN   \n",
       "4                                 NaN                           NaN   \n",
       "\n",
       "  disposition_first_posted_date_type last_update_submitted_qc_date  \\\n",
       "0                                NaN                    2021-02-08   \n",
       "1                                NaN                    2021-02-08   \n",
       "2                                NaN                    2021-02-08   \n",
       "3                                NaN                    2021-02-08   \n",
       "4                                NaN                    2021-02-08   \n",
       "\n",
       "  last_update_posted_date last_update_posted_date_type start_month_year  \\\n",
       "0              2021-03-05                       ACTUAL          2008-01   \n",
       "1              2021-03-05                       ACTUAL          2008-01   \n",
       "2              2021-03-05                       ACTUAL          2008-01   \n",
       "3              2021-03-05                       ACTUAL          2008-01   \n",
       "4              2021-03-05                       ACTUAL          2008-01   \n",
       "\n",
       "  start_date_type start_date verification_month_year verification_date  \\\n",
       "0             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "1             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "2             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "3             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "4             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "\n",
       "  completion_month_year completion_date_type completion_date  \\\n",
       "0            2010-06-24               ACTUAL      2010-06-24   \n",
       "1            2010-06-24               ACTUAL      2010-06-24   \n",
       "2            2010-06-24               ACTUAL      2010-06-24   \n",
       "3            2010-06-24               ACTUAL      2010-06-24   \n",
       "4            2010-06-24               ACTUAL      2010-06-24   \n",
       "\n",
       "  primary_completion_month_year primary_completion_date_type  \\\n",
       "0                    2010-06-24                       ACTUAL   \n",
       "1                    2010-06-24                       ACTUAL   \n",
       "2                    2010-06-24                       ACTUAL   \n",
       "3                    2010-06-24                       ACTUAL   \n",
       "4                    2010-06-24                       ACTUAL   \n",
       "\n",
       "  primary_completion_date  target_duration      study_type acronym  \\\n",
       "0              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "1              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "2              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "3              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "4              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "\n",
       "  baseline_population                                        brief_title  \\\n",
       "0                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "1                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "2                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "3                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "4                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "\n",
       "                                      official_title overall_status  \\\n",
       "0  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "1  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "2  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "3  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "4  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "\n",
       "   last_known_status   phase  enrollment enrollment_type  \\\n",
       "0                NaN  PHASE2       201.0          ACTUAL   \n",
       "1                NaN  PHASE2       201.0          ACTUAL   \n",
       "2                NaN  PHASE2       201.0          ACTUAL   \n",
       "3                NaN  PHASE2       201.0          ACTUAL   \n",
       "4                NaN  PHASE2       201.0          ACTUAL   \n",
       "\n",
       "                          source  \\\n",
       "0  Spectrum Pharmaceuticals, Inc   \n",
       "1  Spectrum Pharmaceuticals, Inc   \n",
       "2  Spectrum Pharmaceuticals, Inc   \n",
       "3  Spectrum Pharmaceuticals, Inc   \n",
       "4  Spectrum Pharmaceuticals, Inc   \n",
       "\n",
       "                             limitations_and_caveats  number_of_arms  \\\n",
       "0  The date of the CRF database cut-off for patie...             2.0   \n",
       "1  The date of the CRF database cut-off for patie...             2.0   \n",
       "2  The date of the CRF database cut-off for patie...             2.0   \n",
       "3  The date of the CRF database cut-off for patie...             2.0   \n",
       "4  The date of the CRF database cut-off for patie...             2.0   \n",
       "\n",
       "   number_of_groups why_stopped has_expanded_access  \\\n",
       "0               NaN         NaN                   f   \n",
       "1               NaN         NaN                   f   \n",
       "2               NaN         NaN                   f   \n",
       "3               NaN         NaN                   f   \n",
       "4               NaN         NaN                   f   \n",
       "\n",
       "   expanded_access_type_individual  expanded_access_type_intermediate  \\\n",
       "0                              NaN                                NaN   \n",
       "1                              NaN                                NaN   \n",
       "2                              NaN                                NaN   \n",
       "3                              NaN                                NaN   \n",
       "4                              NaN                                NaN   \n",
       "\n",
       "   expanded_access_type_treatment has_dmc is_fda_regulated_drug  \\\n",
       "0                             NaN     NaN                   NaN   \n",
       "1                             NaN     NaN                   NaN   \n",
       "2                             NaN     NaN                   NaN   \n",
       "3                             NaN     NaN                   NaN   \n",
       "4                             NaN     NaN                   NaN   \n",
       "\n",
       "  is_fda_regulated_device is_unapproved_device  is_ppsd is_us_export  \\\n",
       "0                     NaN                  NaN      NaN          NaN   \n",
       "1                     NaN                  NaN      NaN          NaN   \n",
       "2                     NaN                  NaN      NaN          NaN   \n",
       "3                     NaN                  NaN      NaN          NaN   \n",
       "4                     NaN                  NaN      NaN          NaN   \n",
       "\n",
       "   biospec_retention  biospec_description ipd_time_frame ipd_access_criteria  \\\n",
       "0                NaN                  NaN            NaN                 NaN   \n",
       "1                NaN                  NaN            NaN                 NaN   \n",
       "2                NaN                  NaN            NaN                 NaN   \n",
       "3                NaN                  NaN            NaN                 NaN   \n",
       "4                NaN                  NaN            NaN                 NaN   \n",
       "\n",
       "  ipd_url plan_to_share_ipd plan_to_share_ipd_description  \\\n",
       "0     NaN               NaN                           NaN   \n",
       "1     NaN               NaN                           NaN   \n",
       "2     NaN               NaN                           NaN   \n",
       "3     NaN               NaN                           NaN   \n",
       "4     NaN               NaN                           NaN   \n",
       "\n",
       "                   created_at                  updated_at source_class  \\\n",
       "0  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "1  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "2  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "3  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "4  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "\n",
       "   delayed_posting expanded_access_nctid expanded_access_status_for_nctid  \\\n",
       "0              NaN                   NaN                              NaN   \n",
       "1              NaN                   NaN                              NaN   \n",
       "2              NaN                   NaN                              NaN   \n",
       "3              NaN                   NaN                              NaN   \n",
       "4              NaN                   NaN                              NaN   \n",
       "\n",
       "   fdaaa801_violation  baseline_type_units_analyzed  patient_registry  \\\n",
       "0                 NaN                           NaN               NaN   \n",
       "1                 NaN                           NaN               NaN   \n",
       "2                 NaN                           NaN               NaN   \n",
       "3                 NaN                           NaN               NaN   \n",
       "4                 NaN                           NaN               NaN   \n",
       "\n",
       "  drug_outcome          disease_type new_therapy_area      id_x  \\\n",
       "0      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "1      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "2      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "3      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "4      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "\n",
       "   number_of_facilities  number_of_nsae_subjects  number_of_sae_subjects  \\\n",
       "0                  47.0                    540.0                   124.0   \n",
       "1                  47.0                    540.0                   124.0   \n",
       "2                  47.0                    540.0                   124.0   \n",
       "3                  47.0                    540.0                   124.0   \n",
       "4                  47.0                    540.0                   124.0   \n",
       "\n",
       "   registered_in_calendar_year  nlm_download_date  actual_duration  \\\n",
       "0                         2008                NaN             29.0   \n",
       "1                         2008                NaN             29.0   \n",
       "2                         2008                NaN             29.0   \n",
       "3                         2008                NaN             29.0   \n",
       "4                         2008                NaN             29.0   \n",
       "\n",
       "  were_results_reported  months_to_report_results has_us_facility  \\\n",
       "0                     t                       6.0               t   \n",
       "1                     t                       6.0               t   \n",
       "2                     t                       6.0               t   \n",
       "3                     t                       6.0               t   \n",
       "4                     t                       6.0               t   \n",
       "\n",
       "  has_single_facility  minimum_age_num  maximum_age_num minimum_age_unit  \\\n",
       "0                   f             18.0              NaN            Years   \n",
       "1                   f             18.0              NaN            Years   \n",
       "2                   f             18.0              NaN            Years   \n",
       "3                   f             18.0              NaN            Years   \n",
       "4                   f             18.0              NaN            Years   \n",
       "\n",
       "  maximum_age_unit  number_of_primary_outcomes_to_measure  \\\n",
       "0              NaN                                    1.0   \n",
       "1              NaN                                    1.0   \n",
       "2              NaN                                    1.0   \n",
       "3              NaN                                    1.0   \n",
       "4              NaN                                    1.0   \n",
       "\n",
       "   number_of_secondary_outcomes_to_measure  \\\n",
       "0                                      3.0   \n",
       "1                                      3.0   \n",
       "2                                      3.0   \n",
       "3                                      3.0   \n",
       "4                                      3.0   \n",
       "\n",
       "   number_of_other_outcomes_to_measure     id_y sampling_method gender  \\\n",
       "0                                  NaN  7316876             NaN    ALL   \n",
       "1                                  NaN  7316876             NaN    ALL   \n",
       "2                                  NaN  7316876             NaN    ALL   \n",
       "3                                  NaN  7316876             NaN    ALL   \n",
       "4                                  NaN  7316876             NaN    ALL   \n",
       "\n",
       "  minimum_age maximum_age healthy_volunteers population  \\\n",
       "0    18 Years         NaN                  f        NaN   \n",
       "1    18 Years         NaN                  f        NaN   \n",
       "2    18 Years         NaN                  f        NaN   \n",
       "3    18 Years         NaN                  f        NaN   \n",
       "4    18 Years         NaN                  f        NaN   \n",
       "\n",
       "                                            criteria gender_description  \\\n",
       "0  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "1  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "2  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "3  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "4  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "\n",
       "  gender_based adult child older_adult   official_role        official_name  \\\n",
       "0          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "1          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "2          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "3          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "4          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "\n",
       "            official_affiliation        id            name removed  \n",
       "0  Spectrum Pharmaceuticals, Inc  10138299  Czech Republic       t  \n",
       "1  Spectrum Pharmaceuticals, Inc  10138896   United States       f  \n",
       "2  Spectrum Pharmaceuticals, Inc  10138897       Argentina       f  \n",
       "3  Spectrum Pharmaceuticals, Inc  10138898          Brazil       f  \n",
       "4  Spectrum Pharmaceuticals, Inc  10138899         Czechia       f  "
      ]
     },
     "execution_count": 137,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# merge countries table with p2_p4 table\n",
    "merged_df_1123 = pd.merge(merged_df_1123, df_countries, left_on=\"nct_id\", right_on=\"nct_id\", how=\"inner\")\n",
    "merged_df_1123.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 138,
   "id": "b492b7f6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(24959, 136)"
      ]
     },
     "execution_count": 138,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "merged_df_1123.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 139,
   "id": "e5147169",
   "metadata": {},
   "outputs": [],
   "source": [
    "# rename few country columns\n",
    "merged_df_1123 = merged_df_1123.rename(columns={'name': 'trial_country'})\n",
    "merged_df_1123 = merged_df_1123.rename(columns={'removed': 'country_removed'})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 140,
   "id": "8a460bf6",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['nct_id',\n",
       " 'intervention_type',\n",
       " 'description',\n",
       " 'trial_drug_cleaned',\n",
       " 'conditions',\n",
       " 'Drug Name',\n",
       " 'Highest Status',\n",
       " 'Other Drug Names',\n",
       " 'Originator Company',\n",
       " 'Originator Company HQ',\n",
       " 'Active Companies',\n",
       " 'Active Companies HQ',\n",
       " 'Therapy Area',\n",
       " 'Active Indications',\n",
       " 'Action',\n",
       " 'Technologies',\n",
       " 'Regulatory Designations',\n",
       " 'Inactive Indications',\n",
       " 'Inactive Companies',\n",
       " 'Has Deals',\n",
       " 'Last Change Date',\n",
       " 'Added Date',\n",
       " 'First Launched Date',\n",
       " 'Extract',\n",
       " 'Drug Id',\n",
       " 'cortellis_cleaned_drug',\n",
       " 'nlm_download_date_description',\n",
       " 'study_first_submitted_date',\n",
       " 'results_first_submitted_date',\n",
       " 'disposition_first_submitted_date',\n",
       " 'last_update_submitted_date',\n",
       " 'study_first_submitted_qc_date',\n",
       " 'study_first_posted_date',\n",
       " 'study_first_posted_date_type',\n",
       " 'results_first_submitted_qc_date',\n",
       " 'results_first_posted_date',\n",
       " 'results_first_posted_date_type',\n",
       " 'disposition_first_submitted_qc_date',\n",
       " 'disposition_first_posted_date',\n",
       " 'disposition_first_posted_date_type',\n",
       " 'last_update_submitted_qc_date',\n",
       " 'last_update_posted_date',\n",
       " 'last_update_posted_date_type',\n",
       " 'start_month_year',\n",
       " 'start_date_type',\n",
       " 'start_date',\n",
       " 'verification_month_year',\n",
       " 'verification_date',\n",
       " 'completion_month_year',\n",
       " 'completion_date_type',\n",
       " 'completion_date',\n",
       " 'primary_completion_month_year',\n",
       " 'primary_completion_date_type',\n",
       " 'primary_completion_date',\n",
       " 'target_duration',\n",
       " 'study_type',\n",
       " 'acronym',\n",
       " 'baseline_population',\n",
       " 'brief_title',\n",
       " 'official_title',\n",
       " 'overall_status',\n",
       " 'last_known_status',\n",
       " 'phase',\n",
       " 'enrollment',\n",
       " 'enrollment_type',\n",
       " 'source',\n",
       " 'limitations_and_caveats',\n",
       " 'number_of_arms',\n",
       " 'number_of_groups',\n",
       " 'why_stopped',\n",
       " 'has_expanded_access',\n",
       " 'expanded_access_type_individual',\n",
       " 'expanded_access_type_intermediate',\n",
       " 'expanded_access_type_treatment',\n",
       " 'has_dmc',\n",
       " 'is_fda_regulated_drug',\n",
       " 'is_fda_regulated_device',\n",
       " 'is_unapproved_device',\n",
       " 'is_ppsd',\n",
       " 'is_us_export',\n",
       " 'biospec_retention',\n",
       " 'biospec_description',\n",
       " 'ipd_time_frame',\n",
       " 'ipd_access_criteria',\n",
       " 'ipd_url',\n",
       " 'plan_to_share_ipd',\n",
       " 'plan_to_share_ipd_description',\n",
       " 'created_at',\n",
       " 'updated_at',\n",
       " 'source_class',\n",
       " 'delayed_posting',\n",
       " 'expanded_access_nctid',\n",
       " 'expanded_access_status_for_nctid',\n",
       " 'fdaaa801_violation',\n",
       " 'baseline_type_units_analyzed',\n",
       " 'patient_registry',\n",
       " 'drug_outcome',\n",
       " 'disease_type',\n",
       " 'new_therapy_area',\n",
       " 'id_x',\n",
       " 'number_of_facilities',\n",
       " 'number_of_nsae_subjects',\n",
       " 'number_of_sae_subjects',\n",
       " 'registered_in_calendar_year',\n",
       " 'nlm_download_date',\n",
       " 'actual_duration',\n",
       " 'were_results_reported',\n",
       " 'months_to_report_results',\n",
       " 'has_us_facility',\n",
       " 'has_single_facility',\n",
       " 'minimum_age_num',\n",
       " 'maximum_age_num',\n",
       " 'minimum_age_unit',\n",
       " 'maximum_age_unit',\n",
       " 'number_of_primary_outcomes_to_measure',\n",
       " 'number_of_secondary_outcomes_to_measure',\n",
       " 'number_of_other_outcomes_to_measure',\n",
       " 'id_y',\n",
       " 'sampling_method',\n",
       " 'gender',\n",
       " 'minimum_age',\n",
       " 'maximum_age',\n",
       " 'healthy_volunteers',\n",
       " 'population',\n",
       " 'criteria',\n",
       " 'gender_description',\n",
       " 'gender_based',\n",
       " 'adult',\n",
       " 'child',\n",
       " 'older_adult',\n",
       " 'official_role',\n",
       " 'official_name',\n",
       " 'official_affiliation',\n",
       " 'id',\n",
       " 'trial_country',\n",
       " 'country_removed']"
      ]
     },
     "execution_count": 140,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "merged_df_1123.columns.to_list()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 148,
   "id": "27ef57eb",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nct_id</th>\n",
       "      <th>id</th>\n",
       "      <th>Drug Name</th>\n",
       "      <th>conditions</th>\n",
       "      <th>Therapy Area</th>\n",
       "      <th>Model_domenicrosati_ratings</th>\n",
       "      <th>Spacy Pregnant Women Excluded</th>\n",
       "      <th>LLama3_2_Criteria_Robustness</th>\n",
       "      <th>LLM_GBT_4o_Human_Importance_Ratings</th>\n",
       "      <th>description</th>\n",
       "      <th>criteria</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00000187</td>\n",
       "      <td>24095864</td>\n",
       "      <td>ritanserin</td>\n",
       "      <td>cocaine-related disorders</td>\n",
       "      <td>Toxicity/Intoxication; Neurology/Psychiatric</td>\n",
       "      <td>0.625245</td>\n",
       "      <td>No</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>The purpose of this study is to assess ritanse...</td>\n",
       "      <td>Please contact site for information.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT00000200</td>\n",
       "      <td>23965890</td>\n",
       "      <td>methadone</td>\n",
       "      <td>cocaine-related disorders</td>\n",
       "      <td>Neurology/Psychiatric</td>\n",
       "      <td>0.662990</td>\n",
       "      <td>No</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>The purpose of this study is to compare the ef...</td>\n",
       "      <td>Please contact site for information.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT00000395</td>\n",
       "      <td>24006623</td>\n",
       "      <td>methotrexate</td>\n",
       "      <td>rheumatoid arthritis</td>\n",
       "      <td>Immune; Dermatologic; Gastrointestinal; Ocular</td>\n",
       "      <td>0.564219</td>\n",
       "      <td>No</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>This study looks at how the arthritis drug met...</td>\n",
       "      <td>Inclusion Criteria:~* Individuals starting met...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00000451</td>\n",
       "      <td>23799489</td>\n",
       "      <td>sertraline</td>\n",
       "      <td>alcoholism</td>\n",
       "      <td>Neurology/Psychiatric; Genitourinary/Sexual Fu...</td>\n",
       "      <td>0.575893</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2</td>\n",
       "      <td>1</td>\n",
       "      <td>This study will assess the ability of naltrexo...</td>\n",
       "      <td>Inclusion Criteria:~* Alaska Native having bio...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT00001723</td>\n",
       "      <td>24120128</td>\n",
       "      <td>orlistat</td>\n",
       "      <td>obesity</td>\n",
       "      <td>Other/Miscellaneous</td>\n",
       "      <td>0.663715</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>Obesity is a condition affecting one-third off...</td>\n",
       "      <td>* INCLUSION CRITERIA:~Good general health. Ind...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        nct_id        id     Drug Name                 conditions  \\\n",
       "0  NCT00000187  24095864    ritanserin  cocaine-related disorders   \n",
       "1  NCT00000200  23965890     methadone  cocaine-related disorders   \n",
       "2  NCT00000395  24006623  methotrexate       rheumatoid arthritis   \n",
       "3  NCT00000451  23799489    sertraline                 alcoholism   \n",
       "4  NCT00001723  24120128      orlistat                    obesity   \n",
       "\n",
       "                                        Therapy Area  \\\n",
       "0       Toxicity/Intoxication; Neurology/Psychiatric   \n",
       "1                              Neurology/Psychiatric   \n",
       "2     Immune; Dermatologic; Gastrointestinal; Ocular   \n",
       "3  Neurology/Psychiatric; Genitourinary/Sexual Fu...   \n",
       "4                                Other/Miscellaneous   \n",
       "\n",
       "   Model_domenicrosati_ratings Spacy Pregnant Women Excluded  \\\n",
       "0                     0.625245                            No   \n",
       "1                     0.662990                            No   \n",
       "2                     0.564219                            No   \n",
       "3                     0.575893                           Yes   \n",
       "4                     0.663715                           Yes   \n",
       "\n",
       "   LLama3_2_Criteria_Robustness  LLM_GBT_4o_Human_Importance_Ratings  \\\n",
       "0                             0                                    0   \n",
       "1                             0                                    1   \n",
       "2                             0                                    2   \n",
       "3                             2                                    1   \n",
       "4                             2                                    2   \n",
       "\n",
       "                                         description  \\\n",
       "0  The purpose of this study is to assess ritanse...   \n",
       "1  The purpose of this study is to compare the ef...   \n",
       "2  This study looks at how the arthritis drug met...   \n",
       "3  This study will assess the ability of naltrexo...   \n",
       "4  Obesity is a condition affecting one-third off...   \n",
       "\n",
       "                                            criteria  \n",
       "0               Please contact site for information.  \n",
       "1               Please contact site for information.  \n",
       "2  Inclusion Criteria:~* Individuals starting met...  \n",
       "3  Inclusion Criteria:~* Alaska Native having bio...  \n",
       "4  * INCLUSION CRITERIA:~Good general health. Ind...  "
      ]
     },
     "execution_count": 148,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# load the features from SLM/LLM \n",
    "df_llm_features = pd.read_csv('nov_24/nov_23/Clincal_data_Language_Model_MAPPINGS.csv', sep=',')\n",
    "df_llm_features.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 160,
   "id": "9cc3f287",
   "metadata": {},
   "outputs": [],
   "source": [
    "# encode pregnant women exclusion\n",
    "df_llm_features['Spacy Pregnant Women Excluded'] = df_llm_features['Spacy Pregnant Women Excluded'].replace({'Yes': 1, 'No': 0})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 167,
   "id": "be221b5b",
   "metadata": {},
   "outputs": [],
   "source": [
    "# group by nct_id, drug_name and conditions\n",
    "LLama3_2_Criteria_Robustness = df_llm_features.groupby(['Drug Name','nct_id','conditions'])['LLama3_2_Criteria_Robustness'].max().reset_index(name='LLama3_2_Criteria_Robustness')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 168,
   "id": "9ff10265",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nct_id</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>description</th>\n",
       "      <th>trial_drug_cleaned</th>\n",
       "      <th>conditions</th>\n",
       "      <th>Drug Name</th>\n",
       "      <th>Highest Status</th>\n",
       "      <th>Other Drug Names</th>\n",
       "      <th>Originator Company</th>\n",
       "      <th>Originator Company HQ</th>\n",
       "      <th>Active Companies</th>\n",
       "      <th>Active Companies HQ</th>\n",
       "      <th>Therapy Area</th>\n",
       "      <th>Active Indications</th>\n",
       "      <th>Action</th>\n",
       "      <th>Technologies</th>\n",
       "      <th>Regulatory Designations</th>\n",
       "      <th>Inactive Indications</th>\n",
       "      <th>Inactive Companies</th>\n",
       "      <th>Has Deals</th>\n",
       "      <th>Last Change Date</th>\n",
       "      <th>Added Date</th>\n",
       "      <th>First Launched Date</th>\n",
       "      <th>Extract</th>\n",
       "      <th>Drug Id</th>\n",
       "      <th>cortellis_cleaned_drug</th>\n",
       "      <th>nlm_download_date_description</th>\n",
       "      <th>study_first_submitted_date</th>\n",
       "      <th>results_first_submitted_date</th>\n",
       "      <th>disposition_first_submitted_date</th>\n",
       "      <th>last_update_submitted_date</th>\n",
       "      <th>study_first_submitted_qc_date</th>\n",
       "      <th>study_first_posted_date</th>\n",
       "      <th>study_first_posted_date_type</th>\n",
       "      <th>results_first_submitted_qc_date</th>\n",
       "      <th>results_first_posted_date</th>\n",
       "      <th>results_first_posted_date_type</th>\n",
       "      <th>disposition_first_submitted_qc_date</th>\n",
       "      <th>disposition_first_posted_date</th>\n",
       "      <th>disposition_first_posted_date_type</th>\n",
       "      <th>last_update_submitted_qc_date</th>\n",
       "      <th>last_update_posted_date</th>\n",
       "      <th>last_update_posted_date_type</th>\n",
       "      <th>start_month_year</th>\n",
       "      <th>start_date_type</th>\n",
       "      <th>start_date</th>\n",
       "      <th>verification_month_year</th>\n",
       "      <th>verification_date</th>\n",
       "      <th>completion_month_year</th>\n",
       "      <th>completion_date_type</th>\n",
       "      <th>completion_date</th>\n",
       "      <th>primary_completion_month_year</th>\n",
       "      <th>primary_completion_date_type</th>\n",
       "      <th>primary_completion_date</th>\n",
       "      <th>target_duration</th>\n",
       "      <th>study_type</th>\n",
       "      <th>acronym</th>\n",
       "      <th>baseline_population</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>official_title</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>last_known_status</th>\n",
       "      <th>phase</th>\n",
       "      <th>enrollment</th>\n",
       "      <th>enrollment_type</th>\n",
       "      <th>source</th>\n",
       "      <th>limitations_and_caveats</th>\n",
       "      <th>number_of_arms</th>\n",
       "      <th>number_of_groups</th>\n",
       "      <th>why_stopped</th>\n",
       "      <th>has_expanded_access</th>\n",
       "      <th>expanded_access_type_individual</th>\n",
       "      <th>expanded_access_type_intermediate</th>\n",
       "      <th>expanded_access_type_treatment</th>\n",
       "      <th>has_dmc</th>\n",
       "      <th>is_fda_regulated_drug</th>\n",
       "      <th>is_fda_regulated_device</th>\n",
       "      <th>is_unapproved_device</th>\n",
       "      <th>is_ppsd</th>\n",
       "      <th>is_us_export</th>\n",
       "      <th>biospec_retention</th>\n",
       "      <th>biospec_description</th>\n",
       "      <th>ipd_time_frame</th>\n",
       "      <th>ipd_access_criteria</th>\n",
       "      <th>ipd_url</th>\n",
       "      <th>plan_to_share_ipd</th>\n",
       "      <th>plan_to_share_ipd_description</th>\n",
       "      <th>created_at</th>\n",
       "      <th>updated_at</th>\n",
       "      <th>source_class</th>\n",
       "      <th>delayed_posting</th>\n",
       "      <th>expanded_access_nctid</th>\n",
       "      <th>expanded_access_status_for_nctid</th>\n",
       "      <th>fdaaa801_violation</th>\n",
       "      <th>baseline_type_units_analyzed</th>\n",
       "      <th>patient_registry</th>\n",
       "      <th>drug_outcome</th>\n",
       "      <th>disease_type</th>\n",
       "      <th>new_therapy_area</th>\n",
       "      <th>id_x</th>\n",
       "      <th>number_of_facilities</th>\n",
       "      <th>number_of_nsae_subjects</th>\n",
       "      <th>number_of_sae_subjects</th>\n",
       "      <th>registered_in_calendar_year</th>\n",
       "      <th>nlm_download_date</th>\n",
       "      <th>actual_duration</th>\n",
       "      <th>were_results_reported</th>\n",
       "      <th>months_to_report_results</th>\n",
       "      <th>has_us_facility</th>\n",
       "      <th>has_single_facility</th>\n",
       "      <th>minimum_age_num</th>\n",
       "      <th>maximum_age_num</th>\n",
       "      <th>minimum_age_unit</th>\n",
       "      <th>maximum_age_unit</th>\n",
       "      <th>number_of_primary_outcomes_to_measure</th>\n",
       "      <th>number_of_secondary_outcomes_to_measure</th>\n",
       "      <th>number_of_other_outcomes_to_measure</th>\n",
       "      <th>id_y</th>\n",
       "      <th>sampling_method</th>\n",
       "      <th>gender</th>\n",
       "      <th>minimum_age</th>\n",
       "      <th>maximum_age</th>\n",
       "      <th>healthy_volunteers</th>\n",
       "      <th>population</th>\n",
       "      <th>criteria</th>\n",
       "      <th>gender_description</th>\n",
       "      <th>gender_based</th>\n",
       "      <th>adult</th>\n",
       "      <th>child</th>\n",
       "      <th>older_adult</th>\n",
       "      <th>official_role</th>\n",
       "      <th>official_name</th>\n",
       "      <th>official_affiliation</th>\n",
       "      <th>id</th>\n",
       "      <th>trial_country</th>\n",
       "      <th>country_removed</th>\n",
       "      <th>LLM_GBT_4o_Human_Importance_Ratings</th>\n",
       "      <th>LLama3_2_Criteria_Robustness</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138299</td>\n",
       "      <td>Czech Republic</td>\n",
       "      <td>t</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138896</td>\n",
       "      <td>United States</td>\n",
       "      <td>f</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138897</td>\n",
       "      <td>Argentina</td>\n",
       "      <td>f</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138898</td>\n",
       "      <td>Brazil</td>\n",
       "      <td>f</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138899</td>\n",
       "      <td>Czechia</td>\n",
       "      <td>f</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        nct_id intervention_type  \\\n",
       "0  NCT00606502              DRUG   \n",
       "1  NCT00606502              DRUG   \n",
       "2  NCT00606502              DRUG   \n",
       "3  NCT00606502              DRUG   \n",
       "4  NCT00606502              DRUG   \n",
       "\n",
       "                                         description trial_drug_cleaned  \\\n",
       "0  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "1  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "2  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "3  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "4  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "\n",
       "                   conditions  Drug Name Highest Status  \\\n",
       "0  non-small cell lung cancer  erlotinib       Launched   \n",
       "1  non-small cell lung cancer  erlotinib       Launched   \n",
       "2  non-small cell lung cancer  erlotinib       Launched   \n",
       "3  non-small cell lung cancer  erlotinib       Launched   \n",
       "4  non-small cell lung cancer  erlotinib       Launched   \n",
       "\n",
       "                                    Other Drug Names       Originator Company  \\\n",
       "0  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "1  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "2  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "3  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "4  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "\n",
       "          Originator Company HQ  \\\n",
       "0  OSI Pharmaceuticals Inc (US)   \n",
       "1  OSI Pharmaceuticals Inc (US)   \n",
       "2  OSI Pharmaceuticals Inc (US)   \n",
       "3  OSI Pharmaceuticals Inc (US)   \n",
       "4  OSI Pharmaceuticals Inc (US)   \n",
       "\n",
       "                                    Active Companies  \\\n",
       "0  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "1  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "2  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "3  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "4  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "\n",
       "                                 Active Companies HQ          Therapy Area  \\\n",
       "0  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "1  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "2  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "3  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "4  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "\n",
       "                                  Active Indications  \\\n",
       "0  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "1  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "2  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "3  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "4  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "\n",
       "                                              Action  \\\n",
       "0  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "1  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "2  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "3  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "4  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "\n",
       "                                        Technologies  Regulatory Designations  \\\n",
       "0  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "1  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "2  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "3  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "4  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "\n",
       "                                Inactive Indications  \\\n",
       "0  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "1  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "2  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "3  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "4  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "\n",
       "            Inactive Companies Has Deals Last Change Date  Added Date  \\\n",
       "0  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "1  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "2  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "3  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "4  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "\n",
       "  First Launched Date                                            Extract  \\\n",
       "0          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "1          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "2          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "3          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "4          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "\n",
       "   Drug Id cortellis_cleaned_drug  nlm_download_date_description  \\\n",
       "0    11961              erlotinib                            NaN   \n",
       "1    11961              erlotinib                            NaN   \n",
       "2    11961              erlotinib                            NaN   \n",
       "3    11961              erlotinib                            NaN   \n",
       "4    11961              erlotinib                            NaN   \n",
       "\n",
       "  study_first_submitted_date results_first_submitted_date  \\\n",
       "0                 2008-01-22                   2010-12-22   \n",
       "1                 2008-01-22                   2010-12-22   \n",
       "2                 2008-01-22                   2010-12-22   \n",
       "3                 2008-01-22                   2010-12-22   \n",
       "4                 2008-01-22                   2010-12-22   \n",
       "\n",
       "  disposition_first_submitted_date last_update_submitted_date  \\\n",
       "0                              NaN                 2021-02-08   \n",
       "1                              NaN                 2021-02-08   \n",
       "2                              NaN                 2021-02-08   \n",
       "3                              NaN                 2021-02-08   \n",
       "4                              NaN                 2021-02-08   \n",
       "\n",
       "  study_first_submitted_qc_date study_first_posted_date  \\\n",
       "0                    2008-02-01              2008-02-04   \n",
       "1                    2008-02-01              2008-02-04   \n",
       "2                    2008-02-01              2008-02-04   \n",
       "3                    2008-02-01              2008-02-04   \n",
       "4                    2008-02-01              2008-02-04   \n",
       "\n",
       "  study_first_posted_date_type results_first_submitted_qc_date  \\\n",
       "0                    ESTIMATED                      2010-12-22   \n",
       "1                    ESTIMATED                      2010-12-22   \n",
       "2                    ESTIMATED                      2010-12-22   \n",
       "3                    ESTIMATED                      2010-12-22   \n",
       "4                    ESTIMATED                      2010-12-22   \n",
       "\n",
       "  results_first_posted_date results_first_posted_date_type  \\\n",
       "0                2011-01-20                      ESTIMATED   \n",
       "1                2011-01-20                      ESTIMATED   \n",
       "2                2011-01-20                      ESTIMATED   \n",
       "3                2011-01-20                      ESTIMATED   \n",
       "4                2011-01-20                      ESTIMATED   \n",
       "\n",
       "  disposition_first_submitted_qc_date disposition_first_posted_date  \\\n",
       "0                                 NaN                           NaN   \n",
       "1                                 NaN                           NaN   \n",
       "2                                 NaN                           NaN   \n",
       "3                                 NaN                           NaN   \n",
       "4                                 NaN                           NaN   \n",
       "\n",
       "  disposition_first_posted_date_type last_update_submitted_qc_date  \\\n",
       "0                                NaN                    2021-02-08   \n",
       "1                                NaN                    2021-02-08   \n",
       "2                                NaN                    2021-02-08   \n",
       "3                                NaN                    2021-02-08   \n",
       "4                                NaN                    2021-02-08   \n",
       "\n",
       "  last_update_posted_date last_update_posted_date_type start_month_year  \\\n",
       "0              2021-03-05                       ACTUAL          2008-01   \n",
       "1              2021-03-05                       ACTUAL          2008-01   \n",
       "2              2021-03-05                       ACTUAL          2008-01   \n",
       "3              2021-03-05                       ACTUAL          2008-01   \n",
       "4              2021-03-05                       ACTUAL          2008-01   \n",
       "\n",
       "  start_date_type start_date verification_month_year verification_date  \\\n",
       "0             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "1             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "2             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "3             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "4             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "\n",
       "  completion_month_year completion_date_type completion_date  \\\n",
       "0            2010-06-24               ACTUAL      2010-06-24   \n",
       "1            2010-06-24               ACTUAL      2010-06-24   \n",
       "2            2010-06-24               ACTUAL      2010-06-24   \n",
       "3            2010-06-24               ACTUAL      2010-06-24   \n",
       "4            2010-06-24               ACTUAL      2010-06-24   \n",
       "\n",
       "  primary_completion_month_year primary_completion_date_type  \\\n",
       "0                    2010-06-24                       ACTUAL   \n",
       "1                    2010-06-24                       ACTUAL   \n",
       "2                    2010-06-24                       ACTUAL   \n",
       "3                    2010-06-24                       ACTUAL   \n",
       "4                    2010-06-24                       ACTUAL   \n",
       "\n",
       "  primary_completion_date  target_duration      study_type acronym  \\\n",
       "0              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "1              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "2              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "3              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "4              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "\n",
       "  baseline_population                                        brief_title  \\\n",
       "0                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "1                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "2                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "3                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "4                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "\n",
       "                                      official_title overall_status  \\\n",
       "0  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "1  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "2  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "3  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "4  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "\n",
       "   last_known_status   phase  enrollment enrollment_type  \\\n",
       "0                NaN  PHASE2       201.0          ACTUAL   \n",
       "1                NaN  PHASE2       201.0          ACTUAL   \n",
       "2                NaN  PHASE2       201.0          ACTUAL   \n",
       "3                NaN  PHASE2       201.0          ACTUAL   \n",
       "4                NaN  PHASE2       201.0          ACTUAL   \n",
       "\n",
       "                          source  \\\n",
       "0  Spectrum Pharmaceuticals, Inc   \n",
       "1  Spectrum Pharmaceuticals, Inc   \n",
       "2  Spectrum Pharmaceuticals, Inc   \n",
       "3  Spectrum Pharmaceuticals, Inc   \n",
       "4  Spectrum Pharmaceuticals, Inc   \n",
       "\n",
       "                             limitations_and_caveats  number_of_arms  \\\n",
       "0  The date of the CRF database cut-off for patie...             2.0   \n",
       "1  The date of the CRF database cut-off for patie...             2.0   \n",
       "2  The date of the CRF database cut-off for patie...             2.0   \n",
       "3  The date of the CRF database cut-off for patie...             2.0   \n",
       "4  The date of the CRF database cut-off for patie...             2.0   \n",
       "\n",
       "   number_of_groups why_stopped has_expanded_access  \\\n",
       "0               NaN         NaN                   f   \n",
       "1               NaN         NaN                   f   \n",
       "2               NaN         NaN                   f   \n",
       "3               NaN         NaN                   f   \n",
       "4               NaN         NaN                   f   \n",
       "\n",
       "   expanded_access_type_individual  expanded_access_type_intermediate  \\\n",
       "0                              NaN                                NaN   \n",
       "1                              NaN                                NaN   \n",
       "2                              NaN                                NaN   \n",
       "3                              NaN                                NaN   \n",
       "4                              NaN                                NaN   \n",
       "\n",
       "   expanded_access_type_treatment has_dmc is_fda_regulated_drug  \\\n",
       "0                             NaN     NaN                   NaN   \n",
       "1                             NaN     NaN                   NaN   \n",
       "2                             NaN     NaN                   NaN   \n",
       "3                             NaN     NaN                   NaN   \n",
       "4                             NaN     NaN                   NaN   \n",
       "\n",
       "  is_fda_regulated_device is_unapproved_device  is_ppsd is_us_export  \\\n",
       "0                     NaN                  NaN      NaN          NaN   \n",
       "1                     NaN                  NaN      NaN          NaN   \n",
       "2                     NaN                  NaN      NaN          NaN   \n",
       "3                     NaN                  NaN      NaN          NaN   \n",
       "4                     NaN                  NaN      NaN          NaN   \n",
       "\n",
       "   biospec_retention  biospec_description ipd_time_frame ipd_access_criteria  \\\n",
       "0                NaN                  NaN            NaN                 NaN   \n",
       "1                NaN                  NaN            NaN                 NaN   \n",
       "2                NaN                  NaN            NaN                 NaN   \n",
       "3                NaN                  NaN            NaN                 NaN   \n",
       "4                NaN                  NaN            NaN                 NaN   \n",
       "\n",
       "  ipd_url plan_to_share_ipd plan_to_share_ipd_description  \\\n",
       "0     NaN               NaN                           NaN   \n",
       "1     NaN               NaN                           NaN   \n",
       "2     NaN               NaN                           NaN   \n",
       "3     NaN               NaN                           NaN   \n",
       "4     NaN               NaN                           NaN   \n",
       "\n",
       "                   created_at                  updated_at source_class  \\\n",
       "0  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "1  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "2  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "3  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "4  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "\n",
       "   delayed_posting expanded_access_nctid expanded_access_status_for_nctid  \\\n",
       "0              NaN                   NaN                              NaN   \n",
       "1              NaN                   NaN                              NaN   \n",
       "2              NaN                   NaN                              NaN   \n",
       "3              NaN                   NaN                              NaN   \n",
       "4              NaN                   NaN                              NaN   \n",
       "\n",
       "   fdaaa801_violation  baseline_type_units_analyzed  patient_registry  \\\n",
       "0                 NaN                           NaN               NaN   \n",
       "1                 NaN                           NaN               NaN   \n",
       "2                 NaN                           NaN               NaN   \n",
       "3                 NaN                           NaN               NaN   \n",
       "4                 NaN                           NaN               NaN   \n",
       "\n",
       "  drug_outcome          disease_type new_therapy_area      id_x  \\\n",
       "0      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "1      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "2      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "3      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "4      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "\n",
       "   number_of_facilities  number_of_nsae_subjects  number_of_sae_subjects  \\\n",
       "0                  47.0                    540.0                   124.0   \n",
       "1                  47.0                    540.0                   124.0   \n",
       "2                  47.0                    540.0                   124.0   \n",
       "3                  47.0                    540.0                   124.0   \n",
       "4                  47.0                    540.0                   124.0   \n",
       "\n",
       "   registered_in_calendar_year  nlm_download_date  actual_duration  \\\n",
       "0                         2008                NaN             29.0   \n",
       "1                         2008                NaN             29.0   \n",
       "2                         2008                NaN             29.0   \n",
       "3                         2008                NaN             29.0   \n",
       "4                         2008                NaN             29.0   \n",
       "\n",
       "  were_results_reported  months_to_report_results has_us_facility  \\\n",
       "0                     t                       6.0               t   \n",
       "1                     t                       6.0               t   \n",
       "2                     t                       6.0               t   \n",
       "3                     t                       6.0               t   \n",
       "4                     t                       6.0               t   \n",
       "\n",
       "  has_single_facility  minimum_age_num  maximum_age_num minimum_age_unit  \\\n",
       "0                   f             18.0              NaN            Years   \n",
       "1                   f             18.0              NaN            Years   \n",
       "2                   f             18.0              NaN            Years   \n",
       "3                   f             18.0              NaN            Years   \n",
       "4                   f             18.0              NaN            Years   \n",
       "\n",
       "  maximum_age_unit  number_of_primary_outcomes_to_measure  \\\n",
       "0              NaN                                    1.0   \n",
       "1              NaN                                    1.0   \n",
       "2              NaN                                    1.0   \n",
       "3              NaN                                    1.0   \n",
       "4              NaN                                    1.0   \n",
       "\n",
       "   number_of_secondary_outcomes_to_measure  \\\n",
       "0                                      3.0   \n",
       "1                                      3.0   \n",
       "2                                      3.0   \n",
       "3                                      3.0   \n",
       "4                                      3.0   \n",
       "\n",
       "   number_of_other_outcomes_to_measure     id_y sampling_method gender  \\\n",
       "0                                  NaN  7316876             NaN    ALL   \n",
       "1                                  NaN  7316876             NaN    ALL   \n",
       "2                                  NaN  7316876             NaN    ALL   \n",
       "3                                  NaN  7316876             NaN    ALL   \n",
       "4                                  NaN  7316876             NaN    ALL   \n",
       "\n",
       "  minimum_age maximum_age healthy_volunteers population  \\\n",
       "0    18 Years         NaN                  f        NaN   \n",
       "1    18 Years         NaN                  f        NaN   \n",
       "2    18 Years         NaN                  f        NaN   \n",
       "3    18 Years         NaN                  f        NaN   \n",
       "4    18 Years         NaN                  f        NaN   \n",
       "\n",
       "                                            criteria gender_description  \\\n",
       "0  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "1  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "2  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "3  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "4  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "\n",
       "  gender_based adult child older_adult   official_role        official_name  \\\n",
       "0          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "1          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "2          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "3          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "4          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "\n",
       "            official_affiliation        id   trial_country country_removed  \\\n",
       "0  Spectrum Pharmaceuticals, Inc  10138299  Czech Republic               t   \n",
       "1  Spectrum Pharmaceuticals, Inc  10138896   United States               f   \n",
       "2  Spectrum Pharmaceuticals, Inc  10138897       Argentina               f   \n",
       "3  Spectrum Pharmaceuticals, Inc  10138898          Brazil               f   \n",
       "4  Spectrum Pharmaceuticals, Inc  10138899         Czechia               f   \n",
       "\n",
       "   LLM_GBT_4o_Human_Importance_Ratings  LLama3_2_Criteria_Robustness  \n",
       "0                                  1.0                           2.0  \n",
       "1                                  1.0                           2.0  \n",
       "2                                  1.0                           2.0  \n",
       "3                                  1.0                           2.0  \n",
       "4                                  1.0                           2.0  "
      ]
     },
     "execution_count": 168,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# merge llm_features with main df\n",
    "merged_df_1123 = pd.merge(merged_df_1123, LLama3_2_Criteria_Robustness, on=['Drug Name','conditions','nct_id'], how=\"left\")\n",
    "merged_df_1123.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 169,
   "id": "0d43fccb",
   "metadata": {},
   "outputs": [],
   "source": [
    "# replace NaN values in LLama3_2_Criteria_Robustness with 0\n",
    "merged_df_1123['LLama3_2_Criteria_Robustness'] = merged_df_1123_v2['LLama3_2_Criteria_Robustness'].fillna(0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 162,
   "id": "38019c49",
   "metadata": {},
   "outputs": [],
   "source": [
    "# group by nct_id, drug_name and conditions\n",
    "LLM_GBT_4o_Human_Importance_Ratings = df_llm_features.groupby(['Drug Name','nct_id','conditions'])['LLM_GBT_4o_Human_Importance_Ratings'].max().reset_index(name='LLM_GBT_4o_Human_Importance_Ratings')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 163,
   "id": "0ce5b351",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nct_id</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>description</th>\n",
       "      <th>trial_drug_cleaned</th>\n",
       "      <th>conditions</th>\n",
       "      <th>Drug Name</th>\n",
       "      <th>Highest Status</th>\n",
       "      <th>Other Drug Names</th>\n",
       "      <th>Originator Company</th>\n",
       "      <th>Originator Company HQ</th>\n",
       "      <th>Active Companies</th>\n",
       "      <th>Active Companies HQ</th>\n",
       "      <th>Therapy Area</th>\n",
       "      <th>Active Indications</th>\n",
       "      <th>Action</th>\n",
       "      <th>Technologies</th>\n",
       "      <th>Regulatory Designations</th>\n",
       "      <th>Inactive Indications</th>\n",
       "      <th>Inactive Companies</th>\n",
       "      <th>Has Deals</th>\n",
       "      <th>Last Change Date</th>\n",
       "      <th>Added Date</th>\n",
       "      <th>First Launched Date</th>\n",
       "      <th>Extract</th>\n",
       "      <th>Drug Id</th>\n",
       "      <th>cortellis_cleaned_drug</th>\n",
       "      <th>nlm_download_date_description</th>\n",
       "      <th>study_first_submitted_date</th>\n",
       "      <th>results_first_submitted_date</th>\n",
       "      <th>disposition_first_submitted_date</th>\n",
       "      <th>last_update_submitted_date</th>\n",
       "      <th>study_first_submitted_qc_date</th>\n",
       "      <th>study_first_posted_date</th>\n",
       "      <th>study_first_posted_date_type</th>\n",
       "      <th>results_first_submitted_qc_date</th>\n",
       "      <th>results_first_posted_date</th>\n",
       "      <th>results_first_posted_date_type</th>\n",
       "      <th>disposition_first_submitted_qc_date</th>\n",
       "      <th>disposition_first_posted_date</th>\n",
       "      <th>disposition_first_posted_date_type</th>\n",
       "      <th>last_update_submitted_qc_date</th>\n",
       "      <th>last_update_posted_date</th>\n",
       "      <th>last_update_posted_date_type</th>\n",
       "      <th>start_month_year</th>\n",
       "      <th>start_date_type</th>\n",
       "      <th>start_date</th>\n",
       "      <th>verification_month_year</th>\n",
       "      <th>verification_date</th>\n",
       "      <th>completion_month_year</th>\n",
       "      <th>completion_date_type</th>\n",
       "      <th>completion_date</th>\n",
       "      <th>primary_completion_month_year</th>\n",
       "      <th>primary_completion_date_type</th>\n",
       "      <th>primary_completion_date</th>\n",
       "      <th>target_duration</th>\n",
       "      <th>study_type</th>\n",
       "      <th>acronym</th>\n",
       "      <th>baseline_population</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>official_title</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>last_known_status</th>\n",
       "      <th>phase</th>\n",
       "      <th>enrollment</th>\n",
       "      <th>enrollment_type</th>\n",
       "      <th>source</th>\n",
       "      <th>limitations_and_caveats</th>\n",
       "      <th>number_of_arms</th>\n",
       "      <th>number_of_groups</th>\n",
       "      <th>why_stopped</th>\n",
       "      <th>has_expanded_access</th>\n",
       "      <th>expanded_access_type_individual</th>\n",
       "      <th>expanded_access_type_intermediate</th>\n",
       "      <th>expanded_access_type_treatment</th>\n",
       "      <th>has_dmc</th>\n",
       "      <th>is_fda_regulated_drug</th>\n",
       "      <th>is_fda_regulated_device</th>\n",
       "      <th>is_unapproved_device</th>\n",
       "      <th>is_ppsd</th>\n",
       "      <th>is_us_export</th>\n",
       "      <th>biospec_retention</th>\n",
       "      <th>biospec_description</th>\n",
       "      <th>ipd_time_frame</th>\n",
       "      <th>ipd_access_criteria</th>\n",
       "      <th>ipd_url</th>\n",
       "      <th>plan_to_share_ipd</th>\n",
       "      <th>plan_to_share_ipd_description</th>\n",
       "      <th>created_at</th>\n",
       "      <th>updated_at</th>\n",
       "      <th>source_class</th>\n",
       "      <th>delayed_posting</th>\n",
       "      <th>expanded_access_nctid</th>\n",
       "      <th>expanded_access_status_for_nctid</th>\n",
       "      <th>fdaaa801_violation</th>\n",
       "      <th>baseline_type_units_analyzed</th>\n",
       "      <th>patient_registry</th>\n",
       "      <th>drug_outcome</th>\n",
       "      <th>disease_type</th>\n",
       "      <th>new_therapy_area</th>\n",
       "      <th>id_x</th>\n",
       "      <th>number_of_facilities</th>\n",
       "      <th>number_of_nsae_subjects</th>\n",
       "      <th>number_of_sae_subjects</th>\n",
       "      <th>registered_in_calendar_year</th>\n",
       "      <th>nlm_download_date</th>\n",
       "      <th>actual_duration</th>\n",
       "      <th>were_results_reported</th>\n",
       "      <th>months_to_report_results</th>\n",
       "      <th>has_us_facility</th>\n",
       "      <th>has_single_facility</th>\n",
       "      <th>minimum_age_num</th>\n",
       "      <th>maximum_age_num</th>\n",
       "      <th>minimum_age_unit</th>\n",
       "      <th>maximum_age_unit</th>\n",
       "      <th>number_of_primary_outcomes_to_measure</th>\n",
       "      <th>number_of_secondary_outcomes_to_measure</th>\n",
       "      <th>number_of_other_outcomes_to_measure</th>\n",
       "      <th>id_y</th>\n",
       "      <th>sampling_method</th>\n",
       "      <th>gender</th>\n",
       "      <th>minimum_age</th>\n",
       "      <th>maximum_age</th>\n",
       "      <th>healthy_volunteers</th>\n",
       "      <th>population</th>\n",
       "      <th>criteria</th>\n",
       "      <th>gender_description</th>\n",
       "      <th>gender_based</th>\n",
       "      <th>adult</th>\n",
       "      <th>child</th>\n",
       "      <th>older_adult</th>\n",
       "      <th>official_role</th>\n",
       "      <th>official_name</th>\n",
       "      <th>official_affiliation</th>\n",
       "      <th>id</th>\n",
       "      <th>trial_country</th>\n",
       "      <th>country_removed</th>\n",
       "      <th>LLM_GBT_4o_Human_Importance_Ratings</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138299</td>\n",
       "      <td>Czech Republic</td>\n",
       "      <td>t</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138896</td>\n",
       "      <td>United States</td>\n",
       "      <td>f</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138897</td>\n",
       "      <td>Argentina</td>\n",
       "      <td>f</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138898</td>\n",
       "      <td>Brazil</td>\n",
       "      <td>f</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138899</td>\n",
       "      <td>Czechia</td>\n",
       "      <td>f</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        nct_id intervention_type  \\\n",
       "0  NCT00606502              DRUG   \n",
       "1  NCT00606502              DRUG   \n",
       "2  NCT00606502              DRUG   \n",
       "3  NCT00606502              DRUG   \n",
       "4  NCT00606502              DRUG   \n",
       "\n",
       "                                         description trial_drug_cleaned  \\\n",
       "0  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "1  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "2  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "3  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "4  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "\n",
       "                   conditions  Drug Name Highest Status  \\\n",
       "0  non-small cell lung cancer  erlotinib       Launched   \n",
       "1  non-small cell lung cancer  erlotinib       Launched   \n",
       "2  non-small cell lung cancer  erlotinib       Launched   \n",
       "3  non-small cell lung cancer  erlotinib       Launched   \n",
       "4  non-small cell lung cancer  erlotinib       Launched   \n",
       "\n",
       "                                    Other Drug Names       Originator Company  \\\n",
       "0  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "1  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "2  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "3  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "4  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "\n",
       "          Originator Company HQ  \\\n",
       "0  OSI Pharmaceuticals Inc (US)   \n",
       "1  OSI Pharmaceuticals Inc (US)   \n",
       "2  OSI Pharmaceuticals Inc (US)   \n",
       "3  OSI Pharmaceuticals Inc (US)   \n",
       "4  OSI Pharmaceuticals Inc (US)   \n",
       "\n",
       "                                    Active Companies  \\\n",
       "0  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "1  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "2  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "3  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "4  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "\n",
       "                                 Active Companies HQ          Therapy Area  \\\n",
       "0  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "1  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "2  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "3  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "4  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "\n",
       "                                  Active Indications  \\\n",
       "0  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "1  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "2  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "3  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "4  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "\n",
       "                                              Action  \\\n",
       "0  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "1  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "2  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "3  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "4  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "\n",
       "                                        Technologies  Regulatory Designations  \\\n",
       "0  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "1  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "2  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "3  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "4  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "\n",
       "                                Inactive Indications  \\\n",
       "0  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "1  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "2  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "3  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "4  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "\n",
       "            Inactive Companies Has Deals Last Change Date  Added Date  \\\n",
       "0  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "1  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "2  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "3  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "4  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "\n",
       "  First Launched Date                                            Extract  \\\n",
       "0          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "1          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "2          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "3          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "4          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "\n",
       "   Drug Id cortellis_cleaned_drug  nlm_download_date_description  \\\n",
       "0    11961              erlotinib                            NaN   \n",
       "1    11961              erlotinib                            NaN   \n",
       "2    11961              erlotinib                            NaN   \n",
       "3    11961              erlotinib                            NaN   \n",
       "4    11961              erlotinib                            NaN   \n",
       "\n",
       "  study_first_submitted_date results_first_submitted_date  \\\n",
       "0                 2008-01-22                   2010-12-22   \n",
       "1                 2008-01-22                   2010-12-22   \n",
       "2                 2008-01-22                   2010-12-22   \n",
       "3                 2008-01-22                   2010-12-22   \n",
       "4                 2008-01-22                   2010-12-22   \n",
       "\n",
       "  disposition_first_submitted_date last_update_submitted_date  \\\n",
       "0                              NaN                 2021-02-08   \n",
       "1                              NaN                 2021-02-08   \n",
       "2                              NaN                 2021-02-08   \n",
       "3                              NaN                 2021-02-08   \n",
       "4                              NaN                 2021-02-08   \n",
       "\n",
       "  study_first_submitted_qc_date study_first_posted_date  \\\n",
       "0                    2008-02-01              2008-02-04   \n",
       "1                    2008-02-01              2008-02-04   \n",
       "2                    2008-02-01              2008-02-04   \n",
       "3                    2008-02-01              2008-02-04   \n",
       "4                    2008-02-01              2008-02-04   \n",
       "\n",
       "  study_first_posted_date_type results_first_submitted_qc_date  \\\n",
       "0                    ESTIMATED                      2010-12-22   \n",
       "1                    ESTIMATED                      2010-12-22   \n",
       "2                    ESTIMATED                      2010-12-22   \n",
       "3                    ESTIMATED                      2010-12-22   \n",
       "4                    ESTIMATED                      2010-12-22   \n",
       "\n",
       "  results_first_posted_date results_first_posted_date_type  \\\n",
       "0                2011-01-20                      ESTIMATED   \n",
       "1                2011-01-20                      ESTIMATED   \n",
       "2                2011-01-20                      ESTIMATED   \n",
       "3                2011-01-20                      ESTIMATED   \n",
       "4                2011-01-20                      ESTIMATED   \n",
       "\n",
       "  disposition_first_submitted_qc_date disposition_first_posted_date  \\\n",
       "0                                 NaN                           NaN   \n",
       "1                                 NaN                           NaN   \n",
       "2                                 NaN                           NaN   \n",
       "3                                 NaN                           NaN   \n",
       "4                                 NaN                           NaN   \n",
       "\n",
       "  disposition_first_posted_date_type last_update_submitted_qc_date  \\\n",
       "0                                NaN                    2021-02-08   \n",
       "1                                NaN                    2021-02-08   \n",
       "2                                NaN                    2021-02-08   \n",
       "3                                NaN                    2021-02-08   \n",
       "4                                NaN                    2021-02-08   \n",
       "\n",
       "  last_update_posted_date last_update_posted_date_type start_month_year  \\\n",
       "0              2021-03-05                       ACTUAL          2008-01   \n",
       "1              2021-03-05                       ACTUAL          2008-01   \n",
       "2              2021-03-05                       ACTUAL          2008-01   \n",
       "3              2021-03-05                       ACTUAL          2008-01   \n",
       "4              2021-03-05                       ACTUAL          2008-01   \n",
       "\n",
       "  start_date_type start_date verification_month_year verification_date  \\\n",
       "0             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "1             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "2             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "3             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "4             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "\n",
       "  completion_month_year completion_date_type completion_date  \\\n",
       "0            2010-06-24               ACTUAL      2010-06-24   \n",
       "1            2010-06-24               ACTUAL      2010-06-24   \n",
       "2            2010-06-24               ACTUAL      2010-06-24   \n",
       "3            2010-06-24               ACTUAL      2010-06-24   \n",
       "4            2010-06-24               ACTUAL      2010-06-24   \n",
       "\n",
       "  primary_completion_month_year primary_completion_date_type  \\\n",
       "0                    2010-06-24                       ACTUAL   \n",
       "1                    2010-06-24                       ACTUAL   \n",
       "2                    2010-06-24                       ACTUAL   \n",
       "3                    2010-06-24                       ACTUAL   \n",
       "4                    2010-06-24                       ACTUAL   \n",
       "\n",
       "  primary_completion_date  target_duration      study_type acronym  \\\n",
       "0              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "1              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "2              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "3              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "4              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "\n",
       "  baseline_population                                        brief_title  \\\n",
       "0                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "1                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "2                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "3                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "4                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "\n",
       "                                      official_title overall_status  \\\n",
       "0  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "1  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "2  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "3  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "4  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "\n",
       "   last_known_status   phase  enrollment enrollment_type  \\\n",
       "0                NaN  PHASE2       201.0          ACTUAL   \n",
       "1                NaN  PHASE2       201.0          ACTUAL   \n",
       "2                NaN  PHASE2       201.0          ACTUAL   \n",
       "3                NaN  PHASE2       201.0          ACTUAL   \n",
       "4                NaN  PHASE2       201.0          ACTUAL   \n",
       "\n",
       "                          source  \\\n",
       "0  Spectrum Pharmaceuticals, Inc   \n",
       "1  Spectrum Pharmaceuticals, Inc   \n",
       "2  Spectrum Pharmaceuticals, Inc   \n",
       "3  Spectrum Pharmaceuticals, Inc   \n",
       "4  Spectrum Pharmaceuticals, Inc   \n",
       "\n",
       "                             limitations_and_caveats  number_of_arms  \\\n",
       "0  The date of the CRF database cut-off for patie...             2.0   \n",
       "1  The date of the CRF database cut-off for patie...             2.0   \n",
       "2  The date of the CRF database cut-off for patie...             2.0   \n",
       "3  The date of the CRF database cut-off for patie...             2.0   \n",
       "4  The date of the CRF database cut-off for patie...             2.0   \n",
       "\n",
       "   number_of_groups why_stopped has_expanded_access  \\\n",
       "0               NaN         NaN                   f   \n",
       "1               NaN         NaN                   f   \n",
       "2               NaN         NaN                   f   \n",
       "3               NaN         NaN                   f   \n",
       "4               NaN         NaN                   f   \n",
       "\n",
       "   expanded_access_type_individual  expanded_access_type_intermediate  \\\n",
       "0                              NaN                                NaN   \n",
       "1                              NaN                                NaN   \n",
       "2                              NaN                                NaN   \n",
       "3                              NaN                                NaN   \n",
       "4                              NaN                                NaN   \n",
       "\n",
       "   expanded_access_type_treatment has_dmc is_fda_regulated_drug  \\\n",
       "0                             NaN     NaN                   NaN   \n",
       "1                             NaN     NaN                   NaN   \n",
       "2                             NaN     NaN                   NaN   \n",
       "3                             NaN     NaN                   NaN   \n",
       "4                             NaN     NaN                   NaN   \n",
       "\n",
       "  is_fda_regulated_device is_unapproved_device  is_ppsd is_us_export  \\\n",
       "0                     NaN                  NaN      NaN          NaN   \n",
       "1                     NaN                  NaN      NaN          NaN   \n",
       "2                     NaN                  NaN      NaN          NaN   \n",
       "3                     NaN                  NaN      NaN          NaN   \n",
       "4                     NaN                  NaN      NaN          NaN   \n",
       "\n",
       "   biospec_retention  biospec_description ipd_time_frame ipd_access_criteria  \\\n",
       "0                NaN                  NaN            NaN                 NaN   \n",
       "1                NaN                  NaN            NaN                 NaN   \n",
       "2                NaN                  NaN            NaN                 NaN   \n",
       "3                NaN                  NaN            NaN                 NaN   \n",
       "4                NaN                  NaN            NaN                 NaN   \n",
       "\n",
       "  ipd_url plan_to_share_ipd plan_to_share_ipd_description  \\\n",
       "0     NaN               NaN                           NaN   \n",
       "1     NaN               NaN                           NaN   \n",
       "2     NaN               NaN                           NaN   \n",
       "3     NaN               NaN                           NaN   \n",
       "4     NaN               NaN                           NaN   \n",
       "\n",
       "                   created_at                  updated_at source_class  \\\n",
       "0  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "1  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "2  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "3  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "4  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "\n",
       "   delayed_posting expanded_access_nctid expanded_access_status_for_nctid  \\\n",
       "0              NaN                   NaN                              NaN   \n",
       "1              NaN                   NaN                              NaN   \n",
       "2              NaN                   NaN                              NaN   \n",
       "3              NaN                   NaN                              NaN   \n",
       "4              NaN                   NaN                              NaN   \n",
       "\n",
       "   fdaaa801_violation  baseline_type_units_analyzed  patient_registry  \\\n",
       "0                 NaN                           NaN               NaN   \n",
       "1                 NaN                           NaN               NaN   \n",
       "2                 NaN                           NaN               NaN   \n",
       "3                 NaN                           NaN               NaN   \n",
       "4                 NaN                           NaN               NaN   \n",
       "\n",
       "  drug_outcome          disease_type new_therapy_area      id_x  \\\n",
       "0      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "1      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "2      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "3      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "4      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "\n",
       "   number_of_facilities  number_of_nsae_subjects  number_of_sae_subjects  \\\n",
       "0                  47.0                    540.0                   124.0   \n",
       "1                  47.0                    540.0                   124.0   \n",
       "2                  47.0                    540.0                   124.0   \n",
       "3                  47.0                    540.0                   124.0   \n",
       "4                  47.0                    540.0                   124.0   \n",
       "\n",
       "   registered_in_calendar_year  nlm_download_date  actual_duration  \\\n",
       "0                         2008                NaN             29.0   \n",
       "1                         2008                NaN             29.0   \n",
       "2                         2008                NaN             29.0   \n",
       "3                         2008                NaN             29.0   \n",
       "4                         2008                NaN             29.0   \n",
       "\n",
       "  were_results_reported  months_to_report_results has_us_facility  \\\n",
       "0                     t                       6.0               t   \n",
       "1                     t                       6.0               t   \n",
       "2                     t                       6.0               t   \n",
       "3                     t                       6.0               t   \n",
       "4                     t                       6.0               t   \n",
       "\n",
       "  has_single_facility  minimum_age_num  maximum_age_num minimum_age_unit  \\\n",
       "0                   f             18.0              NaN            Years   \n",
       "1                   f             18.0              NaN            Years   \n",
       "2                   f             18.0              NaN            Years   \n",
       "3                   f             18.0              NaN            Years   \n",
       "4                   f             18.0              NaN            Years   \n",
       "\n",
       "  maximum_age_unit  number_of_primary_outcomes_to_measure  \\\n",
       "0              NaN                                    1.0   \n",
       "1              NaN                                    1.0   \n",
       "2              NaN                                    1.0   \n",
       "3              NaN                                    1.0   \n",
       "4              NaN                                    1.0   \n",
       "\n",
       "   number_of_secondary_outcomes_to_measure  \\\n",
       "0                                      3.0   \n",
       "1                                      3.0   \n",
       "2                                      3.0   \n",
       "3                                      3.0   \n",
       "4                                      3.0   \n",
       "\n",
       "   number_of_other_outcomes_to_measure     id_y sampling_method gender  \\\n",
       "0                                  NaN  7316876             NaN    ALL   \n",
       "1                                  NaN  7316876             NaN    ALL   \n",
       "2                                  NaN  7316876             NaN    ALL   \n",
       "3                                  NaN  7316876             NaN    ALL   \n",
       "4                                  NaN  7316876             NaN    ALL   \n",
       "\n",
       "  minimum_age maximum_age healthy_volunteers population  \\\n",
       "0    18 Years         NaN                  f        NaN   \n",
       "1    18 Years         NaN                  f        NaN   \n",
       "2    18 Years         NaN                  f        NaN   \n",
       "3    18 Years         NaN                  f        NaN   \n",
       "4    18 Years         NaN                  f        NaN   \n",
       "\n",
       "                                            criteria gender_description  \\\n",
       "0  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "1  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "2  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "3  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "4  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "\n",
       "  gender_based adult child older_adult   official_role        official_name  \\\n",
       "0          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "1          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "2          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "3          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "4          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "\n",
       "            official_affiliation        id   trial_country country_removed  \\\n",
       "0  Spectrum Pharmaceuticals, Inc  10138299  Czech Republic               t   \n",
       "1  Spectrum Pharmaceuticals, Inc  10138896   United States               f   \n",
       "2  Spectrum Pharmaceuticals, Inc  10138897       Argentina               f   \n",
       "3  Spectrum Pharmaceuticals, Inc  10138898          Brazil               f   \n",
       "4  Spectrum Pharmaceuticals, Inc  10138899         Czechia               f   \n",
       "\n",
       "   LLM_GBT_4o_Human_Importance_Ratings  \n",
       "0                                  1.0  \n",
       "1                                  1.0  \n",
       "2                                  1.0  \n",
       "3                                  1.0  \n",
       "4                                  1.0  "
      ]
     },
     "execution_count": 163,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# merge llm_features with main df\n",
    "merged_df_1123 = pd.merge(merged_df_1123, LLM_GBT_4o_Human_Importance_Ratings, on=['Drug Name','conditions','nct_id'], how=\"left\")\n",
    "merged_df_1123.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 164,
   "id": "7581fb37",
   "metadata": {},
   "outputs": [],
   "source": [
    "# replace NaN values in LLama3_2_Criteria_Robustness with 0\n",
    "merged_df_1123['LLM_GBT_4o_Human_Importance_Ratings'] = merged_df_1123['LLM_GBT_4o_Human_Importance_Ratings'].fillna(0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 172,
   "id": "d7b0547c",
   "metadata": {},
   "outputs": [],
   "source": [
    "# group by nct_id, drug_name and conditions\n",
    "Spacy_Pregnant_Women_Excluded = df_llm_features.groupby(['Drug Name','nct_id','conditions'])['Spacy Pregnant Women Excluded'].max().reset_index(name='Spacy_Pregnant_Women_Excluded')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 173,
   "id": "b13da811",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nct_id</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>description</th>\n",
       "      <th>trial_drug_cleaned</th>\n",
       "      <th>conditions</th>\n",
       "      <th>Drug Name</th>\n",
       "      <th>Highest Status</th>\n",
       "      <th>Other Drug Names</th>\n",
       "      <th>Originator Company</th>\n",
       "      <th>Originator Company HQ</th>\n",
       "      <th>Active Companies</th>\n",
       "      <th>Active Companies HQ</th>\n",
       "      <th>Therapy Area</th>\n",
       "      <th>Active Indications</th>\n",
       "      <th>Action</th>\n",
       "      <th>Technologies</th>\n",
       "      <th>Regulatory Designations</th>\n",
       "      <th>Inactive Indications</th>\n",
       "      <th>Inactive Companies</th>\n",
       "      <th>Has Deals</th>\n",
       "      <th>Last Change Date</th>\n",
       "      <th>Added Date</th>\n",
       "      <th>First Launched Date</th>\n",
       "      <th>Extract</th>\n",
       "      <th>Drug Id</th>\n",
       "      <th>cortellis_cleaned_drug</th>\n",
       "      <th>nlm_download_date_description</th>\n",
       "      <th>study_first_submitted_date</th>\n",
       "      <th>results_first_submitted_date</th>\n",
       "      <th>disposition_first_submitted_date</th>\n",
       "      <th>last_update_submitted_date</th>\n",
       "      <th>study_first_submitted_qc_date</th>\n",
       "      <th>study_first_posted_date</th>\n",
       "      <th>study_first_posted_date_type</th>\n",
       "      <th>results_first_submitted_qc_date</th>\n",
       "      <th>results_first_posted_date</th>\n",
       "      <th>results_first_posted_date_type</th>\n",
       "      <th>disposition_first_submitted_qc_date</th>\n",
       "      <th>disposition_first_posted_date</th>\n",
       "      <th>disposition_first_posted_date_type</th>\n",
       "      <th>last_update_submitted_qc_date</th>\n",
       "      <th>last_update_posted_date</th>\n",
       "      <th>last_update_posted_date_type</th>\n",
       "      <th>start_month_year</th>\n",
       "      <th>start_date_type</th>\n",
       "      <th>start_date</th>\n",
       "      <th>verification_month_year</th>\n",
       "      <th>verification_date</th>\n",
       "      <th>completion_month_year</th>\n",
       "      <th>completion_date_type</th>\n",
       "      <th>completion_date</th>\n",
       "      <th>primary_completion_month_year</th>\n",
       "      <th>primary_completion_date_type</th>\n",
       "      <th>primary_completion_date</th>\n",
       "      <th>target_duration</th>\n",
       "      <th>study_type</th>\n",
       "      <th>acronym</th>\n",
       "      <th>baseline_population</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>official_title</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>last_known_status</th>\n",
       "      <th>phase</th>\n",
       "      <th>enrollment</th>\n",
       "      <th>enrollment_type</th>\n",
       "      <th>source</th>\n",
       "      <th>limitations_and_caveats</th>\n",
       "      <th>number_of_arms</th>\n",
       "      <th>number_of_groups</th>\n",
       "      <th>why_stopped</th>\n",
       "      <th>has_expanded_access</th>\n",
       "      <th>expanded_access_type_individual</th>\n",
       "      <th>expanded_access_type_intermediate</th>\n",
       "      <th>expanded_access_type_treatment</th>\n",
       "      <th>has_dmc</th>\n",
       "      <th>is_fda_regulated_drug</th>\n",
       "      <th>is_fda_regulated_device</th>\n",
       "      <th>is_unapproved_device</th>\n",
       "      <th>is_ppsd</th>\n",
       "      <th>is_us_export</th>\n",
       "      <th>biospec_retention</th>\n",
       "      <th>biospec_description</th>\n",
       "      <th>ipd_time_frame</th>\n",
       "      <th>ipd_access_criteria</th>\n",
       "      <th>ipd_url</th>\n",
       "      <th>plan_to_share_ipd</th>\n",
       "      <th>plan_to_share_ipd_description</th>\n",
       "      <th>created_at</th>\n",
       "      <th>updated_at</th>\n",
       "      <th>source_class</th>\n",
       "      <th>delayed_posting</th>\n",
       "      <th>expanded_access_nctid</th>\n",
       "      <th>expanded_access_status_for_nctid</th>\n",
       "      <th>fdaaa801_violation</th>\n",
       "      <th>baseline_type_units_analyzed</th>\n",
       "      <th>patient_registry</th>\n",
       "      <th>drug_outcome</th>\n",
       "      <th>disease_type</th>\n",
       "      <th>new_therapy_area</th>\n",
       "      <th>id_x</th>\n",
       "      <th>number_of_facilities</th>\n",
       "      <th>number_of_nsae_subjects</th>\n",
       "      <th>number_of_sae_subjects</th>\n",
       "      <th>registered_in_calendar_year</th>\n",
       "      <th>nlm_download_date</th>\n",
       "      <th>actual_duration</th>\n",
       "      <th>were_results_reported</th>\n",
       "      <th>months_to_report_results</th>\n",
       "      <th>has_us_facility</th>\n",
       "      <th>has_single_facility</th>\n",
       "      <th>minimum_age_num</th>\n",
       "      <th>maximum_age_num</th>\n",
       "      <th>minimum_age_unit</th>\n",
       "      <th>maximum_age_unit</th>\n",
       "      <th>number_of_primary_outcomes_to_measure</th>\n",
       "      <th>number_of_secondary_outcomes_to_measure</th>\n",
       "      <th>number_of_other_outcomes_to_measure</th>\n",
       "      <th>id_y</th>\n",
       "      <th>sampling_method</th>\n",
       "      <th>gender</th>\n",
       "      <th>minimum_age</th>\n",
       "      <th>maximum_age</th>\n",
       "      <th>healthy_volunteers</th>\n",
       "      <th>population</th>\n",
       "      <th>criteria</th>\n",
       "      <th>gender_description</th>\n",
       "      <th>gender_based</th>\n",
       "      <th>adult</th>\n",
       "      <th>child</th>\n",
       "      <th>older_adult</th>\n",
       "      <th>official_role</th>\n",
       "      <th>official_name</th>\n",
       "      <th>official_affiliation</th>\n",
       "      <th>id</th>\n",
       "      <th>trial_country</th>\n",
       "      <th>country_removed</th>\n",
       "      <th>LLM_GBT_4o_Human_Importance_Ratings</th>\n",
       "      <th>LLama3_2_Criteria_Robustness</th>\n",
       "      <th>Spacy_Pregnant_Women_Excluded</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138299</td>\n",
       "      <td>Czech Republic</td>\n",
       "      <td>t</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138896</td>\n",
       "      <td>United States</td>\n",
       "      <td>f</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138897</td>\n",
       "      <td>Argentina</td>\n",
       "      <td>f</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138898</td>\n",
       "      <td>Brazil</td>\n",
       "      <td>f</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138899</td>\n",
       "      <td>Czechia</td>\n",
       "      <td>f</td>\n",
       "      <td>1.0</td>\n",
       "      <td>2.0</td>\n",
       "      <td>1.0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        nct_id intervention_type  \\\n",
       "0  NCT00606502              DRUG   \n",
       "1  NCT00606502              DRUG   \n",
       "2  NCT00606502              DRUG   \n",
       "3  NCT00606502              DRUG   \n",
       "4  NCT00606502              DRUG   \n",
       "\n",
       "                                         description trial_drug_cleaned  \\\n",
       "0  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "1  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "2  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "3  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "4  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "\n",
       "                   conditions  Drug Name Highest Status  \\\n",
       "0  non-small cell lung cancer  erlotinib       Launched   \n",
       "1  non-small cell lung cancer  erlotinib       Launched   \n",
       "2  non-small cell lung cancer  erlotinib       Launched   \n",
       "3  non-small cell lung cancer  erlotinib       Launched   \n",
       "4  non-small cell lung cancer  erlotinib       Launched   \n",
       "\n",
       "                                    Other Drug Names       Originator Company  \\\n",
       "0  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "1  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "2  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "3  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "4  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "\n",
       "          Originator Company HQ  \\\n",
       "0  OSI Pharmaceuticals Inc (US)   \n",
       "1  OSI Pharmaceuticals Inc (US)   \n",
       "2  OSI Pharmaceuticals Inc (US)   \n",
       "3  OSI Pharmaceuticals Inc (US)   \n",
       "4  OSI Pharmaceuticals Inc (US)   \n",
       "\n",
       "                                    Active Companies  \\\n",
       "0  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "1  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "2  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "3  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "4  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "\n",
       "                                 Active Companies HQ          Therapy Area  \\\n",
       "0  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "1  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "2  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "3  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "4  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "\n",
       "                                  Active Indications  \\\n",
       "0  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "1  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "2  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "3  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "4  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "\n",
       "                                              Action  \\\n",
       "0  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "1  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "2  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "3  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "4  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "\n",
       "                                        Technologies  Regulatory Designations  \\\n",
       "0  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "1  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "2  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "3  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "4  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "\n",
       "                                Inactive Indications  \\\n",
       "0  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "1  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "2  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "3  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "4  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "\n",
       "            Inactive Companies Has Deals Last Change Date  Added Date  \\\n",
       "0  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "1  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "2  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "3  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "4  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "\n",
       "  First Launched Date                                            Extract  \\\n",
       "0          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "1          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "2          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "3          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "4          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "\n",
       "   Drug Id cortellis_cleaned_drug  nlm_download_date_description  \\\n",
       "0    11961              erlotinib                            NaN   \n",
       "1    11961              erlotinib                            NaN   \n",
       "2    11961              erlotinib                            NaN   \n",
       "3    11961              erlotinib                            NaN   \n",
       "4    11961              erlotinib                            NaN   \n",
       "\n",
       "  study_first_submitted_date results_first_submitted_date  \\\n",
       "0                 2008-01-22                   2010-12-22   \n",
       "1                 2008-01-22                   2010-12-22   \n",
       "2                 2008-01-22                   2010-12-22   \n",
       "3                 2008-01-22                   2010-12-22   \n",
       "4                 2008-01-22                   2010-12-22   \n",
       "\n",
       "  disposition_first_submitted_date last_update_submitted_date  \\\n",
       "0                              NaN                 2021-02-08   \n",
       "1                              NaN                 2021-02-08   \n",
       "2                              NaN                 2021-02-08   \n",
       "3                              NaN                 2021-02-08   \n",
       "4                              NaN                 2021-02-08   \n",
       "\n",
       "  study_first_submitted_qc_date study_first_posted_date  \\\n",
       "0                    2008-02-01              2008-02-04   \n",
       "1                    2008-02-01              2008-02-04   \n",
       "2                    2008-02-01              2008-02-04   \n",
       "3                    2008-02-01              2008-02-04   \n",
       "4                    2008-02-01              2008-02-04   \n",
       "\n",
       "  study_first_posted_date_type results_first_submitted_qc_date  \\\n",
       "0                    ESTIMATED                      2010-12-22   \n",
       "1                    ESTIMATED                      2010-12-22   \n",
       "2                    ESTIMATED                      2010-12-22   \n",
       "3                    ESTIMATED                      2010-12-22   \n",
       "4                    ESTIMATED                      2010-12-22   \n",
       "\n",
       "  results_first_posted_date results_first_posted_date_type  \\\n",
       "0                2011-01-20                      ESTIMATED   \n",
       "1                2011-01-20                      ESTIMATED   \n",
       "2                2011-01-20                      ESTIMATED   \n",
       "3                2011-01-20                      ESTIMATED   \n",
       "4                2011-01-20                      ESTIMATED   \n",
       "\n",
       "  disposition_first_submitted_qc_date disposition_first_posted_date  \\\n",
       "0                                 NaN                           NaN   \n",
       "1                                 NaN                           NaN   \n",
       "2                                 NaN                           NaN   \n",
       "3                                 NaN                           NaN   \n",
       "4                                 NaN                           NaN   \n",
       "\n",
       "  disposition_first_posted_date_type last_update_submitted_qc_date  \\\n",
       "0                                NaN                    2021-02-08   \n",
       "1                                NaN                    2021-02-08   \n",
       "2                                NaN                    2021-02-08   \n",
       "3                                NaN                    2021-02-08   \n",
       "4                                NaN                    2021-02-08   \n",
       "\n",
       "  last_update_posted_date last_update_posted_date_type start_month_year  \\\n",
       "0              2021-03-05                       ACTUAL          2008-01   \n",
       "1              2021-03-05                       ACTUAL          2008-01   \n",
       "2              2021-03-05                       ACTUAL          2008-01   \n",
       "3              2021-03-05                       ACTUAL          2008-01   \n",
       "4              2021-03-05                       ACTUAL          2008-01   \n",
       "\n",
       "  start_date_type start_date verification_month_year verification_date  \\\n",
       "0             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "1             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "2             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "3             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "4             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "\n",
       "  completion_month_year completion_date_type completion_date  \\\n",
       "0            2010-06-24               ACTUAL      2010-06-24   \n",
       "1            2010-06-24               ACTUAL      2010-06-24   \n",
       "2            2010-06-24               ACTUAL      2010-06-24   \n",
       "3            2010-06-24               ACTUAL      2010-06-24   \n",
       "4            2010-06-24               ACTUAL      2010-06-24   \n",
       "\n",
       "  primary_completion_month_year primary_completion_date_type  \\\n",
       "0                    2010-06-24                       ACTUAL   \n",
       "1                    2010-06-24                       ACTUAL   \n",
       "2                    2010-06-24                       ACTUAL   \n",
       "3                    2010-06-24                       ACTUAL   \n",
       "4                    2010-06-24                       ACTUAL   \n",
       "\n",
       "  primary_completion_date  target_duration      study_type acronym  \\\n",
       "0              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "1              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "2              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "3              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "4              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "\n",
       "  baseline_population                                        brief_title  \\\n",
       "0                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "1                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "2                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "3                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "4                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "\n",
       "                                      official_title overall_status  \\\n",
       "0  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "1  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "2  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "3  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "4  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "\n",
       "   last_known_status   phase  enrollment enrollment_type  \\\n",
       "0                NaN  PHASE2       201.0          ACTUAL   \n",
       "1                NaN  PHASE2       201.0          ACTUAL   \n",
       "2                NaN  PHASE2       201.0          ACTUAL   \n",
       "3                NaN  PHASE2       201.0          ACTUAL   \n",
       "4                NaN  PHASE2       201.0          ACTUAL   \n",
       "\n",
       "                          source  \\\n",
       "0  Spectrum Pharmaceuticals, Inc   \n",
       "1  Spectrum Pharmaceuticals, Inc   \n",
       "2  Spectrum Pharmaceuticals, Inc   \n",
       "3  Spectrum Pharmaceuticals, Inc   \n",
       "4  Spectrum Pharmaceuticals, Inc   \n",
       "\n",
       "                             limitations_and_caveats  number_of_arms  \\\n",
       "0  The date of the CRF database cut-off for patie...             2.0   \n",
       "1  The date of the CRF database cut-off for patie...             2.0   \n",
       "2  The date of the CRF database cut-off for patie...             2.0   \n",
       "3  The date of the CRF database cut-off for patie...             2.0   \n",
       "4  The date of the CRF database cut-off for patie...             2.0   \n",
       "\n",
       "   number_of_groups why_stopped has_expanded_access  \\\n",
       "0               NaN         NaN                   f   \n",
       "1               NaN         NaN                   f   \n",
       "2               NaN         NaN                   f   \n",
       "3               NaN         NaN                   f   \n",
       "4               NaN         NaN                   f   \n",
       "\n",
       "   expanded_access_type_individual  expanded_access_type_intermediate  \\\n",
       "0                              NaN                                NaN   \n",
       "1                              NaN                                NaN   \n",
       "2                              NaN                                NaN   \n",
       "3                              NaN                                NaN   \n",
       "4                              NaN                                NaN   \n",
       "\n",
       "   expanded_access_type_treatment has_dmc is_fda_regulated_drug  \\\n",
       "0                             NaN     NaN                   NaN   \n",
       "1                             NaN     NaN                   NaN   \n",
       "2                             NaN     NaN                   NaN   \n",
       "3                             NaN     NaN                   NaN   \n",
       "4                             NaN     NaN                   NaN   \n",
       "\n",
       "  is_fda_regulated_device is_unapproved_device  is_ppsd is_us_export  \\\n",
       "0                     NaN                  NaN      NaN          NaN   \n",
       "1                     NaN                  NaN      NaN          NaN   \n",
       "2                     NaN                  NaN      NaN          NaN   \n",
       "3                     NaN                  NaN      NaN          NaN   \n",
       "4                     NaN                  NaN      NaN          NaN   \n",
       "\n",
       "   biospec_retention  biospec_description ipd_time_frame ipd_access_criteria  \\\n",
       "0                NaN                  NaN            NaN                 NaN   \n",
       "1                NaN                  NaN            NaN                 NaN   \n",
       "2                NaN                  NaN            NaN                 NaN   \n",
       "3                NaN                  NaN            NaN                 NaN   \n",
       "4                NaN                  NaN            NaN                 NaN   \n",
       "\n",
       "  ipd_url plan_to_share_ipd plan_to_share_ipd_description  \\\n",
       "0     NaN               NaN                           NaN   \n",
       "1     NaN               NaN                           NaN   \n",
       "2     NaN               NaN                           NaN   \n",
       "3     NaN               NaN                           NaN   \n",
       "4     NaN               NaN                           NaN   \n",
       "\n",
       "                   created_at                  updated_at source_class  \\\n",
       "0  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "1  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "2  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "3  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "4  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "\n",
       "   delayed_posting expanded_access_nctid expanded_access_status_for_nctid  \\\n",
       "0              NaN                   NaN                              NaN   \n",
       "1              NaN                   NaN                              NaN   \n",
       "2              NaN                   NaN                              NaN   \n",
       "3              NaN                   NaN                              NaN   \n",
       "4              NaN                   NaN                              NaN   \n",
       "\n",
       "   fdaaa801_violation  baseline_type_units_analyzed  patient_registry  \\\n",
       "0                 NaN                           NaN               NaN   \n",
       "1                 NaN                           NaN               NaN   \n",
       "2                 NaN                           NaN               NaN   \n",
       "3                 NaN                           NaN               NaN   \n",
       "4                 NaN                           NaN               NaN   \n",
       "\n",
       "  drug_outcome          disease_type new_therapy_area      id_x  \\\n",
       "0      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "1      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "2      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "3      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "4      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "\n",
       "   number_of_facilities  number_of_nsae_subjects  number_of_sae_subjects  \\\n",
       "0                  47.0                    540.0                   124.0   \n",
       "1                  47.0                    540.0                   124.0   \n",
       "2                  47.0                    540.0                   124.0   \n",
       "3                  47.0                    540.0                   124.0   \n",
       "4                  47.0                    540.0                   124.0   \n",
       "\n",
       "   registered_in_calendar_year  nlm_download_date  actual_duration  \\\n",
       "0                         2008                NaN             29.0   \n",
       "1                         2008                NaN             29.0   \n",
       "2                         2008                NaN             29.0   \n",
       "3                         2008                NaN             29.0   \n",
       "4                         2008                NaN             29.0   \n",
       "\n",
       "  were_results_reported  months_to_report_results has_us_facility  \\\n",
       "0                     t                       6.0               t   \n",
       "1                     t                       6.0               t   \n",
       "2                     t                       6.0               t   \n",
       "3                     t                       6.0               t   \n",
       "4                     t                       6.0               t   \n",
       "\n",
       "  has_single_facility  minimum_age_num  maximum_age_num minimum_age_unit  \\\n",
       "0                   f             18.0              NaN            Years   \n",
       "1                   f             18.0              NaN            Years   \n",
       "2                   f             18.0              NaN            Years   \n",
       "3                   f             18.0              NaN            Years   \n",
       "4                   f             18.0              NaN            Years   \n",
       "\n",
       "  maximum_age_unit  number_of_primary_outcomes_to_measure  \\\n",
       "0              NaN                                    1.0   \n",
       "1              NaN                                    1.0   \n",
       "2              NaN                                    1.0   \n",
       "3              NaN                                    1.0   \n",
       "4              NaN                                    1.0   \n",
       "\n",
       "   number_of_secondary_outcomes_to_measure  \\\n",
       "0                                      3.0   \n",
       "1                                      3.0   \n",
       "2                                      3.0   \n",
       "3                                      3.0   \n",
       "4                                      3.0   \n",
       "\n",
       "   number_of_other_outcomes_to_measure     id_y sampling_method gender  \\\n",
       "0                                  NaN  7316876             NaN    ALL   \n",
       "1                                  NaN  7316876             NaN    ALL   \n",
       "2                                  NaN  7316876             NaN    ALL   \n",
       "3                                  NaN  7316876             NaN    ALL   \n",
       "4                                  NaN  7316876             NaN    ALL   \n",
       "\n",
       "  minimum_age maximum_age healthy_volunteers population  \\\n",
       "0    18 Years         NaN                  f        NaN   \n",
       "1    18 Years         NaN                  f        NaN   \n",
       "2    18 Years         NaN                  f        NaN   \n",
       "3    18 Years         NaN                  f        NaN   \n",
       "4    18 Years         NaN                  f        NaN   \n",
       "\n",
       "                                            criteria gender_description  \\\n",
       "0  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "1  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "2  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "3  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "4  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "\n",
       "  gender_based adult child older_adult   official_role        official_name  \\\n",
       "0          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "1          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "2          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "3          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "4          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "\n",
       "            official_affiliation        id   trial_country country_removed  \\\n",
       "0  Spectrum Pharmaceuticals, Inc  10138299  Czech Republic               t   \n",
       "1  Spectrum Pharmaceuticals, Inc  10138896   United States               f   \n",
       "2  Spectrum Pharmaceuticals, Inc  10138897       Argentina               f   \n",
       "3  Spectrum Pharmaceuticals, Inc  10138898          Brazil               f   \n",
       "4  Spectrum Pharmaceuticals, Inc  10138899         Czechia               f   \n",
       "\n",
       "   LLM_GBT_4o_Human_Importance_Ratings  LLama3_2_Criteria_Robustness  \\\n",
       "0                                  1.0                           2.0   \n",
       "1                                  1.0                           2.0   \n",
       "2                                  1.0                           2.0   \n",
       "3                                  1.0                           2.0   \n",
       "4                                  1.0                           2.0   \n",
       "\n",
       "   Spacy_Pregnant_Women_Excluded  \n",
       "0                            1.0  \n",
       "1                            1.0  \n",
       "2                            1.0  \n",
       "3                            1.0  \n",
       "4                            1.0  "
      ]
     },
     "execution_count": 173,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# merge Spacy_Pregnant_Women_Excluded with main df\n",
    "merged_df_1123 = pd.merge(merged_df_1123, Spacy_Pregnant_Women_Excluded, on=['Drug Name','conditions','nct_id'], how=\"left\")\n",
    "merged_df_1123.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 174,
   "id": "c03b9c03",
   "metadata": {},
   "outputs": [],
   "source": [
    "# replace NaN values in Spacy_Pregnant_Women_Excluded with 0\n",
    "merged_df_1123['Spacy_Pregnant_Women_Excluded'] = merged_df_1123['Spacy_Pregnant_Women_Excluded'].fillna(0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 175,
   "id": "c7ae97f2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(24959, 137)"
      ]
     },
     "execution_count": 175,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "merged_df_1123_v2.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 176,
   "id": "b168ee02",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(24959, 139)"
      ]
     },
     "execution_count": 176,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "merged_df_1123.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 141,
   "id": "31dea78d",
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/tmp/ipykernel_139334/4105444768.py:2: DtypeWarning: Columns (22,23) have mixed types. Specify dtype option on import or set low_memory=False.\n",
      "  df_outcome_analyses = pd.read_csv('b3t0zvq5n6oyhvv9h6v8qsqg4j57/outcome_analyses.txt', sep='|')\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>nct_id</th>\n",
       "      <th>outcome_id</th>\n",
       "      <th>non_inferiority_type</th>\n",
       "      <th>non_inferiority_description</th>\n",
       "      <th>param_type</th>\n",
       "      <th>param_value</th>\n",
       "      <th>dispersion_type</th>\n",
       "      <th>dispersion_value</th>\n",
       "      <th>p_value_modifier</th>\n",
       "      <th>p_value</th>\n",
       "      <th>ci_n_sides</th>\n",
       "      <th>ci_percent</th>\n",
       "      <th>ci_lower_limit</th>\n",
       "      <th>ci_upper_limit</th>\n",
       "      <th>ci_upper_limit_na_comment</th>\n",
       "      <th>p_value_description</th>\n",
       "      <th>method</th>\n",
       "      <th>method_description</th>\n",
       "      <th>estimate_description</th>\n",
       "      <th>groups_description</th>\n",
       "      <th>other_analysis_description</th>\n",
       "      <th>ci_upper_limit_raw</th>\n",
       "      <th>ci_lower_limit_raw</th>\n",
       "      <th>p_value_raw</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>3926408</td>\n",
       "      <td>NCT00191152</td>\n",
       "      <td>7567777</td>\n",
       "      <td>SUPERIORITY_OR_OTHER</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.145</td>\n",
       "      <td>NaN</td>\n",
       "      <td>95.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Log Rank</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.145</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>3926409</td>\n",
       "      <td>NCT00191152</td>\n",
       "      <td>7567778</td>\n",
       "      <td>SUPERIORITY_OR_OTHER</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.361</td>\n",
       "      <td>NaN</td>\n",
       "      <td>95.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Log Rank</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.361</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3926410</td>\n",
       "      <td>NCT00191152</td>\n",
       "      <td>7567779</td>\n",
       "      <td>SUPERIORITY_OR_OTHER</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.145</td>\n",
       "      <td>NaN</td>\n",
       "      <td>95.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Log Rank</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.145</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3926411</td>\n",
       "      <td>NCT00191152</td>\n",
       "      <td>7567780</td>\n",
       "      <td>SUPERIORITY_OR_OTHER</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.385</td>\n",
       "      <td>NaN</td>\n",
       "      <td>95.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Log Rank</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.385</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>3926412</td>\n",
       "      <td>NCT00191152</td>\n",
       "      <td>7567781</td>\n",
       "      <td>SUPERIORITY_OR_OTHER</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.377</td>\n",
       "      <td>NaN</td>\n",
       "      <td>95.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Log Rank</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.377</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        id       nct_id  outcome_id  non_inferiority_type  \\\n",
       "0  3926408  NCT00191152     7567777  SUPERIORITY_OR_OTHER   \n",
       "1  3926409  NCT00191152     7567778  SUPERIORITY_OR_OTHER   \n",
       "2  3926410  NCT00191152     7567779  SUPERIORITY_OR_OTHER   \n",
       "3  3926411  NCT00191152     7567780  SUPERIORITY_OR_OTHER   \n",
       "4  3926412  NCT00191152     7567781  SUPERIORITY_OR_OTHER   \n",
       "\n",
       "  non_inferiority_description param_type  param_value dispersion_type  \\\n",
       "0                         NaN        NaN          NaN             NaN   \n",
       "1                         NaN        NaN          NaN             NaN   \n",
       "2                         NaN        NaN          NaN             NaN   \n",
       "3                         NaN        NaN          NaN             NaN   \n",
       "4                         NaN        NaN          NaN             NaN   \n",
       "\n",
       "   dispersion_value p_value_modifier  p_value ci_n_sides  ci_percent  \\\n",
       "0               NaN              NaN    0.145        NaN        95.0   \n",
       "1               NaN              NaN    0.361        NaN        95.0   \n",
       "2               NaN              NaN    0.145        NaN        95.0   \n",
       "3               NaN              NaN    0.385        NaN        95.0   \n",
       "4               NaN              NaN    0.377        NaN        95.0   \n",
       "\n",
       "   ci_lower_limit  ci_upper_limit ci_upper_limit_na_comment  \\\n",
       "0             NaN             NaN                       NaN   \n",
       "1             NaN             NaN                       NaN   \n",
       "2             NaN             NaN                       NaN   \n",
       "3             NaN             NaN                       NaN   \n",
       "4             NaN             NaN                       NaN   \n",
       "\n",
       "  p_value_description    method method_description estimate_description  \\\n",
       "0                 NaN  Log Rank                NaN                  NaN   \n",
       "1                 NaN  Log Rank                NaN                  NaN   \n",
       "2                 NaN  Log Rank                NaN                  NaN   \n",
       "3                 NaN  Log Rank                NaN                  NaN   \n",
       "4                 NaN  Log Rank                NaN                  NaN   \n",
       "\n",
       "  groups_description other_analysis_description ci_upper_limit_raw  \\\n",
       "0                NaN                        NaN                NaN   \n",
       "1                NaN                        NaN                NaN   \n",
       "2                NaN                        NaN                NaN   \n",
       "3                NaN                        NaN                NaN   \n",
       "4                NaN                        NaN                NaN   \n",
       "\n",
       "  ci_lower_limit_raw p_value_raw  \n",
       "0                NaN       0.145  \n",
       "1                NaN       0.361  \n",
       "2                NaN       0.145  \n",
       "3                NaN       0.385  \n",
       "4                NaN       0.377  "
      ]
     },
     "execution_count": 141,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# load outcome analyses table from AACT\n",
    "df_outcome_analyses = pd.read_csv('b3t0zvq5n6oyhvv9h6v8qsqg4j57/outcome_analyses.txt', sep='|')\n",
    "df_outcome_analyses.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 142,
   "id": "4b36657f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(274108, 25)"
      ]
     },
     "execution_count": 142,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_outcome_analyses.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 143,
   "id": "acddadfd",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "ci_lower_limit\n",
       "-1395694.00    1\n",
       "-855009.00     1\n",
       "-525369.24     1\n",
       "-439692.00     1\n",
       "-426928.00     1\n",
       "              ..\n",
       " 168364.92     1\n",
       " 179628.07     1\n",
       " 181313.34     1\n",
       " 194650.78     1\n",
       " 199264.32     1\n",
       "Name: param_value, Length: 25285, dtype: int64"
      ]
     },
     "execution_count": 143,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# check unique primary completion dates\n",
    "# pd.DataFrame(df_outcome_analyses['param_value','param_type'].unique()\n",
    "df_outcome_analyses.groupby('ci_lower_limit')['param_value'].nunique()             "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 144,
   "id": "42584a83",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>nct_id</th>\n",
       "      <th>outcome_id</th>\n",
       "      <th>non_inferiority_type</th>\n",
       "      <th>non_inferiority_description</th>\n",
       "      <th>param_type</th>\n",
       "      <th>param_value</th>\n",
       "      <th>dispersion_type</th>\n",
       "      <th>dispersion_value</th>\n",
       "      <th>p_value_modifier</th>\n",
       "      <th>p_value</th>\n",
       "      <th>ci_n_sides</th>\n",
       "      <th>ci_percent</th>\n",
       "      <th>ci_lower_limit</th>\n",
       "      <th>ci_upper_limit</th>\n",
       "      <th>ci_upper_limit_na_comment</th>\n",
       "      <th>p_value_description</th>\n",
       "      <th>method</th>\n",
       "      <th>method_description</th>\n",
       "      <th>estimate_description</th>\n",
       "      <th>groups_description</th>\n",
       "      <th>other_analysis_description</th>\n",
       "      <th>ci_upper_limit_raw</th>\n",
       "      <th>ci_lower_limit_raw</th>\n",
       "      <th>p_value_raw</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>61352</th>\n",
       "      <td>3989781</td>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>7687855</td>\n",
       "      <td>SUPERIORITY_OR_OTHER_LEGACY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cox Proportional Hazard</td>\n",
       "      <td>0.84</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TWO_SIDED</td>\n",
       "      <td>95.0</td>\n",
       "      <td>0.61</td>\n",
       "      <td>1.14</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.14</td>\n",
       "      <td>0.61</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "            id       nct_id  outcome_id         non_inferiority_type  \\\n",
       "61352  3989781  NCT00606502     7687855  SUPERIORITY_OR_OTHER_LEGACY   \n",
       "\n",
       "      non_inferiority_description               param_type  param_value  \\\n",
       "61352                         NaN  Cox Proportional Hazard         0.84   \n",
       "\n",
       "      dispersion_type  dispersion_value p_value_modifier  p_value ci_n_sides  \\\n",
       "61352             NaN               NaN              NaN      NaN  TWO_SIDED   \n",
       "\n",
       "       ci_percent  ci_lower_limit  ci_upper_limit ci_upper_limit_na_comment  \\\n",
       "61352        95.0            0.61            1.14                       NaN   \n",
       "\n",
       "      p_value_description method method_description estimate_description  \\\n",
       "61352                 NaN    NaN                NaN                  NaN   \n",
       "\n",
       "      groups_description other_analysis_description ci_upper_limit_raw  \\\n",
       "61352                NaN                        NaN               1.14   \n",
       "\n",
       "      ci_lower_limit_raw p_value_raw  \n",
       "61352               0.61         NaN  "
      ]
     },
     "execution_count": 144,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_outcome_analyses[df_outcome_analyses['nct_id'] == 'NCT00606502']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 145,
   "id": "9b7a913f",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/tmp/ipykernel_139334/1506904995.py:2: FutureWarning: Passing 'suffixes' which cause duplicate columns {'id_x'} in the result is deprecated and will raise a MergeError in a future version.\n",
      "  merged_df_1123_v2 = pd.merge(merged_df_1123, df_outcome_analyses, left_on=\"nct_id\", right_on=\"nct_id\", how=\"inner\")\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nct_id</th>\n",
       "      <th>intervention_type</th>\n",
       "      <th>description</th>\n",
       "      <th>trial_drug_cleaned</th>\n",
       "      <th>conditions</th>\n",
       "      <th>Drug Name</th>\n",
       "      <th>Highest Status</th>\n",
       "      <th>Other Drug Names</th>\n",
       "      <th>Originator Company</th>\n",
       "      <th>Originator Company HQ</th>\n",
       "      <th>Active Companies</th>\n",
       "      <th>Active Companies HQ</th>\n",
       "      <th>Therapy Area</th>\n",
       "      <th>Active Indications</th>\n",
       "      <th>Action</th>\n",
       "      <th>Technologies</th>\n",
       "      <th>Regulatory Designations</th>\n",
       "      <th>Inactive Indications</th>\n",
       "      <th>Inactive Companies</th>\n",
       "      <th>Has Deals</th>\n",
       "      <th>Last Change Date</th>\n",
       "      <th>Added Date</th>\n",
       "      <th>First Launched Date</th>\n",
       "      <th>Extract</th>\n",
       "      <th>Drug Id</th>\n",
       "      <th>cortellis_cleaned_drug</th>\n",
       "      <th>nlm_download_date_description</th>\n",
       "      <th>study_first_submitted_date</th>\n",
       "      <th>results_first_submitted_date</th>\n",
       "      <th>disposition_first_submitted_date</th>\n",
       "      <th>last_update_submitted_date</th>\n",
       "      <th>study_first_submitted_qc_date</th>\n",
       "      <th>study_first_posted_date</th>\n",
       "      <th>study_first_posted_date_type</th>\n",
       "      <th>results_first_submitted_qc_date</th>\n",
       "      <th>results_first_posted_date</th>\n",
       "      <th>results_first_posted_date_type</th>\n",
       "      <th>disposition_first_submitted_qc_date</th>\n",
       "      <th>disposition_first_posted_date</th>\n",
       "      <th>disposition_first_posted_date_type</th>\n",
       "      <th>last_update_submitted_qc_date</th>\n",
       "      <th>last_update_posted_date</th>\n",
       "      <th>last_update_posted_date_type</th>\n",
       "      <th>start_month_year</th>\n",
       "      <th>start_date_type</th>\n",
       "      <th>start_date</th>\n",
       "      <th>verification_month_year</th>\n",
       "      <th>verification_date</th>\n",
       "      <th>completion_month_year</th>\n",
       "      <th>completion_date_type</th>\n",
       "      <th>completion_date</th>\n",
       "      <th>primary_completion_month_year</th>\n",
       "      <th>primary_completion_date_type</th>\n",
       "      <th>primary_completion_date</th>\n",
       "      <th>target_duration</th>\n",
       "      <th>study_type</th>\n",
       "      <th>acronym</th>\n",
       "      <th>baseline_population</th>\n",
       "      <th>brief_title</th>\n",
       "      <th>official_title</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>last_known_status</th>\n",
       "      <th>phase</th>\n",
       "      <th>enrollment</th>\n",
       "      <th>enrollment_type</th>\n",
       "      <th>source</th>\n",
       "      <th>limitations_and_caveats</th>\n",
       "      <th>number_of_arms</th>\n",
       "      <th>number_of_groups</th>\n",
       "      <th>why_stopped</th>\n",
       "      <th>has_expanded_access</th>\n",
       "      <th>expanded_access_type_individual</th>\n",
       "      <th>expanded_access_type_intermediate</th>\n",
       "      <th>expanded_access_type_treatment</th>\n",
       "      <th>has_dmc</th>\n",
       "      <th>is_fda_regulated_drug</th>\n",
       "      <th>is_fda_regulated_device</th>\n",
       "      <th>is_unapproved_device</th>\n",
       "      <th>is_ppsd</th>\n",
       "      <th>is_us_export</th>\n",
       "      <th>biospec_retention</th>\n",
       "      <th>biospec_description</th>\n",
       "      <th>ipd_time_frame</th>\n",
       "      <th>ipd_access_criteria</th>\n",
       "      <th>ipd_url</th>\n",
       "      <th>plan_to_share_ipd</th>\n",
       "      <th>plan_to_share_ipd_description</th>\n",
       "      <th>created_at</th>\n",
       "      <th>updated_at</th>\n",
       "      <th>source_class</th>\n",
       "      <th>delayed_posting</th>\n",
       "      <th>expanded_access_nctid</th>\n",
       "      <th>expanded_access_status_for_nctid</th>\n",
       "      <th>fdaaa801_violation</th>\n",
       "      <th>baseline_type_units_analyzed</th>\n",
       "      <th>patient_registry</th>\n",
       "      <th>drug_outcome</th>\n",
       "      <th>disease_type</th>\n",
       "      <th>new_therapy_area</th>\n",
       "      <th>id_x</th>\n",
       "      <th>number_of_facilities</th>\n",
       "      <th>number_of_nsae_subjects</th>\n",
       "      <th>number_of_sae_subjects</th>\n",
       "      <th>registered_in_calendar_year</th>\n",
       "      <th>nlm_download_date</th>\n",
       "      <th>actual_duration</th>\n",
       "      <th>were_results_reported</th>\n",
       "      <th>months_to_report_results</th>\n",
       "      <th>has_us_facility</th>\n",
       "      <th>has_single_facility</th>\n",
       "      <th>minimum_age_num</th>\n",
       "      <th>maximum_age_num</th>\n",
       "      <th>minimum_age_unit</th>\n",
       "      <th>maximum_age_unit</th>\n",
       "      <th>number_of_primary_outcomes_to_measure</th>\n",
       "      <th>number_of_secondary_outcomes_to_measure</th>\n",
       "      <th>number_of_other_outcomes_to_measure</th>\n",
       "      <th>id_y</th>\n",
       "      <th>sampling_method</th>\n",
       "      <th>gender</th>\n",
       "      <th>minimum_age</th>\n",
       "      <th>maximum_age</th>\n",
       "      <th>healthy_volunteers</th>\n",
       "      <th>population</th>\n",
       "      <th>criteria</th>\n",
       "      <th>gender_description</th>\n",
       "      <th>gender_based</th>\n",
       "      <th>adult</th>\n",
       "      <th>child</th>\n",
       "      <th>older_adult</th>\n",
       "      <th>official_role</th>\n",
       "      <th>official_name</th>\n",
       "      <th>official_affiliation</th>\n",
       "      <th>id_x</th>\n",
       "      <th>trial_country</th>\n",
       "      <th>country_removed</th>\n",
       "      <th>id_y</th>\n",
       "      <th>outcome_id</th>\n",
       "      <th>non_inferiority_type</th>\n",
       "      <th>non_inferiority_description</th>\n",
       "      <th>param_type</th>\n",
       "      <th>param_value</th>\n",
       "      <th>dispersion_type</th>\n",
       "      <th>dispersion_value</th>\n",
       "      <th>p_value_modifier</th>\n",
       "      <th>p_value</th>\n",
       "      <th>ci_n_sides</th>\n",
       "      <th>ci_percent</th>\n",
       "      <th>ci_lower_limit</th>\n",
       "      <th>ci_upper_limit</th>\n",
       "      <th>ci_upper_limit_na_comment</th>\n",
       "      <th>p_value_description</th>\n",
       "      <th>method</th>\n",
       "      <th>method_description</th>\n",
       "      <th>estimate_description</th>\n",
       "      <th>groups_description</th>\n",
       "      <th>other_analysis_description</th>\n",
       "      <th>ci_upper_limit_raw</th>\n",
       "      <th>ci_lower_limit_raw</th>\n",
       "      <th>p_value_raw</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138299</td>\n",
       "      <td>Czech Republic</td>\n",
       "      <td>t</td>\n",
       "      <td>3989781</td>\n",
       "      <td>7687855</td>\n",
       "      <td>SUPERIORITY_OR_OTHER_LEGACY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cox Proportional Hazard</td>\n",
       "      <td>0.84</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TWO_SIDED</td>\n",
       "      <td>95.0</td>\n",
       "      <td>0.61</td>\n",
       "      <td>1.14</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.14</td>\n",
       "      <td>0.61</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138896</td>\n",
       "      <td>United States</td>\n",
       "      <td>f</td>\n",
       "      <td>3989781</td>\n",
       "      <td>7687855</td>\n",
       "      <td>SUPERIORITY_OR_OTHER_LEGACY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cox Proportional Hazard</td>\n",
       "      <td>0.84</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TWO_SIDED</td>\n",
       "      <td>95.0</td>\n",
       "      <td>0.61</td>\n",
       "      <td>1.14</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.14</td>\n",
       "      <td>0.61</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138897</td>\n",
       "      <td>Argentina</td>\n",
       "      <td>f</td>\n",
       "      <td>3989781</td>\n",
       "      <td>7687855</td>\n",
       "      <td>SUPERIORITY_OR_OTHER_LEGACY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cox Proportional Hazard</td>\n",
       "      <td>0.84</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TWO_SIDED</td>\n",
       "      <td>95.0</td>\n",
       "      <td>0.61</td>\n",
       "      <td>1.14</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.14</td>\n",
       "      <td>0.61</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138898</td>\n",
       "      <td>Brazil</td>\n",
       "      <td>f</td>\n",
       "      <td>3989781</td>\n",
       "      <td>7687855</td>\n",
       "      <td>SUPERIORITY_OR_OTHER_LEGACY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cox Proportional Hazard</td>\n",
       "      <td>0.84</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TWO_SIDED</td>\n",
       "      <td>95.0</td>\n",
       "      <td>0.61</td>\n",
       "      <td>1.14</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.14</td>\n",
       "      <td>0.61</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT00606502</td>\n",
       "      <td>DRUG</td>\n",
       "      <td>150 mg orally in tablet form~Administered dail...</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>non-small cell lung cancer</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>Launched</td>\n",
       "      <td>CP-358774; CP-358774-01; NSC-718781; OSI-420; ...</td>\n",
       "      <td>OSI Pharmaceuticals Inc</td>\n",
       "      <td>OSI Pharmaceuticals Inc (US)</td>\n",
       "      <td>Astellas Pharma Inc; Baheal Pharmaceutical gro...</td>\n",
       "      <td>Astellas Pharma Inc (Japan); Baheal Pharmaceut...</td>\n",
       "      <td>Cancer; Dermatologic</td>\n",
       "      <td>Acute myelogenous leukemia; Breast tumor; Cent...</td>\n",
       "      <td>Anticancer protein kinase inhibitor; EGFR fami...</td>\n",
       "      <td>Film coating; Oral formulation; Small molecule...</td>\n",
       "      <td>Fast Track; Orphan Drug</td>\n",
       "      <td>Cancer; Colorectal tumor; Ependymoma; Esophagu...</td>\n",
       "      <td>Nippon Roche KK; Pfizer Inc</td>\n",
       "      <td>Yes</td>\n",
       "      <td>2024-07-04</td>\n",
       "      <td>1996-03-28</td>\n",
       "      <td>2004-11-24</td>\n",
       "      <td>Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...</td>\n",
       "      <td>11961</td>\n",
       "      <td>erlotinib</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-22</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2008-02-01</td>\n",
       "      <td>2008-02-04</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>2010-12-22</td>\n",
       "      <td>2011-01-20</td>\n",
       "      <td>ESTIMATED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2021-02-08</td>\n",
       "      <td>2021-03-05</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2008-01</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2008-01-31</td>\n",
       "      <td>2021-02</td>\n",
       "      <td>2021-02-28</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>2010-06-24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Study of Pralatrexate vs. Erlotinib for Non-Sm...</td>\n",
       "      <td>A Randomized, Phase 2b, Multi-center Study of ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>201.0</td>\n",
       "      <td>ACTUAL</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>The date of the CRF database cut-off for patie...</td>\n",
       "      <td>2.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>2024-08-04 13:24:13.009685</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>success</td>\n",
       "      <td>Lung, Non-Small Cell</td>\n",
       "      <td>Oncology</td>\n",
       "      <td>29671336</td>\n",
       "      <td>47.0</td>\n",
       "      <td>540.0</td>\n",
       "      <td>124.0</td>\n",
       "      <td>2008</td>\n",
       "      <td>NaN</td>\n",
       "      <td>29.0</td>\n",
       "      <td>t</td>\n",
       "      <td>6.0</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>18.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.0</td>\n",
       "      <td>3.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7316876</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ALL</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>f</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Inclusion Criteria:~* Confirmed Stage IIIB/ IV...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>t</td>\n",
       "      <td>f</td>\n",
       "      <td>t</td>\n",
       "      <td>STUDY_DIRECTOR</td>\n",
       "      <td>Garry Weems, PharmD</td>\n",
       "      <td>Spectrum Pharmaceuticals, Inc</td>\n",
       "      <td>10138899</td>\n",
       "      <td>Czechia</td>\n",
       "      <td>f</td>\n",
       "      <td>3989781</td>\n",
       "      <td>7687855</td>\n",
       "      <td>SUPERIORITY_OR_OTHER_LEGACY</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Cox Proportional Hazard</td>\n",
       "      <td>0.84</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>TWO_SIDED</td>\n",
       "      <td>95.0</td>\n",
       "      <td>0.61</td>\n",
       "      <td>1.14</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.14</td>\n",
       "      <td>0.61</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        nct_id intervention_type  \\\n",
       "0  NCT00606502              DRUG   \n",
       "1  NCT00606502              DRUG   \n",
       "2  NCT00606502              DRUG   \n",
       "3  NCT00606502              DRUG   \n",
       "4  NCT00606502              DRUG   \n",
       "\n",
       "                                         description trial_drug_cleaned  \\\n",
       "0  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "1  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "2  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "3  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "4  150 mg orally in tablet form~Administered dail...          erlotinib   \n",
       "\n",
       "                   conditions  Drug Name Highest Status  \\\n",
       "0  non-small cell lung cancer  erlotinib       Launched   \n",
       "1  non-small cell lung cancer  erlotinib       Launched   \n",
       "2  non-small cell lung cancer  erlotinib       Launched   \n",
       "3  non-small cell lung cancer  erlotinib       Launched   \n",
       "4  non-small cell lung cancer  erlotinib       Launched   \n",
       "\n",
       "                                    Other Drug Names       Originator Company  \\\n",
       "0  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "1  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "2  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "3  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "4  CP-358774; CP-358774-01; NSC-718781; OSI-420; ...  OSI Pharmaceuticals Inc   \n",
       "\n",
       "          Originator Company HQ  \\\n",
       "0  OSI Pharmaceuticals Inc (US)   \n",
       "1  OSI Pharmaceuticals Inc (US)   \n",
       "2  OSI Pharmaceuticals Inc (US)   \n",
       "3  OSI Pharmaceuticals Inc (US)   \n",
       "4  OSI Pharmaceuticals Inc (US)   \n",
       "\n",
       "                                    Active Companies  \\\n",
       "0  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "1  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "2  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "3  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "4  Astellas Pharma Inc; Baheal Pharmaceutical gro...   \n",
       "\n",
       "                                 Active Companies HQ          Therapy Area  \\\n",
       "0  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "1  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "2  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "3  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "4  Astellas Pharma Inc (Japan); Baheal Pharmaceut...  Cancer; Dermatologic   \n",
       "\n",
       "                                  Active Indications  \\\n",
       "0  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "1  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "2  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "3  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "4  Acute myelogenous leukemia; Breast tumor; Cent...   \n",
       "\n",
       "                                              Action  \\\n",
       "0  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "1  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "2  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "3  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "4  Anticancer protein kinase inhibitor; EGFR fami...   \n",
       "\n",
       "                                        Technologies  Regulatory Designations  \\\n",
       "0  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "1  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "2  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "3  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "4  Film coating; Oral formulation; Small molecule...  Fast Track; Orphan Drug   \n",
       "\n",
       "                                Inactive Indications  \\\n",
       "0  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "1  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "2  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "3  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "4  Cancer; Colorectal tumor; Ependymoma; Esophagu...   \n",
       "\n",
       "            Inactive Companies Has Deals Last Change Date  Added Date  \\\n",
       "0  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "1  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "2  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "3  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "4  Nippon Roche KK; Pfizer Inc       Yes       2024-07-04  1996-03-28   \n",
       "\n",
       "  First Launched Date                                            Extract  \\\n",
       "0          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "1          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "2          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "3          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "4          2004-11-24  Erlotinib (Tarceva; OSI-744; CP-358774; NSC-71...   \n",
       "\n",
       "   Drug Id cortellis_cleaned_drug  nlm_download_date_description  \\\n",
       "0    11961              erlotinib                            NaN   \n",
       "1    11961              erlotinib                            NaN   \n",
       "2    11961              erlotinib                            NaN   \n",
       "3    11961              erlotinib                            NaN   \n",
       "4    11961              erlotinib                            NaN   \n",
       "\n",
       "  study_first_submitted_date results_first_submitted_date  \\\n",
       "0                 2008-01-22                   2010-12-22   \n",
       "1                 2008-01-22                   2010-12-22   \n",
       "2                 2008-01-22                   2010-12-22   \n",
       "3                 2008-01-22                   2010-12-22   \n",
       "4                 2008-01-22                   2010-12-22   \n",
       "\n",
       "  disposition_first_submitted_date last_update_submitted_date  \\\n",
       "0                              NaN                 2021-02-08   \n",
       "1                              NaN                 2021-02-08   \n",
       "2                              NaN                 2021-02-08   \n",
       "3                              NaN                 2021-02-08   \n",
       "4                              NaN                 2021-02-08   \n",
       "\n",
       "  study_first_submitted_qc_date study_first_posted_date  \\\n",
       "0                    2008-02-01              2008-02-04   \n",
       "1                    2008-02-01              2008-02-04   \n",
       "2                    2008-02-01              2008-02-04   \n",
       "3                    2008-02-01              2008-02-04   \n",
       "4                    2008-02-01              2008-02-04   \n",
       "\n",
       "  study_first_posted_date_type results_first_submitted_qc_date  \\\n",
       "0                    ESTIMATED                      2010-12-22   \n",
       "1                    ESTIMATED                      2010-12-22   \n",
       "2                    ESTIMATED                      2010-12-22   \n",
       "3                    ESTIMATED                      2010-12-22   \n",
       "4                    ESTIMATED                      2010-12-22   \n",
       "\n",
       "  results_first_posted_date results_first_posted_date_type  \\\n",
       "0                2011-01-20                      ESTIMATED   \n",
       "1                2011-01-20                      ESTIMATED   \n",
       "2                2011-01-20                      ESTIMATED   \n",
       "3                2011-01-20                      ESTIMATED   \n",
       "4                2011-01-20                      ESTIMATED   \n",
       "\n",
       "  disposition_first_submitted_qc_date disposition_first_posted_date  \\\n",
       "0                                 NaN                           NaN   \n",
       "1                                 NaN                           NaN   \n",
       "2                                 NaN                           NaN   \n",
       "3                                 NaN                           NaN   \n",
       "4                                 NaN                           NaN   \n",
       "\n",
       "  disposition_first_posted_date_type last_update_submitted_qc_date  \\\n",
       "0                                NaN                    2021-02-08   \n",
       "1                                NaN                    2021-02-08   \n",
       "2                                NaN                    2021-02-08   \n",
       "3                                NaN                    2021-02-08   \n",
       "4                                NaN                    2021-02-08   \n",
       "\n",
       "  last_update_posted_date last_update_posted_date_type start_month_year  \\\n",
       "0              2021-03-05                       ACTUAL          2008-01   \n",
       "1              2021-03-05                       ACTUAL          2008-01   \n",
       "2              2021-03-05                       ACTUAL          2008-01   \n",
       "3              2021-03-05                       ACTUAL          2008-01   \n",
       "4              2021-03-05                       ACTUAL          2008-01   \n",
       "\n",
       "  start_date_type start_date verification_month_year verification_date  \\\n",
       "0             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "1             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "2             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "3             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "4             NaN 2008-01-31                 2021-02        2021-02-28   \n",
       "\n",
       "  completion_month_year completion_date_type completion_date  \\\n",
       "0            2010-06-24               ACTUAL      2010-06-24   \n",
       "1            2010-06-24               ACTUAL      2010-06-24   \n",
       "2            2010-06-24               ACTUAL      2010-06-24   \n",
       "3            2010-06-24               ACTUAL      2010-06-24   \n",
       "4            2010-06-24               ACTUAL      2010-06-24   \n",
       "\n",
       "  primary_completion_month_year primary_completion_date_type  \\\n",
       "0                    2010-06-24                       ACTUAL   \n",
       "1                    2010-06-24                       ACTUAL   \n",
       "2                    2010-06-24                       ACTUAL   \n",
       "3                    2010-06-24                       ACTUAL   \n",
       "4                    2010-06-24                       ACTUAL   \n",
       "\n",
       "  primary_completion_date  target_duration      study_type acronym  \\\n",
       "0              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "1              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "2              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "3              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "4              2010-06-24              NaN  INTERVENTIONAL     NaN   \n",
       "\n",
       "  baseline_population                                        brief_title  \\\n",
       "0                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "1                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "2                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "3                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "4                 NaN  Study of Pralatrexate vs. Erlotinib for Non-Sm...   \n",
       "\n",
       "                                      official_title overall_status  \\\n",
       "0  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "1  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "2  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "3  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "4  A Randomized, Phase 2b, Multi-center Study of ...      COMPLETED   \n",
       "\n",
       "   last_known_status   phase  enrollment enrollment_type  \\\n",
       "0                NaN  PHASE2       201.0          ACTUAL   \n",
       "1                NaN  PHASE2       201.0          ACTUAL   \n",
       "2                NaN  PHASE2       201.0          ACTUAL   \n",
       "3                NaN  PHASE2       201.0          ACTUAL   \n",
       "4                NaN  PHASE2       201.0          ACTUAL   \n",
       "\n",
       "                          source  \\\n",
       "0  Spectrum Pharmaceuticals, Inc   \n",
       "1  Spectrum Pharmaceuticals, Inc   \n",
       "2  Spectrum Pharmaceuticals, Inc   \n",
       "3  Spectrum Pharmaceuticals, Inc   \n",
       "4  Spectrum Pharmaceuticals, Inc   \n",
       "\n",
       "                             limitations_and_caveats  number_of_arms  \\\n",
       "0  The date of the CRF database cut-off for patie...             2.0   \n",
       "1  The date of the CRF database cut-off for patie...             2.0   \n",
       "2  The date of the CRF database cut-off for patie...             2.0   \n",
       "3  The date of the CRF database cut-off for patie...             2.0   \n",
       "4  The date of the CRF database cut-off for patie...             2.0   \n",
       "\n",
       "   number_of_groups why_stopped has_expanded_access  \\\n",
       "0               NaN         NaN                   f   \n",
       "1               NaN         NaN                   f   \n",
       "2               NaN         NaN                   f   \n",
       "3               NaN         NaN                   f   \n",
       "4               NaN         NaN                   f   \n",
       "\n",
       "   expanded_access_type_individual  expanded_access_type_intermediate  \\\n",
       "0                              NaN                                NaN   \n",
       "1                              NaN                                NaN   \n",
       "2                              NaN                                NaN   \n",
       "3                              NaN                                NaN   \n",
       "4                              NaN                                NaN   \n",
       "\n",
       "   expanded_access_type_treatment has_dmc is_fda_regulated_drug  \\\n",
       "0                             NaN     NaN                   NaN   \n",
       "1                             NaN     NaN                   NaN   \n",
       "2                             NaN     NaN                   NaN   \n",
       "3                             NaN     NaN                   NaN   \n",
       "4                             NaN     NaN                   NaN   \n",
       "\n",
       "  is_fda_regulated_device is_unapproved_device  is_ppsd is_us_export  \\\n",
       "0                     NaN                  NaN      NaN          NaN   \n",
       "1                     NaN                  NaN      NaN          NaN   \n",
       "2                     NaN                  NaN      NaN          NaN   \n",
       "3                     NaN                  NaN      NaN          NaN   \n",
       "4                     NaN                  NaN      NaN          NaN   \n",
       "\n",
       "   biospec_retention  biospec_description ipd_time_frame ipd_access_criteria  \\\n",
       "0                NaN                  NaN            NaN                 NaN   \n",
       "1                NaN                  NaN            NaN                 NaN   \n",
       "2                NaN                  NaN            NaN                 NaN   \n",
       "3                NaN                  NaN            NaN                 NaN   \n",
       "4                NaN                  NaN            NaN                 NaN   \n",
       "\n",
       "  ipd_url plan_to_share_ipd plan_to_share_ipd_description  \\\n",
       "0     NaN               NaN                           NaN   \n",
       "1     NaN               NaN                           NaN   \n",
       "2     NaN               NaN                           NaN   \n",
       "3     NaN               NaN                           NaN   \n",
       "4     NaN               NaN                           NaN   \n",
       "\n",
       "                   created_at                  updated_at source_class  \\\n",
       "0  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "1  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "2  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "3  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "4  2024-08-04 13:24:13.009685  2024-08-04 13:24:13.009685     INDUSTRY   \n",
       "\n",
       "   delayed_posting expanded_access_nctid expanded_access_status_for_nctid  \\\n",
       "0              NaN                   NaN                              NaN   \n",
       "1              NaN                   NaN                              NaN   \n",
       "2              NaN                   NaN                              NaN   \n",
       "3              NaN                   NaN                              NaN   \n",
       "4              NaN                   NaN                              NaN   \n",
       "\n",
       "   fdaaa801_violation  baseline_type_units_analyzed  patient_registry  \\\n",
       "0                 NaN                           NaN               NaN   \n",
       "1                 NaN                           NaN               NaN   \n",
       "2                 NaN                           NaN               NaN   \n",
       "3                 NaN                           NaN               NaN   \n",
       "4                 NaN                           NaN               NaN   \n",
       "\n",
       "  drug_outcome          disease_type new_therapy_area      id_x  \\\n",
       "0      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "1      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "2      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "3      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "4      success  Lung, Non-Small Cell         Oncology  29671336   \n",
       "\n",
       "   number_of_facilities  number_of_nsae_subjects  number_of_sae_subjects  \\\n",
       "0                  47.0                    540.0                   124.0   \n",
       "1                  47.0                    540.0                   124.0   \n",
       "2                  47.0                    540.0                   124.0   \n",
       "3                  47.0                    540.0                   124.0   \n",
       "4                  47.0                    540.0                   124.0   \n",
       "\n",
       "   registered_in_calendar_year  nlm_download_date  actual_duration  \\\n",
       "0                         2008                NaN             29.0   \n",
       "1                         2008                NaN             29.0   \n",
       "2                         2008                NaN             29.0   \n",
       "3                         2008                NaN             29.0   \n",
       "4                         2008                NaN             29.0   \n",
       "\n",
       "  were_results_reported  months_to_report_results has_us_facility  \\\n",
       "0                     t                       6.0               t   \n",
       "1                     t                       6.0               t   \n",
       "2                     t                       6.0               t   \n",
       "3                     t                       6.0               t   \n",
       "4                     t                       6.0               t   \n",
       "\n",
       "  has_single_facility  minimum_age_num  maximum_age_num minimum_age_unit  \\\n",
       "0                   f             18.0              NaN            Years   \n",
       "1                   f             18.0              NaN            Years   \n",
       "2                   f             18.0              NaN            Years   \n",
       "3                   f             18.0              NaN            Years   \n",
       "4                   f             18.0              NaN            Years   \n",
       "\n",
       "  maximum_age_unit  number_of_primary_outcomes_to_measure  \\\n",
       "0              NaN                                    1.0   \n",
       "1              NaN                                    1.0   \n",
       "2              NaN                                    1.0   \n",
       "3              NaN                                    1.0   \n",
       "4              NaN                                    1.0   \n",
       "\n",
       "   number_of_secondary_outcomes_to_measure  \\\n",
       "0                                      3.0   \n",
       "1                                      3.0   \n",
       "2                                      3.0   \n",
       "3                                      3.0   \n",
       "4                                      3.0   \n",
       "\n",
       "   number_of_other_outcomes_to_measure     id_y sampling_method gender  \\\n",
       "0                                  NaN  7316876             NaN    ALL   \n",
       "1                                  NaN  7316876             NaN    ALL   \n",
       "2                                  NaN  7316876             NaN    ALL   \n",
       "3                                  NaN  7316876             NaN    ALL   \n",
       "4                                  NaN  7316876             NaN    ALL   \n",
       "\n",
       "  minimum_age maximum_age healthy_volunteers population  \\\n",
       "0    18 Years         NaN                  f        NaN   \n",
       "1    18 Years         NaN                  f        NaN   \n",
       "2    18 Years         NaN                  f        NaN   \n",
       "3    18 Years         NaN                  f        NaN   \n",
       "4    18 Years         NaN                  f        NaN   \n",
       "\n",
       "                                            criteria gender_description  \\\n",
       "0  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "1  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "2  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "3  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "4  Inclusion Criteria:~* Confirmed Stage IIIB/ IV...                NaN   \n",
       "\n",
       "  gender_based adult child older_adult   official_role        official_name  \\\n",
       "0          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "1          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "2          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "3          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "4          NaN     t     f           t  STUDY_DIRECTOR  Garry Weems, PharmD   \n",
       "\n",
       "            official_affiliation      id_x   trial_country country_removed  \\\n",
       "0  Spectrum Pharmaceuticals, Inc  10138299  Czech Republic               t   \n",
       "1  Spectrum Pharmaceuticals, Inc  10138896   United States               f   \n",
       "2  Spectrum Pharmaceuticals, Inc  10138897       Argentina               f   \n",
       "3  Spectrum Pharmaceuticals, Inc  10138898          Brazil               f   \n",
       "4  Spectrum Pharmaceuticals, Inc  10138899         Czechia               f   \n",
       "\n",
       "      id_y  outcome_id         non_inferiority_type  \\\n",
       "0  3989781     7687855  SUPERIORITY_OR_OTHER_LEGACY   \n",
       "1  3989781     7687855  SUPERIORITY_OR_OTHER_LEGACY   \n",
       "2  3989781     7687855  SUPERIORITY_OR_OTHER_LEGACY   \n",
       "3  3989781     7687855  SUPERIORITY_OR_OTHER_LEGACY   \n",
       "4  3989781     7687855  SUPERIORITY_OR_OTHER_LEGACY   \n",
       "\n",
       "  non_inferiority_description               param_type  param_value  \\\n",
       "0                         NaN  Cox Proportional Hazard         0.84   \n",
       "1                         NaN  Cox Proportional Hazard         0.84   \n",
       "2                         NaN  Cox Proportional Hazard         0.84   \n",
       "3                         NaN  Cox Proportional Hazard         0.84   \n",
       "4                         NaN  Cox Proportional Hazard         0.84   \n",
       "\n",
       "  dispersion_type  dispersion_value p_value_modifier  p_value ci_n_sides  \\\n",
       "0             NaN               NaN              NaN      NaN  TWO_SIDED   \n",
       "1             NaN               NaN              NaN      NaN  TWO_SIDED   \n",
       "2             NaN               NaN              NaN      NaN  TWO_SIDED   \n",
       "3             NaN               NaN              NaN      NaN  TWO_SIDED   \n",
       "4             NaN               NaN              NaN      NaN  TWO_SIDED   \n",
       "\n",
       "   ci_percent  ci_lower_limit  ci_upper_limit ci_upper_limit_na_comment  \\\n",
       "0        95.0            0.61            1.14                       NaN   \n",
       "1        95.0            0.61            1.14                       NaN   \n",
       "2        95.0            0.61            1.14                       NaN   \n",
       "3        95.0            0.61            1.14                       NaN   \n",
       "4        95.0            0.61            1.14                       NaN   \n",
       "\n",
       "  p_value_description method method_description estimate_description  \\\n",
       "0                 NaN    NaN                NaN                  NaN   \n",
       "1                 NaN    NaN                NaN                  NaN   \n",
       "2                 NaN    NaN                NaN                  NaN   \n",
       "3                 NaN    NaN                NaN                  NaN   \n",
       "4                 NaN    NaN                NaN                  NaN   \n",
       "\n",
       "  groups_description other_analysis_description ci_upper_limit_raw  \\\n",
       "0                NaN                        NaN               1.14   \n",
       "1                NaN                        NaN               1.14   \n",
       "2                NaN                        NaN               1.14   \n",
       "3                NaN                        NaN               1.14   \n",
       "4                NaN                        NaN               1.14   \n",
       "\n",
       "  ci_lower_limit_raw p_value_raw  \n",
       "0               0.61         NaN  \n",
       "1               0.61         NaN  \n",
       "2               0.61         NaN  \n",
       "3               0.61         NaN  \n",
       "4               0.61         NaN  "
      ]
     },
     "execution_count": 145,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# merge outcome analyses table with p2_p4 table\n",
    "merged_df_1123_v2 = pd.merge(merged_df_1123, df_outcome_analyses, left_on=\"nct_id\", right_on=\"nct_id\", how=\"inner\")\n",
    "merged_df_1123_v2.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 146,
   "id": "ce78ac06",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(203074, 160)"
      ]
     },
     "execution_count": 146,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "merged_df_1123_v2.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 177,
   "id": "2d991b99",
   "metadata": {},
   "outputs": [],
   "source": [
    "merged_df_1123.to_csv('nov_24/nov_23/merged_df_1123.txt', sep='|', index=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "83d510c8",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
